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ABSTRACT 
 
 Double-strand breaks and stalled forks arise when the replication machinery 
encounters damage from exogenous sources like DNA damaging agents or ionizing 
radiation, and require specific DNA helicases to resolve these structures. Sgs1 of 
Saccharomyces cerevisiae is a member of the RecQ family of DNA helicases and has a 
role in DNA repair and recombination. The RecQ family includes human genes BLM, 
WRN, RECQL4, RECQL1, and RECQL5. Mutations in BLM, WRN, and RECQL4 result 
in genetic disorders characterized by developmental abnormalities and a predisposition 
to cancer. All RecQ helicases have common features including a helicase domain, an 
RQC domain, and a HRDC domain. In order to elucidate the role of these domains and 
to identify additional regions in Sgs1 that are required for the maintenance of genome 
integrity, a series of systematic truncations to the C terminus of Sgs1 were created. We 
found that ablating the HRDC domain does not cause an increase in accumulating 
gross chromosomal rearrangements (GCRs). But deleting the RQC domain and leaving 
the helicase domain intact resulted in a rate similar to that of a helicase-defective 
mutant. Additionally, we exposed these truncation mutants to HU and MMS and 
demonstrated that losing up to 200 amino acids from the C terminus did not increase 
sensitivity to HU or MMS, whereas losing 300 amino acids or more led to sensitivity 
similar to that of an sgs1∆ cell. These results suggest that the RQC domain, believed to 
mediate protein-protein interactions and required for DNA recognition, is important for 
	 xvi 
Sgs1’s role in suppressing GCRs and sensitivity to HU and MMS, whereas the HRDC 
domain that is important for DNA binding is not necessary.  RecQL5 is a RecQ-like 
helicase that is distinct from the other members through its three different isoforms, 
RecQL5α, RecQL5β, and RecQL5ɣ. It has a helicase domain and an RQC domain, but 
lacks the HRDC domain that other RecQ-like helicases possess. In contrast to Blm, 
Wrn, and RecQL4, no human disorder has been associated with defects in RecQL5. For 
this reason the role of RecQL5 in the cell has remained largely unknown. To try to 
elucidate the pathways RecQL5 may be involved in we performed a yeast two hybrid to 
identify RecQL5-interacting proteins. We found that RecQL5 interacts with Hlp2, an 
ATP-dependent RNA helicase, and Ube2I, a SUMO-conjugating enzyme. These novel 
interactions shed light on a potential role of RecQL5 in the cell as a transcriptional 
regulator. 
 Saccharomyces cerevisiae, Rrm3, is a 5’-3’ DNA helicase that is part of the Pif1 
family of DNA helicases and is conserved from yeast to humans. It was initially 
discovered as a suppressor of recombination between tandem arrays and ribosomal 
DNA (rDNA) repeats. In its absence there are increased rates of extra-chromosomal 
rDNA circles, and cells accumulate X-shaped intermediates at stalled forks. Rrm3 may 
be involved in displacing DNA-protein blocks and unwinding DNA to facilitate fork 
progression. We used stable isotope labeling by amino acids in cell culture (SILAC)-
based quantitative mass spectrometry in order to determine proteins that deal with the 
stalled fork in the absence of Rrm3. We found that in the absence of Rrm3 and 
increased replication fork pausing, there is a requirement for the error-free DNA 
damage bypass factor Rad5 and the homologous recombination factor Rdh54 for fork 
	 xvii 
recovery. We also report a novel role for Rrm3 in controlling DNA synthesis upon 
exposure to replication stress and that this requirement is due to interaction with Orc5, a 
subunit of the origin recognition complex. Interaction of Orc5 was found to be located 
within a 26-residue region in the unstructured N-terminal tail of Rrm3 and loss of this 
interaction resulted in lethality with cells devoid of the replication checkpoint mediator 
Mrc1, and DNA damage sensitivity with cells lacking Tof1. In this study we describe two 
independent roles of Rrm3, a helicase-dependent role that requires Rad5 and Rdh54 for 
fork recovery, and a helicase-independent role that requires Orc5 interaction to control 
DNA synthesis.  
 Our data provides novel insight into the role of DNA helicases and their role in 
protecting the genome. Through yeast genetics it was possible to determine the 
importance of the C terminus of Sgs1 and elucidate new RecQL5 interacting partners 
that shed light onto roles for RecQL5 distinct from other RecQ like helicases. 
Quantitative mass spectrometry allowed us to take on a more global view of the cell and 
determine how it responds to replication fork pausing in the absence of Rrm3. Using 
both proteomics and yeast genetics we were able to better understand how these DNA 
helicases contribute to maintaining genome stability.   
 
 
 
 
 
 
CHAPTER ONE: 
INTRODUCTION 
 
 Helicases have a role in numerous processes in the cell from DNA replication 
and repair, transcription, to translation. Defects in their function have been linked to 
several diseases, including neurodegenerative diseases, cancers, and developmental 
defects [1-4]. They were first discovered through multiple alignment and sequence 
conservation of three related sequence motifs within the ATPase domain [5]. Helicases 
were initially characterized by these conserved motifs, but it has become clear that 
these motifs characterize proteins, specifically translocases, which possess the ability to 
move along DNA [2, 6]. Helicases and translocases are characterized by their 
processivity, likely due to their interaction with other proteins, and polarity. Since DNA is 
double stranded and asymmetric within the duplex, it is important that the ATP-
dependent helicases move along the nucleic acid with some direction or polarity [2, 7-9]. 
 Helicases can be classified within six superfamilies with the largest groups being 
Superfamily 1 (SF1) and Superfamily 2 (SF2), which contain seven signature motifs [5]. 
They can also be distinguished based on their affinity for DNA, RNA, or DNA-RNA 
hybrids and ability to move on DNA with either 3’-5’ or 5’-3’ polarity [7]. The activity of 
these helicases is often altered by accessory domains, which may direct the helicase to 
a specific substrate or enhance its catalytic activity [10]. 
 
1
SUPERFAMILY 1 HELICASES 
 Superfamily 1 helicases are the best characterized, with roles in DNA or RNA 
metabolism, and can be subdivided into Superfamily 1A (SF1A) and Superfamily 1B 
(SF1B) helicases. The first crystal structure determined for a helicase was of PcrA, a 
UvrD-like enzyme from Geobacillus stearothermophilus [11]. SF1 helicases possess a 
four-subdomain structure with 1A/2A subdomains forming the helicase core and 1B/2B 
interacting with the duplex DNA substrate [11, 12]. After ssDNA binds to a helicase a 
conformational change allows the 1B/2B subdomains to interact with DNA. With the 
addition of ATP, an additional conformational change occurs and allows subdomains 
1A/2A to encircle the nucleotide [13]. These core domains constantly open and close as 
ATP is bound, hydrolyzed, and released, resulting in translocation along DNA [14].  SF1 
family of helicases are divided into three families (Rep/UrvD, Pif1/RecD, and Upf1-like) 
based on their polarity on ssDNA with SF1A moving 3’-5’ and SF1B moving 5’-3’ [2].   
 
SUPERFAMILY 2 HELICASES 
 Superfamily 2 helicases contain a more diverse group of helicases than the SF1 
family and are involved in DNA or RNA unwinding and have a role in DNA repair, 
transcription, RNA metabolism, and chromatin organization [9, 15-18]. They include the 
following families: RecG-like, Swi/Snf, Ski2-like, RIG-I-like, NS3/NPH-II, DEAH/RHA, 
DEAD-box, Rad3/XPD, type I restriction enzyme, and RecQ-like [10, 18, 19].  
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 Figure 1.1. RecQ-like helicases from various species 
RecQ helicases have several domains in common. The most conserved domain 
amongst RecQ- like helicases is the helicase core. Most RecQ helicases also share a 
conserved helicase and RNAse D C-terminal (HRDC) and RecQ C-terminal (RQC) 
domain. WRN, BLM and RECQL1 contain a nuclear localization sequence and 
interestingly WRN and FFA-1 in Xenopus has an exonuclease domain. 
  
THE RECQ PROTEIN FAMILY 
 RecQ-like helicases have 3’-5’ polarity and have been implicated in 
recombination, telomere maintenance, and DNA repair [20]. They bind to specific DNA 
substrates and prevent unscheduled recombination. In their absence there is a higher 
level of recombination, chromosome missegregation, and meiotic defects [21, 22]. The 
first RecQ helicase was discovered in Escherichia coli as a mutant that was resistant to 
thymine starvation in the RecF pathway and in its absence there was increased 
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sensitivity to UV damage and genome instability [23]. Saccharomyces cerevisiae and 
Schizosaccharomyces pombe contain one RecQ helicase. Others contain multiple, like 
humans who possess five homologs; WRN, BLM, RecQL4, RecQL1, and RecQL5. 
RecQ helicases from different organisms are defined by their sequence similarity to the 
E. coli RecQ helicase. They possess highly conserved protein domains, the helicase 
domain, the RecQ C-terminal (RQC) domain, and the helicase and RNAse D-like C-
terminal (HRDC) domain (Figure 1.1) [5, 24].  
 RecQ helicases belong to the SF2 family of helicases and contain seven 
sequence motifs [25]. Functions of these motifs have been studied based on their 
structural similarity between motifs of other helicases. The function of Motif 0 was 
determined by looking at the crystal structure of E. coli RecQ and was found to facilitate 
ATP binding [2]. Motif 1 and Motif II are conserved amongst many helicases and have a 
role in binding and hydrolysis of ATP [10]. The crystal structure of the helicase domain 
of RecQ has revealed that there are two lobes that are separated by a cleft, which is 
thought to play a role in ATP and ssDNA binding [26-28]. Mutations to these motifs 
result in deleterious effects in the cell as seen in BLM, where mutations adjacent to the 
cleft of the helicase domain have resulted in reduced catalytic activity of this protein [2, 
27-31].  
 The RQC domain is not a common feature of all RecQ helicases like the core 
helicase domain, but it is a unique characteristic of the RecQ family and has been 
implicated in DNA binding [32]. The structure of the RQC domain was initially resolved 
using X-ray crystallography [26, 27, 33]. This domain possesses a zinc-binding motif, a 
helix-hairpin-helix, winged-helix, and a β-hairpin motif [26, 27, 33]. The winged-helix 
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domain of both WRN and BLM shows affinity for DNA and the crystal structure for WRN 
shows that the winged-helix domain interacts with the phosphate backbone of a 5’ 
single-stranded DNA overhang [28, 32]. Mutating the residues in WRN that interact with 
the phosphate backbone results in loss of DNA-binding and helicase activity [33, 34].  
 RecQL1, which is a much shorter protein than other RecQ like helicases, 
possesses a conserved RQC domain that has been shown to bind dsDNA through its 
winged helix [35]. Additionally, the β-hairpin motif in the RQC domain of RecQL1 
coordinates its ATPase activity and ability to unwind DNA through dimer formation [31].  
 The helicase and RNAse D-Like C-Terminal domain (HRDC) of RecQ-like 
helicases is seen in WRN, BLM, E. coli RecQ, and S. cerevisiae Sgs1 and its crystal 
structure has been resolved [24, 28, 36]. RecQ and Sgs1 have been shown to bind to 
the HRDC domain but interaction is not needed for their catalytic activity [37]. In human 
WRN and BLM, the HRDC domain is important for recruiting the protein to methyl 
methanesulfonate (MMS), mitomycin C damage as well as dsDNA breaks [38]. 
Although this domain is not needed for catalytic activity of these RecQ-like helicases, it 
is important for recruitment to damaged DNA [39].  
 
SACCHAROMYCES CEREVISIAE RECQ-LIKE HELICASE, SGS1 
 RecQ helicases are highly conserved from bacteria to humans but, only one 
RecQ helicase is present in bacteria and yeast. Sgs1 was initially discovered as a 
suppressor to the slow-growth phenotype of a yeast strain lacking Topoisomerase 3 
(Top3), a type IA topoisomerase capable of relaxing negatively supercoiled DNA [40]. 
Sgs1 is 1447 residues long and has a helicase domain, RQC domain, and a HRDC 
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domain (Figure 1.1) [41]. It is involved in repair of double strand breaks by homologous 
recombination (HR), restart of stalled replication forks, resolving aberrant intermediates 
during meiosis, and telomere maintenance [37, 42-46]. Cells lacking Sgs1 show 
increased sensitivity to DNA-damaging agents hydroxyurea (HU) and methyl 
methanesulfonate (MMS), accumulate gross-chromosomal rearrangements (GCRs), 
and have defects in chromosome segregation during mitosis and meiosis [21, 46-50]. 
 
 
Figure 1.2. Requirement for the RecQ helicase, Sgs1, during end resection   
Double-strand breaks are recognized by the Mre11-Rad50-Xrs2 (MRX) complex and 
the ends are partially resected by the Mre11 nuclease with help from Sae2 leaving a 3’ 
ssDNA overhang. The ends are further resected by Sgs1 and Dna2 (left) or by the Exo1 
nuclease (right) resulting in ssDNA that is coated by RPA. This image has been 
adapted and modified from Gobbini, Cesena et al. (2013). 
6
 Figure 1.3. Double strand break repair 
The RecQ helicase, Sgs1, of S. cerevisiae is required during double strand break repair 
by HR. After a double strand break has occurred the MRX complex and Sae resect the 
5’ ends. Sgs1, Exo1, and Dna2 then further resect resulting in a 3’ ssDNA strand. This 
strand can invade the sister chromatid and be extended by DNA synthesis and aberrant 
structures can be prevented by the activity of Sgs1. A double Holliday junction (dHJ) is 
then formed and can undergo dissolution by Sgs1/Top3/Rmi1 resulting in non-cross-
over products. The dHJ can also be processed by other resolvases to create either a 
non-cross-over product or crossover product. This image has been adapted and 
modified from Ashton and Hickson (2010), Brosh (2013). 
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 Repair of double strand breaks by homologous recombination 
 HR is important to repair double strand breaks (DSBs) and DNA crosslinks by 
utilizing two homologous DNA sequences [51]. In the presence of a double strand 
break, the MRX complex (Mre11-Rad50-Xrs2) is recruited to each end of the break and 
initiates resection of the 5’ ends (Figure 1.2) [51]. Sae2 interacts with Mre11 and its 
absence has shown reduced nuclease activity similar to a Mre11 deficient strain 
suggesting that these two proteins work in coordination with each other to produce a 
substrate for Sgs1 or Exo1 [52-56]. Sgs1, Exo1, and Dna2 are then needed to further 
resect the DNA in order to create a substrate for HR (Figure 1.2) [42].  
 After extensive resection, ssDNA is coated with Rad51, which searches for a 
homologous sequence to use for error-free repair [57]. Efficient resection during DSB 
repair requires not only Sgs1 but also its interacting partners Top3 and Rmi1 (STR 
complex) [58].  Rmi1 may have a role in recruiting Sgs1 and Top3 to ssDNA so that 
Top3 can remove any torsional strain caused by the helicase activity of Sgs1 during 
resection [45]. Cells deficient for any member of the STR complex results in increased 
rates of recombination [59].  
 
 Restart of damaged replication forks by Sgs1 
 In S. cerevisiae the intra-S phase checkpoint is activated in the presence of HU, 
which depletes dNTP pools, or MMS, which alkylates DNA, and results in slowing of 
DNA replication (Figure 1.5) [60]. Upon activation of the intra-S phase checkpoint, 
proteins involved in DNA repair are activated [61, 62]. When cells defective in intra-S 
phase checkpoint proteins, Mec1, Mrc1, Rad9, and Rad53 are exposed to DNA 
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damaging agents HU or MMS, the replication forks are unable to proceed and stall [63]. 
Therefore, it is thought that the intra-S phase checkpoint serves to stabilize the forks in 
order to resume replication after repair has occurred (Figure 1.4) [64].  
 DNA checkpoints are complex signal transduction pathways that require sensors, 
transducers, and effectors [65, 66]. The sensor, ATR-like Mec1 kinase and its binding 
partner, Ddc2, are required to sense and detect lesions [66]. The transducers Mrc1 
which functions in the intra-S phase checkpoint, and Rad9, which functions in the DNA 
damage checkpoint receives, and transmits the signal [67]. Lastly, the effector kinase 
Rad53, functions in both the intra-S phase and DNA damage checkpoint, and is 
required to start downstream events [63]. Sgs1 interacts with Rad53 in vitro and in vivo 
and activates this kinase in the presence of HU [68, 69]. This activation is independent 
of Sgs1’s helicase activity and suggests that the physical interaction between these two 
proteins is what is required [68]. In MMS, sgs1∆ cells accumulate HR intermediates that 
are not observed in the presence of HU, suggesting Sgs1 has several roles at forks 
upon MMS treatment [70-72]. Top3 and Rmi1 also activate Rad53 in a MMS dependent 
manner, which is independent of Top3 catalytic activity but dependent on protein-protein 
interaction with Sgs1 [72-74]. Sgs1 seems to have a HU dependent role in activating 
Rad53 through protein-protein interaction and a MMS dependent role, which requires 
Top3 and Rmi1. 
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 Figure 1.4. Checkpoint response 
The sensor kinase, Mec1, detects lesions and helps to activate Mrc1 or Rad9, which are 
mediators of the checkpoint response. Mrc1, the replication stress checkpoint and 
Rad9, the DNA damage checkpoint can both activate Rad53 under replication stress. 
Activation of Rad53 leads to numerous downstream events that stabilize the fork and 
allow for repair to take place. Rad53 has roles in DNA repair, preventing late origins 
from firing, regulation of transcription and maintaining dNTP levels. In addition to 
Rad53, Rad9 can also activate the effector kinase Chk1, which functions during G2/M. 
This image is adapted from Fu et al. (2008). 
 
 
Figure 1.5. Regulation of dNTP levels 
Sml1 inhibits Rnr1 from associating with the RNR complex and prevents production of 
dNTPs. Upon exposure to replication stress, Dun1 is activated and phosphorylates 
Sml1, targeting it for degredation by the 26S proteasome, allowing production of dNTPs. 
This image is adapted from Andreson et al. (2010). 
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 Role of Sgs1 in maintaining genome stability during meiosis  
 Cells lacking Sgs1 show reduced spore viability and tetrad formation [75, 76]. 
The meiotic defect in sgs1∆ mutants can be attributed to missegregation of 
chromosomes during meiosis and unscheduled separation of sister chromatids [76]. 
Disrupting meiotic checkpoint genes, RAD17 and RED1, results in rescue of the poor 
sporulation phenotype seen in an sgs1∆ mutant suggesting that this defect may be a 
result of accumulation of aberrant recombination intermediates that require Sgs1 to be 
resolved [77]. A sgs1∆C795 allele sporulates just as well as a wildtype suggesting that 
the instability seen in sgs1∆ is due to loss of interaction with Top2 or Top3 which both 
interact with the N terminus of Sgs1 that is present in a sgs1∆C795 mutant allele [78]. 
Additional work has revealed that Sgs1 is also able to disrupt D-loop structures and 
promotes formation of a Holliday junction intermediate that is dissolved by Top3/Rmi1 
activity further supporting its role in meiosis considering similar substrates are present 
[37, 72, 79-82]. 
 
 Sgs1 facilitates repair at telomeres 
 Telomeres are composed of protein-DNA complexes at the ends of 
chromosomes that help to maintain genome stability. In humans, telomeres contain a 10 
kb TTAGGG repeat, the shelterin complex, and a 3’ ssDNA overhang [83, 84]. In the 
absence of telomerase, the DNA ends shorten after each cell division and if left 
unchecked the cell will eventually die [85]. To avoid this, the cell can use telomerase or 
it can go through alternative lengthening of telomeres (ALT), which is a process that 
utilizes recombination [86-89]. The ALT pathway uses recombination to elongate 
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telomeres and is used in 5-15% of human cancers, including osteosarcoma and 
glioblastoma [88, 89]. RecQ helicases have been shown to co-localize with other 
components in this pathway, but their role remains unclear [90].  
 The G-rich regions of telomeric DNA may lead to the formation of G-
quadruplexes, which if left unresolved can be toxic to the cell [91]. Sgs1 has been 
suggested to resolve these secondary structures and has been shown to resect 
telomeric regions that have a higher incidence of G-quadruplex formation [92, 93]. By 
inducing a site specific DSB in an sgs1∆ exo1∆ mutant, the presence of telomeric 
sequences in non-telomeric regions was observed suggesting Sgs1 and Exo1 work 
together to prevent these events from occurring [94, 95].  It was recently reported that 
Sgs1 is sumoylated at K621 and that this modification is important for its function in 
telomere-telomere recombination and is dispensable in its role in DNA repair  [96]. If 
components at telomeres are disregulated, unwanted intermediates may arise, which 
require the function of Sgs1 to be resolved and if they persist, can lead to cell death 
[97].  
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Figure 1.6. Conserved protein-protein interactions with Sgs1 and BLM  
Sgs1 and BLM have several protein-protein interactions with proteins involved in DNA 
repair and recombination. Sgs1 interacts with Top3, Srs2, Top2, Rad16, Rpa70, Rad53, 
Mlh1, and Rad51. Many of the protein-protein interactions in Sgs1 are conserved in 
BLM with some additional interactions like WRN specific to BLM helicase. The colors for 
Sgs1 and BLM are the same as those in Figure 1.1. 
 
 
 
 
 Sgs1 interacting proteins 
 Sgs1 physically interacts with Top2 and Top3 through its N terminus (Figure 1.6) 
[76, 98]. In yeast, Top2 has a function in decatination of DNA molecules that form as a 
result of DNA replication [99, 100]. Without this function chromosomes run the risk of 
fragmenting and may not separate properly during mitosis [99, 100]. Top3 also interacts 
with Sgs1 and forms a complex that is required to resolve aberrant structures that result 
from Sgs1 activity [40, 101, 102]. Sgs1 has also been shown to interact genetically with 
Srs2, a DNA helicase involved in displacing Rad51 filaments. sgs1∆ srs2∆ double 
mutants show a growth defect suggesting the inability to displace Rad51 filaments may 
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be causing toxic intermediates, which, if left unresolved are deleterious to the cell  [46, 
103]. Rad51 of S. cerevisiae has a role in HR and repair of DSBs by recombination 
[104]. rad51∆ mutants have mitotic and meiotic defects and are sensitive to ionizing 
radiation (IR) [104]. Interaction between Sgs1 and its human counterpart, BLM, with 
Rad51 has been shown through yeast two-hybrid [104].  
 Apart from its role in DSB repair, Sgs1 also has a role in mismatch repair and 
nucleotide excision repair. Sgs1 interacts with Mlh1, a member of the MutLα complex 
that works with Pms1, required for ATP binding, during mismatch repair [105]. Through 
yeast two-hybrid analysis interaction with Rad16 has been observed. Rad16 belongs to 
the Swi2/Snf2 superfamily of DNA-dependent ATPase and functions during nucleotide 
excision repair [106]. Interaction between Sgs1 and Rad16 was confirmed by co-
immunoprecipitation and the interaction was found to be between amino acids 421-792 
[107]. sgs1∆ rad16∆ cells show slow growth in the presence of DNA damaging agents 
suggesting a role for Sgs1 during nucleotide excision repair [107].  
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Table 1.1. Comparison of helicase activities of E. coli RecQ with human and S. 
cerevisiae RecQ helicasesa 
 
 
 
This table has been adapted and modified from a review by Croteau, Popuri et al. 
(2014).  
 
a The data presented here is from the following studies: [44, 108-118] 
 
b DNA is represented as red and blue; RNA is represented as green. 
 
c Helicase activity: +, weak; ++, moderate; +++, strong; -, no activity; ~/-, partial activity; 
ND, not determined. 
 
d Activity of RECQL4 is shown in the absence of ssDNA 
 
 
 
HUMAN RECQ-LIKE HELICASES 
 Humans possess five RecQ-like homologs BLM, WRN, RecQL1, RecQL4, and 
RecQL5. Defects in three of these five RecQ-like proteins (BLM, WRN, RECQL4) result 
in genetic disorders for which there is no cure as of yet.  
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 Bloom Syndrome is an autosomal recessive disorder caused by a mutation 
 in  BLM  
 Mutations to BLM (15q26.1) result in Bloom syndrome (BS), also known as 
Bloom-Torre-Machacek syndrome, and patients have a predisposition to cancer, 
diabetes, and pulmonary disease [119-122]. Bloom syndrome is extremely rare and 
most patients are of Central and Eastern European (Ashkenazi) background [123]. 
Patients are characterized by having short stature and rarely exceed five feet in height 
during adulthood [123]. They are sensitive to sun exposure and suffer from 
telangiectases and hyper- or hypopigmentation of the skin (Figure 1.7) [124]. Other 
distinctive physical features include high vocal inflection and a long narrow face with 
prominent nose and ears [125]. Men usually do not produce sperm and are infertile and 
women have reduced fertility with early onset menopause [112]. BLM is expressed in 
the spleen, thymus, testis, and ovaries during embryogenesis [126]. Mouse models 
containing mutations in BLM found in the general population have been generated. 
BLM-/- mice are smaller than BLM+/- or wildtype mice, show developmental defects, 
have increased incidence of SCEs, and have a higher incidence of cancer upon 
inactivation of the helicase domain [120]. Additionally, inactivating the helicase domain 
of BLM in a cell with a mutation in the tumor suppressor gene APC results in higher 
levels of tumor formation [125]. Cells deficient for BLM are characterized by high levels 
of SCEs, increased mutation rates, inability to resolve DNA intermediates leading to 
slowed replication, and presence of quadriradials [20]. 
 In mammalian cells, the central kinases ATM and ATR regulate the intra-S phase 
checkpoint, which responds to replication stress and inhibits cell cycle progression, 
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induces genes involved in the DNA damage response, restricts HR, and inhibits late 
origin firing [127]. Both ATM and ATR phosphorylate BLM at threonine 99 and 122 in 
the presence of UV irradiation, and phospho-defective mutants cannot recover [128]. 
Although phosphorylation of these residues inhibits recovery of BLM from replication 
stress, BLM is still able to suppress SCEs and localize to DNA damage foci [128]. In 
addition to being phosphorylated by ATM and ATR, BLM is also modified by Chk1 and 
Chk2, which are downstream of the checkpoint response and lead to localization of 
BLM to sites of DNA damage [129]. Cells depleted for BLM have checkpoint defects, 
cannot activate CHK1, and are more sensitive to the DNA damaging agent 
camptothecin [125, 130].  
 As it is a member of the RecQ family of helicases, BLM has a core helicase 
domain with ATP-binding and DEAH motifs, a RecQ helicase C-terminal domain (RQC) 
adjacent to the helicase domain that promotes protein-protein interactions, and a 
helicase and RNase D C-terminal domain (HRDC) that is on its C terminus [2, 10, 24, 
32]. The disordered N terminal tail of BLM contains several sites of post-translational 
modifications (PTM) that mediate interaction with RMI1/2, TOP3α, and RAD51 [40, 73, 
104, 131-134]. BLM has a role in resolving recombination intermediates similar to that of 
Sgs1 in yeast and is able to dissociate D-loops in vitro with specificity for invaded 5’ 
ends by preventing the formation of RAD51 filaments [135, 136].  It has been further 
shown that BLM and TOP3α in combination with RMI1 and RMI2 are required for dHJ 
dissolution [125]. RMI1 and RMI2 are thought to help recruit TOP3α to the dHJ  [137].  
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 Figure 1.7. Individuals with Bloom syndrome  
Patient on the left and center have facial telangiectasias, a hallmark of the syndrome. 
The patients on the right are siblings with the brother to the left positive for Bloom 
syndrome. Images are from the Bloom syndrome registry, Weill Cornell Medical 
College. 
 
 
 
 Werner syndrome is an autosomal recessive disorder characterized by 
 premature aging  
 Werner syndrome protein, WRN, like BLM is a RecQ-like DNA helicase and 
defects in this protein are associated with a predisposition to cancer with a majority of 
patients with this syndrome linked to a founder mutation in Japan [138]. Cells from 
individuals suffering from Werner syndrome have increased sister chromatid exchange, 
shortened telomeres, and genomic instability, specifically chromosome rearrangements 
like translocations, inversions, and deletions [139-141]. In addition to these cellular 
defects, patients with Werner syndrome show distinct clinical features such as type II 
diabetes, cataracts, atherosclerosis, arteriosclerosis, osteoporosis, and accelerated 
aging [142, 143]. Patients develop normally until adolescence, then symptoms manifest 
in early adulthood and death occurs around 46-54 years of age (Figure 1.8) [138]. BLM 
manifests different clinical symptoms and these differences in physical features of 
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patients with this syndrome compared to BLM show that WRN and BLM cannot 
compensate for each other, suggesting they have independent roles in the cell.  
 WRN is 1432 amino acids in length and contains an exonuclease domain on its 
N terminus, the RQC domain, and an HRDC domain (Figure 1.1) [144]. Both WRN and 
BLM possess the helicase core and HRDC domain, but the ATPase domain of WRN 
and BLM is only 30% similar while the RQC domain and HRDC domains are 10% and 
20% similar [145]. The RQC domain of WRN is critical for DNA strand separation and is 
linked to the Zn binding domain by a short linker sequence resulting in a winged-helix 
motif [33, 146].  
The function of the HRDC domain, unlike the RQC domain, is not well 
understood. In human RecQ helicases only WRN and BLM possess the HRDC domain. 
The HRDC domain was initially discovered from studies of bacterial DNA helicase PcrA 
and Rep [11, 12, 147]. Studies of S. cerevisiae Sgs1 have shown that the HRDC 
domain weakly binds DNA via its attraction to its positive surface [24]. Notably, the 
surface of WRN does not share the same characteristics as that of Sgs1. The HRDC 
domain of WRN is linked to the RQC domain by residues 1065-1141 which is 
unstructured and contributes to the distance of the HRDC domain from the RQC domain 
[142]. This flexibility might allow for protein-protein interactions that may help recruit 
WRN to sites of damage.  
 WRN has several roles during DNA repair. During base excision repair (BER), 
WRN, through its exonuclease activity is thought to have a role in post replication repair 
[148]. WRN interacts with poly (ADP-ribose) polymerase I (PARP1), which adds 
substrates into chromatin-binding proteins allowing for modification of chromatin 
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structure [149, 150]. Cells depleted for WRN are unable to activate PARP1, which 
results in an inability to resolve oxidized and alkylated DNA demonstrating an important 
role for WRN in BER [148]. During double strand break repair, DNA can be resolved by 
non-homologous end joining (NHEJ) or HR. NHEJ requires 53BP1, DNA-PKcs, 
XLF/XRCC4/LIG4, and Ku70/Ku80 (Ku) [151, 152]. WRN is a substrate for DNA-PKcs 
and physically interacts with Ku [153-156]. Cells depleted for WRN show increased 
chromosomal deletions and are sensitive to IR [155]. Even though WRN possesses 
exonuclease activity it has been observed that this activity hinders proper resection 
during HR and that BLM has a more important role with its interaction with EXO1 and 
DNA2 [157]. WRN lacks anti-recombinogenic activities like BLM but has been thought to 
suppress recombination [104, 158]. This may be mediated through its interaction with 
several HR proteins: BRCA1, MRN, RAD51, RAD54, and RAD52 [159-162]. WRN 
depleted cells are defective in telomere replication and these cells have increased sister 
telomere loss (STL) which suggest that WRN may prevent deletions during telomeric 
replication and that it may resolve secondary structures that may lead to telomere 
defects [163]. If the damage cannot be resolved then there is a risk of cell cycle arrest 
and chromosomal instability. 
 WRN also undergoes post-translational modifications, which are critical for 
regulating its catalytic activities, protein-protein interactions, and cellular localization. 
WRN undergoes phosphorylation by DNA-PKcs, ATR, ATM, and c-Abl tyrosine kinase 
[164-167]. Phosphorylation of WRN occurs when the replication machinery encounters 
a block, and both ATM and ATR kinases have been shown to activate WRN in the 
presence of HU [164]. Experiments have shown that inhibiting ATR mediated 
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phosphorylation prevents WRN from localizing to nuclear foci and can result in 
collapsed forks [164]. Acetylation of WRN by p300 allows WRN to move from nucleolar 
foci to nuclear foci and may enhance its helicase and exonuclease activity shedding 
light on its role during BER [168].  
 Mouse models, constitutively expressing Wrn, have been generated to study the 
phenotype seen in Werner patients. One specific model has the helicase domain 
disrupted resulting in a truncated protein [169]. Although this particular model did not 
exhibit the premature aging phenotype of Werner patients, it is sensitive to 
camptothecin, an inhibitor of topoisomerase I [170]. WRN has an important role in 
maintaining telomeres and mouse models with telomerase RNA, Terc, depleted in 
combination with a Wrn -/- mutation showed premature aging phenotypes and early 
development of type II diabetes and osteoporosis [41, 171].  
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 Figure 1.8. Patients with Werner syndrome at various ages  
These images show patients who suffer from Werner syndrome and specifically 
premature ageing that is associated with this syndrome. A and B) Patients from 
America that suffer from Werner syndrome. C) A patient of Japenese descent that has 
Werner syndrome and premature ageing is most evident in this patient. Images are from 
University of Washington and a review by Bohr et al. (2008). 
 
 
 
 Rothmund-Thomson syndrome is caused by a mutation to RECQL4  
 Mutations in RecQL4 result in Rothmund-Thomson Syndrome (RTS), 
RAPADALINO syndrome, or Baller-Gerold Syndrome (BGS). Patients suffering from 
these syndromes display growth retardation and radial defects [111]. RAPADALINO 
patients are most commonly found in Finland and are distinct from those suffering from 
the other syndromes in that they do not show clinical features such as poikiloderma. 
RTS is the most common of the three syndromes, and patients age rapidly, are 
A
.
B
.
C
.
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sensitive to light, have skin and skeletal abnormalities and, at the cellular level, cells 
depleted for RecQL4 have increased chromosomal instability (Figure 1.9) [172-174]. 
 RecQL4 can be found in the cytosol, mitochondria and nucleus, has peak 
expression during S phase and highest expression is found in the testis and thymus 
[175]. RecQL4 has a role during replication, particularly in its initiation, and work has 
been carried out in Drosophila, Xenopus, and Chicken DT40 cells to explore this 
function. In Drosophila and Chicken DT40 cells, RecQL4 binds to origins of replication 
during G1/S phase of the cell cycle and physically interacts with MCM2-7 helicase, 
MCM10, GINS, and CDC45 [35, 176-179]. Additionally, RecQL4 in Xenopus shares 
sequence similarity to S. cerevisiae Sld2, which is responsible for initiating replication 
and DNA Pol α loading onto origins. RecQL4 interacts with TRF1, TRF2, and POT1 
(shelterin proteins), which help unwind telomeric D-loops by stimulating RecQL4 activity 
[180-182]. Cells depleted for RecQL4 have telomere defects, specifically in telomere 
replication, and it has been shown that RecQL4 localizes to telomeres during S phase 
[157, 180, 181, 183-185]. RecQL4 may also play a role in the intra-S phase checkpoint 
response as cells depleted for RecQL4 are unable to arrest in S phase following 
treatment with HU, UV light, or IR [186, 187]. 
 Mouse models have been generated to study RTS and most mutations in 
patients who have RTS syndrome map to the helicase domain [188]. One such mutation 
has exon 13 (motif III) deleted and mice have reduced lifespan and those that do 
survive are smaller and have skin abnormalities [188]. Another mouse model to study 
RTS was created by mutating the helicase domain in exons 9-13 of RecQL4, which 
results in a truncated protein. These mice die rapidly, within 24 hours of birth, and have 
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skin and skeletal abnormalities. Additionally, in these mice if the mutated tumor 
suppressor gene APC is combined with the RecQL4 mutation, the mice have a higher 
incidence of cancer and increased chromosomal instability [189, 190].  
 
 
Figure 1.9. Patients showing clinical features of Rothmund-Thomson syndrome 
A) This patient is a 4 year-old girl who shows chronic poikloderma on the cheek. B) This 
is another patient who shows poikloderma on the cheek more visibly. C) X-Ray of a 
patient showing bone defects. Images are from Bartyik et al. (2013) and Wang et al. 
(2001). 
 
 
 
 RECQL1 and RECQL5 
 RECQL1 has no associated human disease and is the smallest of the RecQ like 
proteins with a molecular mass of approximately 71 kD [173]. Several studies have 
implicated RECQL1 as being an important component in regulating genome stability 
[35, 191]. Studies have revealed that RECQL1 possess ATPase activity and is capable 
of unwinding short lengths of duplex DNA in vitro [192]. RECQL1 has been shown to 
interact with RPA and mismatch repair factors Msh2/Msh6, Exo1, Mlh1/Pms2, 
Topoisomerase III, importin homologs, and Rad51 [191, 193-195]. The functional 
significance of these protein-protein interactions, however, remains unknown. 
 RecQL5 consists of 19 exons and encodes three alternatively spliced isoforms, 
RecQL5α, RecQL5β and RecQL5γ [196]. In human tissues RecQL5 isoforms are 
A B C
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expressed with high abundance in the testis [196]. RECQL5 possess DNA dependent 
ATPase activity and contains a DExH and Zn binding domains at its N terminus [197]. 
The helicase possesses 3’-5’ polarity and has a unique C terminal half that has been 
implicated in DNA strand annealing activity [197]. RecQL5 has also been found to 
interact with RNAPII, which may implicate RecQL5 in transcription [197].  
 
Table 1.2. DNA helicases involved in maintaining genome integrity 
Gene Disease 
Metabolic 
Pathway 
Biochemical 
properties 
Type of 
Cancer 
BLM Bloom syndrome 
DSB repair and 
repair of 
damage during 
replication 
3’-5’ helicase, 
HJ branch 
migration, G4 
structure 
resolution, fork 
regression and 
strand 
annealing 
Leukemia, 
lymphomas, 
adult epithelial 
tumors 
WRN Werner syndrome 
DSB repair and 
response to 
replication 
stress 
3’-5’ helicase 
and 
exonuclease, 
HJ branch 
migration, G4 
structure 
resolution, fork 
regression and 
strand 
annealing 
Melanomas, 
sarcomas, 
meningiomas, 
osteosarcomas, 
thryroid 
neoplasms, 
lymphoid 
neoplasms 
RECQL4 
Rothmund-
Thomson 
syndrome, 
Baller Gerald 
syndrome, and 
RAPADILINO 
syndome 
BER, 
mitochondrial 
genome 
stability, DNA 
replication 
3’-5’ helicase 
and strand 
annealing 
Lymphomas 
and osteogenic 
sarcomas 
RECQL1 ND 
DNA replication 
and oxidative 
DNA damage 
response 
3’-5’ helicase, 
HJ branch 
migration and 
strand 
annealing 
Pancreatic 
cancer 
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Table 1.2 (continued) 	
PIF1 ND 
Fork 
progression, 
telomere 
maintenance, 
and 
mitochondrial 
DNA 
metabolism 
5’-3’ helicase 
and G4 
resolvase 
Breast cancer 
predisposition 
FANCJ Fanconi Anemia (FA) 
DSB repair and 
intercross link 
repair 
5’-3’ helicase 
and G4 
resolvase 
Acute myeloid 
leukemia and 
breast cancer 
XPD 
Xeroderma 
pigmentosum, 
xeroderma 
pigmentosum 
with Cockayne 
syndrome, TTD 
and COFS 
Nucleotide 
excision repair 
and 
transcription 
5’-3’ helicase Skin cancer 
XPB 
Xeroderma 
pigmentosum, 
xeroderma 
pigmentosum 
with Cockayne 
syndrome, and 
TTD 
Nucleotide 
excision repair 
and 
transcription 
3’-5’ helicase Skin cancer 
RTEL1 Dyskeratosis congenita 
Maintenance of 
telomeres and 
HR 
5’-3’ helicase, 
and 
disassembly of 
D-loops and T-
loops 
Adult glioma 
This table was adapted and modified from a review by Brosh (2013). 
 
NON-RECQ LIKE DNA HELICASES AND THEIR ROLE IN THE MAINTENANCE OF 
GENOME INTEGRITY 
 Among nuclear proteins in S. cerevisiae, there are 23 with helicase activity and 
evidence for functions in DNA repair. Of the 23 proteins with helicase activity, non-RecQ 
DNA helicases with a role in DNA repair were selected and will be discussed here. 
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 Chl1 has a role in sister chromatid cohesion 
 S. cerevisiae Chl1 is a DNA helicase that is important for sister chromatid 
cohesion. Mutations in the human cohesion subunits (SMC1A/Smc1, 
RAD21/Mcd1/Scc1, SMC3, HDAC8/Hos1, APRIN/Pds5, NPBL/Scc2, 
BACH1/BRIP/FANCJ/Chl1, ESCO2/Eco1/Ctf7, and ChIR1/DDX11/Chl1) result in 
Cornelia de Lange Syndrome, Roberts Syndrome, Warsaw Breakage Syndrome and 
Fanconi Anemia [198-210]. Chl1 has recently been shown to play a role in recruiting 
and regulating the cohesion subunit Scc2 to chromatin during S-phase [211]. It has 
been proposed that Chl1 may be removing DNA secondary structures to allow for 
recruitment of Scc2 during S phase and thereby promoting sister chromatid cohesion 
[211]. 
 
 Irc20 functions during DSB repair 
 IRC20 was found in a screen for gene deletions that increase the formation of 
Rad52 foci [212]. Irc20 is part of the Snf2/Swi2 family of helicases and has a C3HC4 
domain that is part of the RING subset of E3 ligases [213]. Cells lacking Irc20 have 
reduced SDSA events, shows decreased crossover events, and inhibit activity of Srs2 
and Mre11 [214]. It was found through crossover assays that Irc20 may function prior to 
the formation of a D-loop, followed by disassembly by Srs2 to promote SDSA over dHJ 
intermediate formation [214]. It was found that irc20∆ suppressed the defects of mre11∆ 
cells (inhibition of SDSA, NHEJ, and crossover events) and that this suppression was 
partially dependent on Exo1 [214]. This suggests that Irc20 is important in shuttling 
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DSBs to be processed by Mre11 to initiate end resection and that the absence of Irc20 
results in formation of more 3’ ssDNA at DSBs [215]. 
 
 Mph1 is involved in preventing crossovers and has a role in error-free 
 bypass of DNA lesions 
 Mph1, a 3’-5’ DNA helicase, is related to human FANCM, and has been shown to 
disrupt Rad51 D-loops, suggesting that it has anti-recombination functions [216, 217]. 
The absence of Mph1 results in increased crossover frequency, and this role is 
independent of Sgs1 and Srs2 [218]. Mph1 has been proposed to play a role in error-
free lesion bypass repair by template switching and cells lacking Mph1 have a mutator 
phenotype and impairment of sister chromatid cohesion [219, 220]. Mph1 can form and 
unwind D-loop structures during SDSA repair of DSBs, and may be involved in 
reversing these D-loop structures at stalled replication forks [218].  
 
 Pif1 has a role at telomeres, double-strand breaks and promoting fork 
 progression through aberrant DNA structures 
 Pif1 is a 5’-3’ DNA helicase that is found in the nucleus and mitochondria, and 
has roles in telomere maintenance, resolving G-quadruplex DNA, Okazaki fragment 
processing, and unwinding duplex DNA [221-226]. Pif1 was initially discovered from a 
screen for mutations that affect recombination between rho+ and rho- mitochondrial 
genomes and it was found that Pif1 deficient cells had reduced mitochondrial DNA 
recombination resulting in a greater loss of mtDNA compared to wildtype [221, 227, 
228].  
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 In the absence of Pif1, the length of telomeres increased by ~75 base pairs and 
this was not only at chromosomal ends but also at intrachromosomal DSBs [229]. Pif1 
directly disassembles telomerase from telomeric ends in a helicase dependent manner, 
thereby reducing the processivity of telomerase [226]. Pif1’s role at telomeres is further 
evidenced by the fact that it binds RNA-DNA hybrids with greater affinity than DNA-
DNA, supporting the notion that Pif1 disassembles TLC1, the RNA portion of 
telomerase [230-232].  
 Using ChIP analysis it was found that Pif1 has a strong affinity for G4 structures 
in vivo during late S/G2 phase of the cell cycle and fork progression is hindered in its 
absence [233]. Pif1 also has a role at the replication fork and is thought to pause the 
fork at the rDNA region. During HR, Pif1 works with Pol δ to displace the newly 
synthesized DNA strand and promote D-loop migration [225]. Although mutations in 
mice show no visible phenotype, defects in human PIF1 results in breast cancer 
predisposition, suggesting a possible role for PIF1 as a tumor suppressor [234].  
 
 Rad5 is involved in error-free PRR 
 DNA lesions can be resolved by post replication repair (PRR). PRR is dependent 
upon Rad6 and Rad18, which form a ubiquitin ligase and conjugating enzyme complex 
[235]. In S. cerevisiae, the Rad6-Rad18 complex promotes replication through DNA 
lesions through several pathways. DNA polymerase pol ƞ and pol ƹ allow for 
progression through DNA lesions in an error-prone manner [236]. Alternatively, an error-
free mode of repair using Rad5-Mms2-Ubc13 can used. Rad5 belongs to the SWI/SNF2 
superfamily of proteins and contains seven conserved helicase-like motifs [237, 238]. 
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Mms2 and Ubc13 interact and promote the assembly of polyubiquitin chains linked 
through lysine 63 [239, 240]. Pol30 encodes PCNA which is the proliferating cell nuclear 
antigen, a sliding clamp on DNA, which is important for modulating different lesion 
bypass pathways and possibly providing support for TLS polymerases to bind [240]. In 
the presence of DNA damage, PCNA is monoubiquitinated at lysine 164 by Rad6-
Rad18 [241]. The lysine is then polyubiquitinated by a lysine 63-linked ubiquitin chain in 
an Mms2-Ubc13-Rad5 dependent manner [241]. Monoubiquitination of PCNA results in 
activation of TLS (Pol ƞ and Pol ƹ) whereas polyubiquitination of PCNA results in PRR 
[239, 242]. In PRR, it is thought that the lesion is bypassed by template switching and 
fork regression where the newly synthesized strand encountering an obstacle uses the 
sister duplex as a template to ensure error-free repair (Figure 1.10) [236]. 
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 Figure 1.10. Mechanisms for DNA lesion bypass. 
Lesions at the replication fork can lead to fork stalling and genome instability. The cell 
can bypass these lesions using translesion synthesis or template switching. In the 
presence of such lesions, Rad6-Rad18 have a key role in shuttling the damage to a 
particular pathway. Rad6-Rad18 monoubuitinates PCNA, promoting error prone 
translesion synthesis. Rad5-Mms2-Ubc13 can promote polyubiquitination of PCNA 
which leads to an error-free mode of repair using template switching. The lesion can be 
bypassed using the nascent lagging strand as a template for synthesis past this lesion. 
Image adapted from Cimprich and Chang (2009). 
 
 
 Rrm3 has a role in replication fork progression 
Rrm3 is a 5’-3’ DNA helicase that is a member of the Pif1 family of DNA 
helicases and is highly conserved from yeast to humans [61]. S. cerevisiae RRM3 was 
first discovered as a suppressor of recombination between tandem arrays and 
ribosomal DNA (rDNA) repeats [243]. In the absence of Rrm3 there are elevated levels 
of extrachromosomal rDNA circles, suggesting a role in maintaining rDNA stability. The 
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cells accumulate X-shaped intermediates at stalled replication forks, which are detected 
by 2D gel electrophoresis. This has led to the possibility that Rrm3 facilitates in 
displacing the DNA-protein block and in unwinding of DNA to help fork convergence 
during replication termination [244]. Additionally, in the absence of Rrm3 there is an 
increase in replication fork pausing at the ribosomal DNA, centromeres, telomeres, 
tRNA, HML/HMR loci, inactive origins, and RNA polymerase II (Pol II) – transcribed 
genes [243, 245, 246]. 
Rrm3 has an important role in fork progression and maintaining genome integrity, 
because in its absence there are broken replication forks within rDNA, tRNA, and 
subtelomeric DNA [61, 245]. The mechanism by which Rrm3 aids in fork progression is 
poorly understood, but it is thought that Rrm3 removes aberrant structures during 
replication [61]. S. cerevisiae rDNA is composed of 200 tandem copies of ~9.1-kb 
repeating unit on chromosome XII [247, 248]. Within the coding regions of these RNAs 
there are two intergenic spacers, IGS1 and IGS2, that contain two tandem Ter sites 
[249]. The two Ter sites are bound by the replication terminator protein, Fob1, to 
promote fork arrest in order to prevent unscheduled transcription [250, 251]. The Ter 
sites also require the intra-S phase checkpoint proteins Tof1 and Csm3, which form a 
complex at the replication fork and antagonize Rrm3 function [252, 253]. It is thought 
that Rrm3 removes Fob1 and X-shaped intermediates from Ter sites during fork 
movement and other non-histone proteins on DNA ahead of the replication fork [244]. 
Type IA (Top3) and type II (Top2) topoisomerases have a role in replication termination, 
but Top2 resolves the strain created at TERs as evidenced by the fact that in the 
absence of Top2, there are increased levels of breaks and rearrangements [244, 254-
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258]. Direct evidence for Rrm3 in facilitating fork merging has not been shown, but 
recent evidence shows that fission yeast Pfh1 has similar functions to Rrm3 and 
promotes fork merging at replication termination sites [259]. Rrm3 also has a role in 
replicating telomeric and subtelomeric DNA and in the absence of Rrm3 there is 
increased pausing within telomeric repeats [246]. It has been shown that the ability of 
Rrm3 to promote replication through these regions is dependent on its catalytic function 
[260]. Taken together this data suggests that Rrm3 helps to prevent aberrant 
chromosome segregation and helps to maintain genome stability. 
 Further evidence indicating Rrm3 has a role in fork progression is shown by the 
fact that rrm3∆ shows growth defects with rad53∆, srs2∆, sgs1∆, mrc1∆, and rtt101∆, 
components involved in maintaining the stalled fork [261-263]. Srs2 is also a 3’-5’ DNA 
helicase that has been implicated in resolving lethal recombination intermediates at 
sites of DNA damage and this function becomes crucial in the absence of Rrm3 or Sgs1 
[261, 262]. Cells lacking Rrm3 and Sgs1 or Srs2 have increased doubling times and 
rrm3∆ srs2∆ cells accumulate in G2/M [261]. In the absence of Mrc1 there is a slower 
rate of replication and it has been shown that Rrm3 is important in repairing the damage 
[264]. The sensor and effector kinases Mec1 and Rad53 are important in the absence of 
Rrm3, as there is a severe growth defect in their absence [245, 262]. Upon activation of 
the checkpoint response in the presence of DNA damage in rrm3∆ cells, Rad53 is 
constitutively phosphorylated [245, 265]. Rrm3 is hyper-phosphorylated by Rad53 under 
replication stress, and it has been proposed that this inhibits its activity in response to 
DNA damage to allow for repair [265].  
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 Srs2 functions in multiple DNA metabolic processes 
 Srs2 is a DNA helicase that shares homology with the bacterial Rep, PcrA, and 
UvrD [266]. It was first discovered as a suppressor of sensitivity of rad6∆ and rad18∆ 
mutants (Suppressor of RAD Six mutant 2) [267, 268]. Srs2 has 3’-5’ polarity, strong 
ssDNA dependent ATPase activity, and can resolve D-loops and forks [269]. RPA 
enhances Srs2’s ability to resolve long substrates and in its absence cells have higher 
recombination events, cannot accurately complete post replication repair, and have 
problems with the DNA damage checkpoint [270-272].  
 Srs2 is thought to function early in HR and displaces Rad51 presynaptic filament 
[273]. This is supported by experiments in S. cerevisiae where SRS2 deletion resulted 
in a hyper-recombination phenotype [272]. A srs2∆ sgs1∆ cell was found to be slow 
growing, suggesting that improper regulation of HR can be deleterious to the cell. Srs2 
may also have a role in PRR as shown by increased sensitivity of srs2∆ cells to UV light 
[274]. Srs2 may be deciding whether a lesion should be repaired by HR or PRR [235].  
   
HYPOTHESIS AND AIMS 
 Helicases have important roles in DNA metabolism and maintaining genome 
integrity. Defects in many helicases are associated with cancers and genetic disorders. 
Studying helicases involved in maintaining genome stability in S. cerevisiae has helped 
elucidate their functions in humans, but the complexity of the DNA damage response 
leaves us with many unanswered questions. Here, we functionally characterize RecQ-
like (Sgs1 and RecQL5) and non-RecQ like (Rrm3) helicases and hypothesize that 
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defects in these helicases, with roles in DNA replication and repair, will result in genome 
instability. This hypothesis will be addressed through the following aims: 
 
Aim 1 (Chapter Two) – We seek to identify the role of the conserved functional domains 
of Sgs1 of S. cerevisiae in the maintenance of genome integrity.  
 
Aim 2 (Chapter Three) – We seek to identify human RecQL5 interacting proteins and to 
test the ability of RecQL5 to complement Sgs1 functions in yeast to shed light on 
cellular pathways that RecQL5 functions in. 
 
Aim 3 (Chapter Four) – We seek to identify DNA metabolic pathways that respond to 
stalled forks in the absence of Rrm3 using stable isotope labeling by amino acids in cell 
culture (SILAC)-based quantitative mass spectrometry. 
  
SIGNIFICANCE 
 This work will allow for a better understanding of nonreplicative helicases 
involved in DNA repair and may reveal additional components involved in the DNA 
damage response. Elucidating such factors may lead to a greater understanding of how 
these proteins are involved in the development of hereditary cancer syndromes, with 
implications that may lead to a greater quality of life among affected individuals. 
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ABSTRACT 
 RecQ-like DNA helicases are conserved from bacteria to humans. They perform 
functions in the maintenance of genome stability, and their mutation is associated with 
cancer predisposition and premature aging syndromes in humans. Here, a series of C-  
terminal deletions and point mutations of Sgs1, the only RecQ-like helicase in yeast,  
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show that the HRDC and Rad51 interaction domain are dispensable for Sgs1’s role in 
suppressing genome instability, whereas the zinc-binding domain and the helicase 
domain are required. BLM expression from the native SGS1 promoter had no adverse 
effects on cell growth, but also was unable to complement any sgs1Δ defects. BLM 
overexpression, however, significantly increased the rate of accumulating GCRs in a 
dosage dependent manner and greatly exacerbated sensitivity to DNA-damaging 
agents. Co-expressing sgs1 truncations of up to 900 residues, lacking all known 
functional domains of Sgs1, suppressed HU sensitivity of BLM overexpressing cells, 
suggesting a functional relationship between Sgs1 and BLM. Indeed, protein disorder 
prediction analysis of Sgs1 and BLM was used to produce a functional Sgs1-BLM 
chimera by replacing the N-terminus of BLM with the disordered N-terminus of Sgs1. 
The functionality of this chimera suggests that it is the disordered N-terminus, a site of 
protein binding and post-translational modification, that confers species-specificity to 
these two RecQ-like proteins.  
 
INTRODUCTION 
RecQ-like DNA helicases, named after the DNA repair protein RecQ of 
Escherichia coli, (Hegde, Qin et al. 1996, Morimatsu and Kowalczykowski 2003, 
Ivancic-Bace, Salaj-Smic et al. 2005) are evolutionarily highly conserved. These 3′- to 
5′-helicases function at the interface between DNA replication and recombination to 
maintain genome integrity. Sgs1 is the only known member of this helicase family in 
Saccharomyces cerevisiae (Gangloff, McDonald et al. 1994). Sgs1-deficient cells show 
increased sensitivity to the DNA-damaging agents hydroxyurea (HU) and methyl 
58
methanesulfonate (MMS), missegregate chromosomes, accumulate gross-
chromosomal rearrangements (GCRs), and have a shortened life span (Sinclair, Mills et 
al. 1997, Mullen, Kaliraman et al. 2000, Fricke and Brill 2003, Schmidt, Wu et al. 2006). 
In contrast, five RecQ-like helicases (RecQL1, BLM, WRN, RecQL4, and RecQL5) are 
known in humans, and mutations in the BLM, WRN, and RECQL4 genes are associated 
with the rare, cancer-prone Bloom's syndrome (BS), Werner syndrome, and Rothmund–
Thompson syndrome, respectively (Ellis, Groden et al. 1995, Yu, Oshima et al. 1996, 
Kitao, Ohsugi et al. 1998, Kitao, Shimamoto et al. 1999, German, Sanz et al. 2007, 
Garcia-Rubio, Chavez et al. 2008). All RecQ-like helicases share a seven-motif helicase 
domain with Walker A and DEAH motifs. The RecQ-helicase-conserved (RQC) domain, 
located C-terminal to the helicase domain, is thought to be involved in DNA binding and 
conferring specificity of binding to DNA structures, such as G4 tetrads (von Kobbe, 
Thoma et al. 2003, Guo, Rigolet et al. 2005, Lee, Kusumoto et al. 2005, Huber, 
Duquette et al. 2006). The Helicase/RNase D C-terminal (HRDC) domain is the most C-
terminal of the conserved domains and resembles domains in other proteins that are 
involved in nucleic acid metabolism, such as RNase D and UvrD; however, similar to 
the RQC domain, it is not found in all RecQ-like helicases (Morozov, Mushegian et al. 
1997, Kitano, Yoshihara et al. 2007). The HRDC domain has been implicated in binding 
and resolving DNA structures, such as Holliday junctions, and in mediating protein–
protein interactions (Liu, Macias et al. 1999, Bernstein and Keck 2005, Wu, Chan et al. 
2005, Kitano, Yoshihara et al. 2007, Killoran and Keck 2008). Two acidic regions have 
also been identified N-terminal of the helicase domain and may be involved in mediating 
protein–protein interactions (Kitao, Ohsugi et al. 1998, Miyajima, Seki et al. 2000, 
59
Bernstein, Shor et al. 2009). Sgs1 is found in a complex with Top3 and Rmi1, and there 
is also evidence of physical interactions of the N-terminal half of Sgs1 with Top2, Srs2, 
and Rad16 and interactions of the C-terminus with Mlh1 and Rad51 (Watt, Louis et al. 
1995, Bennett, Noirot-Gros et al. 2000, Duno, Thomsen et al. 2000, Fricke, Kaliraman et 
al. 2001, Chang, Bellaoui et al. 2005, Chiolo, Carotenuto et al. 2005).  
Defects in BLM, the human RecQ helicase considered to be most closely related 
to Sgs1, cause BS, an autosomal recessive disorder characterized by chromosome 
gaps and breaks, elevated sister chromatid exchange, mitotic hyper-recombination, and 
aberrant DNA replication events (Chaganti, Schonberg et al. 1974, Hojo, van Diemen et 
al. 1995, Bachrati and Hickson 2003). Affected individuals suffer from a high incidence 
and wide variety of cancers, infertility, and dwarfism (reviewed in Bachrati et al. 2003). 
BLM catalyzes ATP-dependent 3′- to 5′-DNA unwinding, with a preference for DNA 
structures that may arise spontaneously during DNA replication or as a result of 
homologous recombination (HR) (Mohaghegh, Karow et al. 2001). For example, by 
unwinding unusual secondary DNA structures, BLM may aid replication fork 
progression, prevent illegitimate recombination during replication, and assist in 
restarting stalled forks (Ralf, Hickson et al. 2006, Wu and Hickson 2006, Hanada and 
Hickson 2007, Bachrati and Hickson 2008). Evidence supporting a role of BLM in 
maintaining genome integrity has been accumulating. For example, BLM-defective cells 
exhibit a retarded rate of strand elongation during DNA replication (Hand and German 
1975), accumulate abnormal replication intermediates (Lonn, Lonn et al. 1990), and are 
hypersensitive to agents that impair DNA replication (Davies, North et al. 2004). BLM 
physically interacts with several proteins that play important roles during DNA 
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replication and repair, such as replication protein A, flap endonuclease 1, chromatin 
assembly factor 1, the mismatch repair protein Mlh1, HR factor Rad51, and 
topoisomerase III α (Brosh, Li et al. 2000, Johnson, Lombard et al. 2000, Langland, 
Kordich et al. 2001, Wu, Davies et al. 2001, Jiao, Bachrati et al. 2004, Sharma, 
Sommers et al. 2004, Wu, Bachrati et al. 2006). BLM peaks in S phase and it localizes 
to replication foci, most likely through its physical interaction with a subunit of DNA 
polymerase δ (Dutertre, Ababou et al. 2000, Sanz, Proytcheva et al. 2000, Yankiwski, 
Marciniak et al. 2000, Bischof, Kim et al. 2001, Selak, Bachrati et al. 2008). 
Here, we have determined the role of C-terminal domains and protein interaction 
sites of Sgs1 in suppressing GCR accumulation by expressing point mutants and 
truncations of Sgs1, lacking as few as 20 residues and as many as 1428 residues. 
Human BLM cDNA was expressed under control of the native SGS1 promoter and 
overexpressed from a galactose-inducible promoter to investigate BLM's ability to 
complement sgs1Δ defects (such as increased genome instability and sensitivity to HU 
and MMS), revealing that BLM could suppress sgs1Δ defects neither in haploid nor in 
diploid cells. However, using computational protein disorder prediction tools, we have 
designed a yeast–human chimera that consists of two nonfunctional segments of BLM 
and Sgs1. The ability of this chimera to suppress all sgs1Δ defects that we tested 
suggests a functional relationship between BLM and Sgs1, which is also supported by 
our finding that short N-terminal fragments of Sgs1, which are devoid of all known 
functional domains for helicase activity and DNA binding, suppress severely detrimental 
effects of BLM overexpression in yeast. 
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RESULTS 
Requirement of the RQC domain of Sgs1, but not the HRDC domain, for 
GCR suppression 
Sgs1 contains a conserved DEAH helicase domain, a conserved HRDC domain, 
two acidic regions (AR1 and AR2), and an RQC domain composed of zinc-binding and 
winged-helix domains. Several protein interaction sites have also been located in the 
1447-amino-acid-long protein (Fig. 1a). To determine the role of these domains in the 
maintenance of genome stability, we generated systematic deletions to the 3′-end of the 
chromosomal SGS1 gene, such that truncations of the C-terminus of Sgs1, ranging 
from 20 to 1428 amino acids, were expressed as fusions to a myc epitope. Truncations 
of up to 80 amino acids were constructed to not affect any known functional domain of 
Sgs1, while ΔC100 and ΔC200 deletions partially and completely removed the HRDC 
domain and ΔC300 and ΔC400 deletions partially and completely removed the RQC 
domain, respectively. The largest deletions (ΔC700, ΔC800, ΔC900, ΔC1000, and 
ΔC1100) eliminate the entire helicase domain, including the Walker A motif (residues 
803-812), with the ΔC800–ΔC1100 deletions also affecting the part of the N-terminal 
half of Sgs1 that contains protein interaction sites (e.g., Rad16, residues 421–792; 
Top2, residues 432–724; and Srs2, residues 422–722) and two acidic regions (AR1, 
residues 321–447; AR2, residues 502–648), whereas ΔC500 and ΔC600 deletions 
partially remove the helicase domain while leaving the Walker A motif intact (Fig. 1a). 
All truncation alleles were stably expressed from the chromosomal SGS1 locus under 
control of the native SGS1 promoter (Fig. 1b). C-terminal fusion to the myc epitope did 
not adversely affect Sgs1 function, as indicated by equal sensitivity to HU and MMS of 
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strains expressing tagged and untagged Sgs1 (wild type) (Fig. 2a). The largest deletion, 
leaving intact only the 19 N-terminal amino acids of Sgs1 (sgs1ΔC1428), was as 
sensitive to HU and MMS as a complete SGS1 deletion (sgs1Δ), thus behaving similar 
to a null allele (Fig. 2a). Loss of up to 200 C-terminal amino acids did not increase 
sensitivity to HU or MMS, whereas loss of 300 or more amino acids led to sensitivity 
similar to that of the sgs1ΔC1428 and sgs1Δ mutants (Fig. 2a). The construction of 
additional 20-amino-acid truncations extended the C-terminal region that is dispensable 
for HU/MMS resistance to 240 amino acids (Fig. 2b). 
It was previously shown that cells lacking the DNA helicase Srs2 (srs2Δ) depend 
on functional Sgs1 for their viability (Lee, Johnson et al. 1999). To assess the ability of 
sgs1 truncation alleles to support growth of the srs2Δ mutant, we constructed diploid 
strains heterozygous for the srs2Δ deletion and heterozygous for the sgs1ΔC200, 
sgs1ΔC260, or sgs1ΔC300 allele. The meiotic products of the sporulated diploids were 
spread on nonselective, rich media [yeast–peptone–dextrose (YPD)], allowing all spores 
to grow (Fig. 2c). Diploids heterozygous for the srs2Δ deletion and for the sgs1ΔC200 
truncation yielded spores that grew into colonies of the same size, suggesting that the 
200 C-terminal amino acid residues of Sgs1, which harbor the HRDC domain and an 
interaction site with the HR factor Rad51, are not required for the viability of the srs2Δ 
mutant. In contrast, sporulation of diploids heterozygous for the srs2Δ deletion and 
sgs1ΔC260 or sgs1ΔC300 allele yielded mixtures of normal-sized and small colonies. 
Genotyping revealed that the small colonies were srs2Δ sgs1ΔC260 or srs2Δ 
sgs1ΔC300 mutants, whereas the normal-sized colonies corresponded to wild-type 
spores or single mutants. Thus, Sgs1 that lacks 260 or more C-terminal residues and 
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therefore does not contain a complete RQC domain cannot support normal growth of 
cells lacking Srs2. 
When we tested the effect of the C-terminal deletions on the accumulation of 
GCRs, we found that 240 C-terminal amino acids were dispensable for maintaining 
genome integrity, whereas deleting as little as an additional 20 amino acids 
(sgs1ΔC260) caused the GCR rate to increase to that exhibited by the null mutant 
without a discernable intermediate phenotype (Table 1). Combining the sgs1ΔC300 
truncation allele with a deletion of the DNA-damage checkpoint sensor MEC3 led to a 
synergistic GCR rate increase, while, as expected, combining the sgs1ΔC200 allele with 
a mec3Δ mutation did not. Thus, these findings show that the HRDC domain and the 
previously reported C-terminal interaction with Rad51 are not required for Sgs1's role in 
preventing the accumulation of GCRs and supporting normal growth of the srs2Δ 
mutant, whereas the integrity of the RQC domain, which has been suggested to span 
residues 1075–1207 based on the alignment of three-dimensional structures (Kitano, 
Kim et al. 2010), is essential. 
 
BS-associated RQC domain mutations cause loss of Sgs1 function in vivo 
Of the 32 exonic base substitutions that are causative of BS, 13 are missense 
mutations (Ellis, Groden et al. 1995, Foucault, Vaury et al. 1997, Barakat, Ababou et al. 
2000, German, Sanz et al. 2007), with 6 of these mutations affecting conserved 
residues that have been shown in vitro to participate in zinc binding and G-tetrad DNA 
binding activity (Fig. 3a). Studies, however, have been limited to biochemical and 
biophysical analyses of mutant proteins and were hampered by the inability to purify 
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some mutant BLM proteins (Janscak, Garcia et al. 2003, Guo, Rigolet et al. 2005, 
Huber, Duquette et al. 2006). Since the cysteine residues are highly conserved between 
RecQ-like helicases, including Sgs1, we replaced the corresponding cysteine residue in 
Sgs1 with the BS-associated mutation (sgs1-C1047F). Unlike BLM with mutations in 
any of the three conserved cysteine residues C1036, C1063, or C1066, which degraded 
upon purification and could therefore not be characterized (Janscak, Garcia et al. 2003), 
the sgs1-C1047F mutant allele was stably expressed in vivo from the native SGS1 
locus (Fig. 3b). The sgs1-C1047F mutant showed an increased HU and MMS 
sensitivity, which, however, did not reach the level of the sgs1Δ allele, and exhibited 
levels of GCR accumulation comparable to the sgs1Δ mutant, demonstrating that the 
C1047F mutation severely impairs Sgs1 function (Fig. 3c; Table 1). In addition to 
conserved cysteine residues and immediately adjoining arginine (R1037) and aspartic 
acid (D1064) residues, ClustalW2 alignments showed F1056 to be the only other fully 
conserved amino acid residue in the zinc-binding domain of Sgs1 (Fig. 3a). Although 
the corresponding residue in BLM (F1045) is not associated with a BS mutation, the 
BLM-F1045A mutation has been shown to cause a severe helicase defect and a single-
stranded DNA (ssDNA) binding deficiency in vitro (Janscak, Garcia et al. 2003). When 
we introduced the corresponding mutation into Sgs1 (F1056A), however, the mutant 
was no more sensitive to HU and MMS than wild-type cells (Fig. 3c) but instead 
appeared fully functional with a wild-type GCR rate (Table 1). 
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Expression of human BLM cDNA from the endogenous SGS1 promoter 
does not complement sgs1Δ defects 
RecQ-like DNA helicases are evolutionarily conserved from bacteria to humans. 
Since cells from BS patients share defects seen in sgs1Δ cells, including increased 
sensitivity to DNA-damaging agents, increased levels of aberrant genetic exchange, 
and reduced life span, it has been suggested that RecQ-like DNA helicases from 
different phyla or even kingdoms might complement each other, thus allowing the 
development of simple model organisms for the functional and mutational 
characterization of disease-associated human RecQ-like helicases, such as BLM and 
WRN (Yamagata, Kato et al. 1998). Thus, to assess the ability of BLM to suppress 
genome instability in the sgs1Δ mutant, BLM cDNA was inserted in-frame with the start 
codon of SGS1 at its chromosomal locus (PSGS1BLM). We reasoned that insertion at the 
wild-type SGS1 locus would promote cell-cycle-dependent regulation of BLM 
expression and expression levels similar to those previously shown for Sgs1 (Frei and 
Gasser 2000). Stable expression of BLM was confirmed by Western blot analysis, using 
a yeast strain expressing myc-tagged BLM (Fig. 4a); however, all subsequent 
experiments were carried out with untagged BLM. Expression of a single copy of BLM 
(PSGS1BLM) neither led to a statistically significant difference in the GCR rate compared 
to the sgs1Δ mutant (Table 1 and Table 2) nor alleviated HU sensitivity (Fig. 4b), 
demonstrating that BLM can be successfully expressed in yeast under control of the 
native SGS1 promoter without detrimental effects on cell growth, but is unable to 
complement the tested sgs1Δ defects to any extent. 
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Overexpression of BLM leads to increased sensitivity to DNA-damaging 
agents and rapid accumulation of GCRs 
Since a single copy of BLM (PSGS1BLM) did not complement sgs1Δ defects, we 
examined the effect of increasing BLM expression levels on sgs1Δ mutant phenotypes. 
For this purpose, the native SGS1 promoter was replaced with a GAL1 promoter and 
galactose-dependent expression of BLM was verified by fusing BLM to a myc epitope 
tag (Fig. 4a). Overexpression of BLM did not compensate for the lack of Sgs1 when 
cells were exposed to HU but instead led to a further increase in sensitivity to HU 
compared to the sgs1ΔC1428 cells or cells expressing BLM under the SGS1 promoter 
(Fig. 4b). We found that maximum induction of BLM expression led to a 1665-fold 
increase in the GCR rate compared to wild type and a 34-fold increase compared to the 
sgs1Δ mutant assayed under the same conditions (Table 2). In contrast, overexpression 
of Sgs1 from the GAL1 promoter did not lead to GCR accumulation (Table 2). The GCR 
rate increase upon BLM overexpression was dependent on induction levels, with the 
GCR rate gradually decreasing to that of the sgs1Δ mutant as the galactose 
concentration in the media decreased (Table 2). Thus, sgs1Δ defects cannot be 
complemented by any level of BLM expression; in fact, increasing BLM expression 
levels induce higher sensitivity to DNA-damaging agents and significantly higher 
genome instability compared to that of the sgs1Δ mutant. 
 
N-terminus of Sgs1 suppresses detrimental effects of BLM overexpression 
Since Sgs1 is important for the suppression of illegitimate recombination 
between identical sequences, such as those found in related genes, on homologous 
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chromosomes, and on sister chromatids, we tested the HU sensitivity of diploid strains 
expressing truncated sgs1 alleles in the presence or in the absence of the SGS1 wild-
type allele (Fig. 5). HU sensitivity was fully suppressed for all alleles if a single copy of 
wild-type SGS1 was expressed from the other allele (Fig. 5a), demonstrating that the 
sgs1 truncation alleles did not have a dominant effect. As in haploid cells, only the 
sgs1ΔC200 allele complemented HU sensitivity of the sgs1Δ diploid completely (Fig. 
5b); however, cells expressing the sgs1ΔC300 to sgs1ΔC900 alleles were less sensitive 
than diploids that expressed larger truncations or the sgs1ΔC1428 null allele (Fig. 5b). 
This ability of sgs1Δ300–sgs1ΔC900 truncation alleles to at least partially suppress HU 
sensitivity indicates that there may be N-terminal segments in Sgs1 that contribute to 
HU resistance. 
Diploids expressing BLM from native SGS1 promoters on both alleles were as 
sensitive to HU as diploids not expressing Sgs1, whereas diploids overexpressing BLM 
from one allele or from both alleles were severely HU sensitive, with the highest 
expression level lacking any growth on 100 mM HU (Fig. 5c), reflecting the severe HU 
sensitivity of haploid cells expressing the PGALBLM allele (Fig. 4b). Diploids 
overexpressing BLM also appeared to grow more slowly than any other diploid tested 
here (Fig. 5c). Remarkably, expression of a single copy of SGS1 from its endogenous 
promoter (SGS1/PGALBLM) completely eliminated the severe HU sensitivity conferred by 
overexpression of BLM. To determine if full-length Sgs1 was required for this 
suppression, we crossed the haploid strain overexpressing BLM with haploids 
expressing various Sgs1 truncations. We found that a single copy of the sgs1ΔC200 
allele was as sufficient as wild-type Sgs1 in suppressing HU sensitivity and slow growth 
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of the BLM-overexpressing strain, and as few as 547 N-terminal amino acids remaining 
in the sgs1ΔC900 allele were sufficient for significant suppression of HU sensitivity and 
slow growth caused by BLM overexpression (Fig. 5c). These findings suggest that none 
of the known enzymatic activities or functional and conserved domains are required for 
suppressing the HU sensitivity of the BLM-overexpressing diploids but that 547 N-
terminal amino acids are sufficient for suppressing the detrimental effects of BLM 
overexpression in a diploid. That the sgs1ΔC1000 and sgs1ΔC1100 alleles were clearly 
less effective at suppressing HU sensitivity shows that 447 N-terminal amino acids, 
which contain the Top3 interaction site, are necessary but not sufficient for 
complementation. 
 
Design of a functional Sgs1–BLM chimera 
Sgs1 and BLM share about 21% of their amino acid residues in a pairwise 
alignment of the full-length proteins (ClustalW2), with most of the identical residues in 
the helicase domain. In fact, the N-terminal segment of Sgs1 expressed by the 
sgs1ΔC800 allele, which is able to suppress the HU sensitivity of BLM-overexpressing 
diploids, shares only 11% with the corresponding N-terminal segment of BLM. Devoid of 
conserved domains and known enzymatic activities, the N-terminus of Sgs1 has been 
shown to be required for physical interactions with Top3, Top2, Srs2, and Rad16 (Watt, 
Louis et al. 1995, Bennett, Noirot-Gros et al. 2000, Duno, Thomsen et al. 2000, Mullen, 
Kaliraman et al. 2000, Fricke, Kaliraman et al. 2001, Chiolo, Carotenuto et al. 2005). 
Using IUPred, an algorithm for the prediction of intrinsically disordered proteins, we 
found that the 650 N-terminal residues contain a similar distribution of ordered and 
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intrinsically disordered segments (Fig. 6a and b). In disorder prediction algorithms, such 
as IUPred (Dosztanyi, Csizmok et al. 2005, Dosztanyi, Csizmok et al. 2005) a score of 
> 0.5 predicts a disordered amino acid residue and a score of < 0.5 predicts an ordered 
residue, with 30 consecutive disordered amino acids commonly being used as a lower 
limit for detecting disorder in whole proteome searches (Ward, Sodhi et al. 2004, 
Dosztanyi, Csizmok et al. 2005, Dosztanyi, Csizmok et al. 2005, Peng, Vucetic et al. 
2005). The helicase domains of Sgs1 and of BLM coincide with the predicted ordered 
regions in both proteins, starting at around residue 648, and are surrounded by a long 
N-terminal and a short C-terminal segment, which contain mostly disordered residues. 
In fact, based on the IUPred output scores, 83% of the 648 N-terminal residues of Sgs1 
(538/648) are disordered, with 70% of all 648 residues being located in segments of 
more than 30 consecutive disordered residues, whereas only 16% of the 800 C-terminal 
residues of Sgs1 are predicted to be disordered, with only a single disordered segment 
that is longer than 30 residues (residues 1396–1447). Based on the IUPred prediction, 
BLM can also be divided into a disordered N-terminus and an ordered C-terminus (Fig. 
6a and b). For BLM, 52% of 648 N-terminal residues are predicted to be disordered, but 
only 15% of these residues are found in stretches of more than 30 disordered residues. 
The difference in the pattern of disorder predicted for the N-terminal segments of Sgs1 
and BLM led us to hypothesize that this region may be involved in conferring species 
specificity to BLM and Sgs1 function and, thus, prevent BLM from functioning in yeast. 
This hypothesis is supported by the fact that the N-terminus of Sgs1 is sufficient for the 
complementation of the HU sensitivity induced by overexpression of BLM. To test this 
hypothesis, we constructed a yeast–human chimera in which the 647 N-terminal 
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residues of BLM were replaced by the 647 N-terminal residues of Sgs1 (sgs1ΔC800-
blmΔN647) (Fig. 6c). To express this chimera from the native SGS1 promoter, we 
replaced nucleotides 1941 to 4344 of the endogenous SGS1 gene with nucleotides 
1941 to 4254 of BLM cDNA (Fig. 6e). Remarkably, the chimera was nearly as effective 
as wild-type SGS1 in conferring resistance to HU, whereas the N-terminal segment of 
Sgs1 by itself was ineffective (Fig. 6d). Moreover, when we combined the chimeric allele 
with a mec3Δ mutation, GCRs accumulated at a significantly lower rate than in the 
mec3Δ mutant carrying the GCR-deficient sgs1ΔC300 or sgs1ΔC800 allele, albeit not at 
the low rate of the mec3Δ mutant carrying the GCR-proficient sgs1ΔC200 allele, 
signifying partial functionality of the chimerical protein in the suppression of 
chromosomal rearrangements (Table 1). Finally, besides Srs2, the sgs1Δ mutant also 
requires the DNA helicase Rrm3 for viability. Synthetic lethality between sgs1Δ and 
rrm3Δ mutations is suppressed by disrupting HR factors such as Rad51 and Rad55, 
suggesting that the lethality is due to accumulation of aberrant HR intermediates (Ooi, 
Shoemaker et al. 2003, Schmidt and Kolodner 2004, Torres, Schnakenberg et al. 2004). 
To assess if the Sgs1–BLM chimera was capable of preventing the accumulation of 
lethal levels of aberrant recombination intermediates, we constructed a diploid 
heterozygous for the rrm3Δ mutation and heterozygous for the sgs1ΔC800-blmΔN647 
allele, expressing the Sgs1–BLM chimera. Spreading of spores from this diploid on 
YPD, which allows all spores to grow, showed that the rrm3Δ mutant expressing the 
chimera grows normally with the diameter of double-mutant colonies measuring 
approximately 90% of that of the single mutants (Fig. 6f). These findings indicate that 
the Sgs1–BLM chimera is functional and, while not capable of fully suppressing 
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chromosomal rearrangements, prevents the accumulation of lethal levels of aberrant 
recombination intermediates when Rrm3 helicase is absent. 
 
DISCUSSION 
Yeast cells that lack Sgs1 exhibit upregulated and aberrant recombination in 
mitosis, increased sensitivity to DNA-damaging agents, accumulation of GCRs, 
synthetic lethality with mutations in other DNA metabolic genes, such as the SRS2 and 
RRM3 helicase genes, and meiotic defects that lead to poor spore viability (Watt, Louis 
et al. 1995, Lee, Johnson et al. 1999, Frei and Gasser 2000, Miyajima, Seki et al. 2000, 
Myung, Datta et al. 2001, Cobb, Bjergbaek et al. 2002, Ira, Malkova et al. 2003, Versini, 
Comet et al. 2003, Schmidt and Kolodner 2004, Schmidt, Wu et al. 2006). Sgs1 
contains several conserved domains (DEAD helicase, RQC, HRDC, AR1, and AR2), 
and protein interaction sites (Top2, Top3, Srs2, Rad16, Rad51, and Mlh1) have been 
identified by two-hybrid screens (Watt, Louis et al. 1995, Duno, Thomsen et al. 2000, 
Saffi, Feldmann et al. 2001, Wu, Davies et al. 2001, Chiolo, Carotenuto et al. 2005). 
How the integrity of these conserved motifs and protein–protein interaction sites affects 
the role of Sgs1 in suppression of aberrant genome rearrangements has not been 
determined. The requirement of some domains and/or protein interaction sites, but not 
others, may shed light on the poorly understood mechanism(s) by which Sgs1 
contributes to the maintenance of genome integrity in yeast. Here, we find that the 
segment made up of 240 C-terminal amino acids, which contains Rad51 and Mlh1 
interaction sites and the conserved HRDC domain thought to be involved in DNA 
binding and in recognition and processing of double Holliday junctions (Liu, Macias et 
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al. 1999, Wu, Chan et al. 2005), is dispensable for Sgs1's role in suppressing GCRs. 
The integrity of the RQC domain, however, is essential for GCR suppression. That zinc 
binding is crucial for Sgs1 activity, as well as the fact that loss of function of the C-
terminal truncation allele was not due to disruption of protein structure/function because 
of such a large deletion, was further confirmed by the finding that the point mutation of a 
conserved zinc-coordinating cysteine, which has also been observed in BS patients 
(Foucault, Vaury et al. 1997), led to the loss of Sgs1's ability to suppress HU sensitivity 
and GCR accumulation. This loss of function was not due to degradation of the mutant 
protein as had been previously observed for some cysteine mutants of BLM during 
attempts at overexpression and purification from E. coli. However, we cannot exclude 
the possibility that the loss of function resulted from intracellular mislocalization of the 
mutant protein. Previously, modeling of the zinc-binding domain of BLM and instability 
of purified mutant proteins had indicated that hydrogen bonds between three conserved 
residues, Y1029 (Y1040 in Sgs1), R1037 (R1048 in Sgs1), and D1064 (D1070 in Sgs1), 
are required for the folding of the zinc-binding domain and overall protein stability (Guo, 
Rigolet et al. 2005). Although F1056 of Sgs1 does not appear to be involved in this zinc-
domain stabilization and the Sgs1-F1056A mutant protein appears stable in this study, 
F1056 is the only other fully conserved residue in the zinc-binding domain of RecQ-like 
helicases, suggesting functional significance. However, introduction of the F1056A 
mutation had no effect on Sgs1 function in vivo when we assessed HU sensitivity, 
consistent with a previous study (Ui, Satoh et al. 2001), or GCR accumulation. That, in a 
previous in vitro study (Janscak, Garcia et al. 2003), the corresponding BLM mutation 
(F1045A) had severely impaired helicase and ssDNA binding activities could be either 
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due to differences in the importance of this residue for enzymatic activity of BLM and 
Sgs1 or, more likely, due to the fact that only the helicase-core segment of BLM, lacking 
769 residues of N- and C-termini, was purified. The in vitro function of this isolated 
domain could be more strongly affected by a mutation than the in vivo function of the 
full-length Sgs1 mutant protein assessed here. Although nearly half of all BLM alleles 
that are associated with single-amino-acid changes (7 of 17 alleles) in BS patients are 
located in the RQC domain (Ellis, Groden et al. 1995, Foucault, Vaury et al. 1997, 
Barakat, Ababou et al. 2000, German, Sanz et al. 2007), none affect F1045, consistent 
with our finding that mutation of this conserved residue may not be associated with 
significant loss of function in vivo. 
We find that Sgs1 retains partial functionality even when it lacks the HRDC, 
RQC, and DEAH helicase domains, as demonstrated by the greater HU resistance of 
diploids that only express 547 N-terminal amino acid residues compared to those alleles 
expressing fewer than 447 residues of Sgs1. One possible explanation for this finding is 
that protein–protein interactions conferred by the N-terminus could contribute to the 
structural stability of multi-protein complexes, such as the Sgs1–Top3–Rmi1 (Chang, 
Bellaoui et al. 2005) complex or, even more relevant to HU resistance, DNA-damage-
specific complexes with Srs2 and Mre11 (Chiolo, Carotenuto et al. 2005). In these multi-
protein complexes, enzymatic activity of Sgs1 may be dispensable. Indeed, sgs1 alleles 
with point mutations in the helicase domain have been shown to be capable of 
performing some functions of the wild-type allele, including those carried out during 
meiosis and checkpoint activation (Miyajima, Seki et al. 2000, Bjergbaek, Cobb et al. 
2005). 
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In contrast to two previous reports (Yamagata, Kato et al. 1998, Heo, 
Tatebayashi et al. 1999), which both used the same yeast strain that constitutively 
expressed BLM from a GAPDH promoter and showed partial suppression of some 
sgs1Δ defects, including HU sensitivity, we found that neither BLM expression under 
control of the natural SGS1 promoter nor varying levels of BLM expression under 
control of a galactose-inducible promoter had any positive effect on the sgs1Δ mutant. 
That a single copy of BLM, when expressed under control of the native SGS1 promoter, 
cannot alleviate sgs1Δ defects initially suggested to us that BLM had no functionality in 
yeast. In fact, the strong increase in genome instability, accompanied by severe HU 
sensitivity and some growth retardation upon overexpression of BLM, indicated that 
BLM expression is detrimental to yeast cells. The absence of any GCR accumulation 
upon Sgs1 overexpression suggests that increased accumulation of GCRs in BLM-
overexpressing cells is not simply due to increased unwinding. Rather, we propose that 
BLM may possess helicase activity in yeast, leading to increased unwinding upon 
overexpression, but fails to elicit proper downstream responses, for example, due to 
lack of proper N-terminal protein–protein interactions, which ultimately leads to an 
overabundance of aberrantly repaired lesions. That endogenous levels of N-terminal 
segments of Sgs1 as short as 547 residues suppressed the slow growth phenotype and 
the severe HU sensitivity of BLM-overexpressing cells argues in favor of a functional 
relationship between Sgs1 and BLM. For example, co-expression of Sgs1 and BLM 
could alleviate HU sensitivity in BLM-overexpressing cells by acting as a bridge 
between BLM and Top3 (and/or other protein complexes interacting with the Sgs1 N-
terminus), thereby linking enzymatic activity to appropriate upstream and downstream 
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events. Remarkably, even relatively short N-terminal fragments of Sgs1 are sufficient for 
the suppression of the increased HU sensitivity of BLM-overexpressing cells, further 
supporting the importance of the Sgs1 N-terminus with its role in mediating interaction 
with other DNA metabolic factors. HU resistance comparable to wild-type cells and 
significantly reduced GCR accumulation of cells expressing a chimeric fusion of the 
Sgs1 N-terminus, which is devoid of enzymatic function and dispensable for helicase 
activity and ssDNA binding in vitro, and the BLM C-terminus, which contains 
helicase/RQC and HRDC domains, are consistent with helicase activity of BLM in yeast 
and a biologically significant, functional interaction between BLM and Sgs1. That fusion 
of the Sgs1 and BLM segments provides HU resistance as well as co-expression of 
BLM and Sgs1 polypeptides from separate alleles in the same cell may indicate that the 
N-terminus of Sgs1 can physically interact with BLM. Our findings also suggest that it is 
the inability of the N-terminus of BLM to interact with or be modified by yeast proteins 
that leads to the inability of BLM to function in yeast. A previous report that BLM 
expression in yeast alleviates several sgs1Δ phenotypes, including partial suppression 
of HU sensitivity (Yamagata, Kato et al. 1998, Heo, Tatebayashi et al. 1999), could be 
explained by the fact that, in the earlier study, BLM was expressed from a GAPDH 
promoter, whereas here it was expressed either from the native SGS1 promoter or from 
a galactose-inducible promoter. However, in light of the findings presented here, there 
could also be an alternative explanation. Since the GAPDH promoter–BLM construct 
appears to have been inserted into the middle of the wild-type SGS1 gene, an N-
terminal segment of Sgs1 could have been expressed from the native SGS1 promoter 
in addition to BLM being expressed from the GAPDH promoter. As shown here for 
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haploids expressing the chimera and for diploids co-expressing the N-termini of Sgs1 
and full-length BLM, such co-expression of an N-terminal Sgs1 segment from the native 
SGS1 promoter and BLM from the GAPDH promoter could be an explanation for the 
reported increase in HU resistance of BLM-expressing cells compared to sgs1Δ cells. 
Of the five human RecQ-like DNA helicases, BLM is considered to be most 
closely related to Sgs1. Even though we show here that BLM cannot suppress any 
defects of the sgs1Δ mutant, the functional chimera does provide evidence for a 
functional relationship between the two RecQ-like helicases and provides a model 
system for the further characterization of BLM functional domains in yeast. In fact, all 
BS-associated missense mutations and numerous polymorphisms are located within the 
770-residue C-terminal fragment of BLM that is part of the chimera, so that they are now 
accessible to further functional and mutational characterization in yeast. The in vivo 
functionality of the Sgs1–BLM chimera also demonstrates the remarkable utility of 
protein disorder prediction as a tool for the construction of functional mutants. It will be 
interesting to see whether domains of any of the other human RecQ-like helicases, are 
capable of forming functional chimeras with the Sgs1 N-terminus. 
 
MATERIALS AND METHODS 
Yeast strains and media 
All strains are derived from KHSY802, a derivative of S288C. Yeast strains 
expressing truncations of Sgs1 helicase were constructed by HR-mediated integration 
of PCR products, replacing the desired 3′-segment of SGS1 on chromosome VIII with a 
myc epitope coding sequence (from pFA6a-13Myc.His3MX6 (Longtine, McKenzie et al. 
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1998), a gift from Mark Longtine, University of Washington) in-frame with the SGS1 
coding sequence. The expression of all truncation alleles and the myc-epitope-tagged 
wild-type allele of SGS1 was confirmed by Western blot analysis. All gene 
replacements, insertions, and truncations were performed via the standard LiAc protocol 
(Gietz and Woods 2006), using PCR products with at least 50 nt on each end, which 
matched the chromosomal target locus. A PCR fragment containing BLM cDNA (Open 
Biosystems) and a HIS3 cassette was amplified by PCR from plasmid pKHS293 using 
primers that include 50-nt homology to the chromosomal SGS1 locus to express BLM 
from the native SGS1 promoter (PSGS1). This PCR product was fused to the native 
chromosomal SGS1 promoter by HR-mediated integration (Gietz and Woods 2006). A 
PCR fragment coding for a 13Myc epitope tag was amplified from pFA6a-13Myc-
kanMX6 (Longtine, McKenzie et al. 1998) and integrated in-frame at the 3′-end of 
cDNAs or sgs1 alleles for detection of protein expression by Western blot analysis. In 
strains KHSY3350 and KHSY3218, galactose-inducible promoters amplified from 
plasmids pFA6a-kanMX6-PGAL1 and pFA6a-TRP1-PGAL1 (Longtine, McKenzie et al. 
1998), respectively, were used to replace the native SGS1 promoter. To construct 
KHSY3355, we amplified the 3′-terminal 2313 bp of BLM cDNA linked to a HIS3 
cassette by PCR from plasmid pKHS293 and used them to replace the 3′-terminal 
2400 bp of SGS1 in KHSY802. The accuracy of PCR-derived SGS1 or BLM integrations 
was confirmed by sequencing. Amino acid changes C1047F and F1056A in Sgs1 were 
made by site-directed mutagenesis (QuikChange, Stratagene) of pKHS360 and 
integrated at the sgs1∷HIS3 locus in KHSY1338. All yeast strains used in this study 
are listed in Table S1. Cells were grown in YPD consisting of 10 g/l yeast extract (Fisher 
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Scientific), 20 g/l Bacto-peptone (BD Diagnostic Systems), and 2% glucose (Fisher 
Scientific), unless indicated otherwise. For plates, agar (BD Diagnostic Systems) was 
added at a concentration of 20 g/l. 
 
Western blot analysis 
Cells were grown to an OD600 = 0.5 in YPD, and whole-cell extracts were 
prepared from 5 ml of culture (∼ 3.5 × 107 cells) by standard trichloroacetic acid (TCA, 
Fisher Scientific) extraction to confirm expression of myc-epitope-tagged BLM and 
SGS1 alleles (Foiani, Liberi et al. 1999). Five microliters of TCA extract was separated 
on 10% polyacrylamide gels, transferred to a PVDF membrane (Bio-Rad), probed with 
anti-c-myc monoclonal antibody (9E10, Covance Research Products), and visualized by 
chemiluminescence (ECL Plus, GE Healthcare). To confirm expression of SGS1 and 
BLM from the GAL1 promoter, we used the same Western blot procedure, but cells 
were grown overnight in yeast–peptone (YP) [(10 g/l yeast extract (Fisher Scientific), 
20 g/l Bacto-peptone (BD Diagnostic Systems)] supplemented with 2% sucrose (Fisher 
Scientific), diluted to an OD600 = 0.2 in YP supplemented with either 2% sucrose 
(uninduced sample) or 2% galactose (induced sample), and harvested for TCA 
extraction when cultures reached OD600 = 0.5. Molecular weight marker (Broad Range) 
was from Bio-Rad. 
 
Sensitivity to DNA-damaging agents HU and MMS 
Cell cultures were grown in YPD to an OD600 = 0.5, and 10-fold serial dilutions 
were spotted on YPD supplemented with 0.05% MMS (Sigma Aldrich) or with 50 mM or 
79
100 mM HU (US Biological), as indicated. For experiments that included strains 
expressing BLM or Sgs1 from the GAL1 promoter (Fig. 5), cultures were grown in YP-
2% sucrose instead of YPD and spotted on YP-1% sucrose + 1% galactose (to induce 
gene expression) supplemented with 100 mM HU or without HU as the growth control. 
 
GCR rate measurements 
Rates of accumulating GCRs in YPD were determined as previously described 
(Schmidt, Pennaneach et al. 2006). For GCR rate measurements of yeast strains 
expressing BLM or Sgs1 from the GAL1 promoter, the same procedure was followed, 
except that media were supplemented with 2% galactose to induce gene expression. 
Briefly, 10 ml of YP-2% galactose was inoculated with a single colony, which had been 
grown on YPD agar for 3 days. After 3 days of growth in liquid media at 30 °C with 
vigorous shaking, cells were plated on GCR plates (Schmidt, Pennaneach et al. 2006) 
supplemented with 2% galactose instead of 2% glucose, and 10− 6 dilutions were plated 
on YPD to obtain the viable cell count. Colonies on GCR plates were counted after 
5 days of incubation at 30 °C. For GCR rate measurements in the presence of varying 
BLM expression levels (Table 2), 0.1% or 0.5% galactose instead of 2% galactose was 
added to liquid YP media and to GCR plates, and sucrose was supplemented to reach a 
total of 2% sugar in the media. We calculated 95% confidence intervals according to 
Nair (Nair 1940). 
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Random spore analysis 
Diploids heterozygous for the desired mutant alleles were grown overnight at 
30 °C in YPD, washed, transferred to 0.1% potassium acetate (Fisher Scientific), and 
incubated for 5 days at 30 °C with vigorous shaking. Asci were incubated in the 
presence of 500 µg/ml zymolase (MP Biomedicals) in 1 M sorbitol (Fisher Scientific) for 
20 min at 30 °C and enriched for haploid spores as previously described (Rockmill, 
Lambie et al. 1991). Spores were plated on YPD, incubated at 30 °C, and genotyped by 
spotting on synthetic drop-out media (US Biological) to detect the presence of TRP1 
and HIS3 marker cassettes linked to the mutant alleles. The presence of mutant alleles 
linked to the kanMX6 cassette was detected by the ability of haploids to grow on YPD 
supplemented with 200 µg/ml G418 (Axxora LLC, San Diego, CA). 
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FIGURES AND TABLES 
 
Figure 2.1. C-terminal truncations of Sgs1 used in this study.  
(A) Full-length Sgs1 contains a DEAH-helicase domain, an RQC domain and an HRDC 
domain in its C-terminal half; interaction sites with Top3, Top2, Srs2, Rad51 and Rad16 
are indicated. C-terminal truncations ranging in size from 200 residues to 1428 residues 
were constructed by fusion to a myc-epitope tag. All truncations were introduced to the 
endogenous SGS1 locus on chromosome VIII. (B) Expression of wild-type Sgs1 and 
truncation alleles from the endogenous SGS1 promoter (PSGS1) was confirmed by 
Western blotting, using a myc-antibody. Molecular weights (MW) are indicated on the 
left. 
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 Figure 2.2. Sensitivity of cells expressing Sgs1 truncation alleles to the DNA 
damaging agents HU and MMS. Ten-fold dilutions of exponentially growing cultures 
(OD600 = 0.5) were spotted on YPD for viable cell count and on YPD containing 
100mM HU or 0.05% MMS, followed by incubation at 30° C. (A) Haploid cells 
expressing sgs1 alleles lacking 300 or more residues from the C-terminus are as 
sensitive to HU and MMS as the null allele. (B). Additional incremental 20-amino-acid 
deletions reveal that cells expressing sgs1 alleles lacking up to 240 residues are as 
resistant to HU and MMS as wildtype cells whereas those lacking 260 or more residues 
are as sensitive as the sgs1Δ mutant. (C) Spores from diploids heterozygous for an 
srs2Δ deletion and heterozygous either for the sgs1-ΔC200, sgs1Δ-C260 or sgs1- 
ΔC300 were spread on YPD to allow for growth of spores of all possible genotypes. 
Similar sized colonies obtained from the spores of the diploid heterozygous for 
sgs1ΔC200 and srs2Δ mutations (left) indicate that the sgs1ΔC200 srs2Δ mutant grows 
as well as the single mutants, suggesting that deletion of the C-terminal 200 amino acid 
residues does not negatively affect growth of the srs2Δ mutant. In contrast, spores from 
diploids heterozygous for the srs2Δ mutation and the sgs1ΔC260 allele (middle) or the 
sgs1ΔC300 allele (right), grew into a mixture of normal-sized colonies (corresponding to 
single mutants and wildtype) and small-sized colonies (corresponding to srs2Δ 
sgs1ΔC260 or srs2Δ sgs1ΔC300 mutants as determined by genotyping), demonstrating 
that an intact RQC domain in Sgs1 is required for the viability of the srs2Δ mutant.  
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 Figure 2.3. Effect of zinc-binding domain mutations on Sgs1 function in vivo. (A) 
Zinc-binding domain is conserved from bacterial to human RecQ-like DNA helicases. 
Protein sequences were aligned with ClustalW2 (Chenna, Sugawara et al. 2003). The 
alignment of RecQL1 was manually adjusted. Amino acid residues identical in all 
sequences are highlighted in gray and indicated by '*' below the alignment, conserved 
substitutions are indicated by ':' below the alignment, and cysteine residues thought to 
be involved in zinc-binding are shown in red. At least six different missense mutations in 
the zinc-binding domain are associated with Bloom’s syndrome. (B) C1047F and 
F1056A mutations were introduced into Sgs1 and expression was confirmed by western 
blot using antibody against the C-terminal myc-epitope. Molecular weights (MW) are 
indicated in kDa to the left. (C) Mutation of the highly conserved F1056 does not impair 
Sgs1 function whereas the C1047F mutation leads to an increase in sensitivity to HU 
and MMS, but not to the level seen in the sgs1Δ mutant.  
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 Figure 2.4. BLM expression does not suppress sgs1Δ defects and BLM 
overexpression is detrimental to yeast cells. (A) Expression of myc-epitope tagged 
Sgs1 (lane 1) and BLM (lane 2) from the native chromosomal SGS1 locus or galactose- 
inducible overexpression of myc-epitope tagged Sgs1 (lane 4) and BLM (lane 6) in 
yeast cells grown in YP supplemented with 1% sucrose and 1% galactose (to induce 
expression, lanes 4 and 6) or without galactose (lanes 3 and 5). Both BLM and Sgs1 
show signs of degradation upon overexpression (lanes 4 and 6) whereas expression 
from the native SGS1 promoter is stable (lanes 1 and 2). Molecular weights (MW) are 
indicated in kDa on the left. (B) Cells expressing BLM from the SGS1 promoter on 
chromosome VIII are as sensitive to HU as cells lacking Sgs1 (Δsgs1). Replacement of 
the natural SGS1 promoter with a galactose-inducible GAL1 promoter induces BLM 
overexpression and leads to increased HU sensitivity. Ten-fold dilutions of cells were 
spotted on media containing 1% sucrose and 1% galactose (to induce BLM 
overexpression) with and without 100 mM HU.  
 
 
85
 Figure 2.5. HU sensitivity of diploid cells expressing BLM and mutant alleles of 
SGS1. (A) Ten-fold dilutions of exponentially growing diploids expressing truncation 
alleles of SGS1 in the presence of a wildtype allele were spotted on YPD media with 
and without 100 mM HU. (B) Ten-fold dilutions of exponentially growing diploids 
expressing truncation alleles of SGS1 in the absence of a wildtype allele were spotted 
on YPD media with and without 100 mM HU. (C) Ten-fold dilutions of exponentially 
growing diploids overexpressing BLM from a GAL1 promoter inserted at the native 
SGS1 locus and expressing truncation alleles of SGS1 under control of the native SGS1 
promoter on the other allele were spotted on media containing 1% galactose (to induce 
gene expression) and 1% sucrose with or without 100 mM HU.  
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Figure 2.6. Construction of a functional chimerical protein composed of the N- 
terminus of Sgs1 and the C-terminus of BLM. (A – B) Protein disorder prediction of 
Sgs1 (red) and BLM (black) using the IUPred algorithm. Values above 0.5 indicate a 
disordered residue whereas values below 0.5 indicate ordered residues; amino acid 
residue numbers (1–1447) are indicated on the abscissa. Black lines above the graph 
show a simplified order and disorder distribution along the length of the protein with 
values above 0.5 being assigned a “1” and values below 0.5 being assigned a “0”. The 
vertical red line indicates the site in Sgs1, BLM and the chimera where the disordered 
N-terminal segment transitions into the ordered helicase domain at residue 647/648. 
This site was chosen as the fusion site for the chimera. The approximate location of 
Sgs1 domains is indicated above panel A. (C) Disorder prediction for the Sgs1-BLM 
chimera in which the N-terminal 647 residues of BLM (black) were replaced with the N- 
terminal 647 residues of Sgs1 (red). (D) Ten-fold dilutions of exponentially growing 
haploids were spotted on YPD with or without 100 mM HU. (E) The C-terminus of the 
Sgs1-BLM chimera was fused to a myc-epitope tag and expression was confirmed by 
western blotting. Molecular weight marker bands (kD) are indicated on the left (F) A 
diploid heterozygous for the rrm3Δ mutation and the sgs1ΔC800-blmΔN647 allele 
expressing the chimera was sporulated and random spores were plated on YPD to 
allow all spores to grow. An open circle indicates the haploid double mutant, and the 
open square and pentagon indicate haploid sgs1ΔC800-blmΔN647 and rrm3Δ single 
mutants, respectively.  
 
 
 
 
87
Table 2.1. Accumulation of GCRs in cells expressing mutant alleles of SGS1 
 
Relevant Genotypea 
GCR rate (Canr 5-
FOAr × 10− 10) 
95% CIb (Canr 5-
FOAr × 10− 10) 
Wild type 1.1 < 1–6.2 
sgs1Δ 251 80–310 
sgs1ΔC200 7 < 6–23 
sgs1ΔC220 31 5–41 
sgs1ΔC240 10 < 6–27 
sgs1ΔC260 159 85–362 
sgs1ΔC280 244 166–387 
sgs1ΔC300 145 76–204 
sgs1ΔC400 106 60–180 
sgs1ΔC500 102 53–252 
sgs1ΔC600 152 26–283 
sgs1ΔC700 189 49–271 
sgs1ΔC800 133 71–225 
sgs1ΔC1428 206 97–273 
sgs1-C1047F 64 35–131 
sgs1-F1056A  < 16 < 10–26 
mec3Δsgs1ΔC200 11 < 7–22 
mec3Δsgs1ΔC300 1003 691–1500 
mec3Δsgs1ΔC800 758 645–895 
mec3Δsgs1ΔC800-
blmΔN647c 
361 330–419 
a. All sgs1 truncations (sgs1ΔC) are C-terminally fused to a myc epitope tag. 
b. We calculated 95% confidence intervals (CIs) according to Nair (Nair 1940). 
c. The sgs1ΔC800-blmΔN647 allele expresses a chimeric protein that consists of the 
647 N-terminal residues of Sgs1 and the 770 C-terminal residues of human BLM. 
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Table 2.2. Effect of BLM expression on GCR accumulation in the sgs1Δ mutant 
 
Relevant 
genotypea 
Galactose concentration 
in media (%) 
GCR rate (Canr 5-
FOAr × 10− 10) 
95% CIb (Canr 5-
FOAr × 10− 10) 
Wild type 0 1.1 < 1–6.2 
PSGS1BLM 0 70 56–151 
PGALBLM 0 61 30–153 
PGALBLM 0.1 335 233–576 
PGALBLM 0.5 382 170–777 
PGALBLM 2 1832 1090–2910 
PGALSGS1 2 < 11 < 9–12 
sgs1Δ 2 54 23–104 
a. Human BLM cDNA was inserted at the endogenous SGS1 locus and fused to the 
native SGS1 promoter (PSGS1) or fused to a galactose-inducible promoter (PGAL). In 
PGALSGS1, the native SGS1 promoter region was disrupted by fusing the SGS1 open 
reading frame to a galactose-inducible promoter. If strains expressing BLM or SGS1 
genes from the galactose-inducible GAL1 promoter were grown in less than 2% 
galactose (to lower protein expression levels), media were supplemented with sucrose 
to reach a total sugar concentration of 2%. 
b. We calculated 95% confidence intervals (CIs) 
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TABLE 2.S1. Yeast Strains used in this study 
Strain Genotype 
KHSY802 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3 
KHSY1338 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1::HIS3 
KHSY1705 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::ura3::TRP1, sgs1::BLM.HIS3 
KHSY2341 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, mec3::kanMX6, sgs1ΔC200.MYC.HIS3 
KHSY2347 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, mec3::kanMX6, sgs1ΔC300.MYC.HIS3 
KHSY2599 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3 
KHSY2602 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1::kanMX6 
KHSY2726 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C200.MYC.HIS3 
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TABLE 2.S1 (continued) 
KHSY2828 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,  
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1C200.MYC.HIS3 
KHSY2837 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1C300.MYC.HIS3 
KHSY2880 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC300.MYC.HIS3 
KHSY2883 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC400.MYC.HIS3 
KHSY2886 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC500.MYC.HIS3 
KHSY2889 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC600.MYC.HIS3 
 
 
91
TABLE 2.S1 (continued) 
KHSY2892 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC700.MYC.HIS3 
KHSY2895 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC800.MYC.HIS3 
KHSY2898 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC1428.MYC.HIS3 
KHSY2928 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC400.MYC.HIS3 
KHSY2931 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC500.MYC.HIS3 
KHSY2934 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC600.MYC.HIS3 
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TABLE 2.S1 (continued) 
KHSY2937 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC700.MYC.HIS3 
KHSY2940 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC800.MYC.HIS3 
KHSY2943 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC1428.MYC.HIS3 
KHSY2970 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1.MYC.HIS3 
KHSY2972 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC200.MYC.HIS3 
KHSY2973 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC300.MYC.HIS3 
KHSY2974 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC400.MYC.HIS3 
KHSY2975 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC500.MYC.HIS3 
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TABLE 2.S1 (continued) 
KHSY2976 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC600.MYC.HIS3 
KHSY2977 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC700.MYC.HIS3 
KHSY2978 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC800.MYC.HIS3 
KHSY2979 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC1428.MYC.HIS3 
KHSY3181 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC1100.MYC.HIS3 
KHSY3218 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, TRP1.PGAL1.SGS1 
KHSY3332 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1::BLM.HIS3 
KHSY3346 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::ura3::TRP1, BLM.MYC.kanMX6.HIS3 
KHSY3350 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, kanMX6.PGAL1.BLM.HIS3 
KHSY3353 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, kanMX6.PGAL1.BLM.HIS3 
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TABLE 2.S1 (continued) 
KHSY3355 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3 
KHSY3363 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC800-blmΔN647.HIS3, Δmec3::kanMX6 
KHSY3372 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, sgs1::BLM.HIS3/sgs1::BLM.HIS3 
KHSY3409 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/SGS1.MYC.HIS3 
KHSY3410 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC200.MYC.HIS3 
KHSY3412 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC300.MYC.HIS3 
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TABLE 2.S1 (continued) 
KHSY3414 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC400.MYC.HIS3 
KHSY3416 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC500.MYC.HIS3 
KHSY3417 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC600.MYC.HIS3 
KHSY3419 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC700.MYC.HIS3 
KHSY3420 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC800.MYC.HIS3 
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TABLE 2.S1 (continued) 
KHSY3422 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC900.MYC.HIS3 
KHSY3423 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC1000.MYC.HIS3 
KHSY3424 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC1100.MYC.HIS3 
KHSY3425 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/sgs1ΔC1428.MYC.HIS3 
KHSY3426 ura3-52/ura3-52, leu2Δ/leu2Δ , trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, 
kanMX6.PGAL1.BLM.HIS3/kanMX6.PGAL1.BLM.HIS3 
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TABLE 2.S1 (continued) 
KHSY3429 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC1100.MYC.HIS3 
KHSY3470 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC220.MYC.HIS3 
KHSY3473 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC240.MYC.HIS3 
KHSY3476 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC260.MYC.HIS3 
KHSY3479 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC280.MYC.HIS3 
KHSY3500 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC900.MYC.HIS3 
KHSY3502 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC1000.MYC.HIS3 
KHSY3504 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1ΔC1100.MYC.HIS3 
KHSY3510 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, TRP1.PGAL1. SGS1.MYC.HIS3 
KHSY3512 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1-C1047F.TRP1 
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TABLE 2.S1 (continued) 
KHSY3516 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1-F1056A.TRP1 
KHSY3517 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1-C1047F.MYC.HIS3 
KHSY3520 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sgs1-F1056A.MYC.HIS3 
KHSY3523 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, kanMX6.PGAL1.BLM.MYC.TRP1.HIS3 
KHSY3528 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC1000.MYC.HIS3 
KHSY3534 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::ura3::TRP1, 
sgs1::kanMX6/sgs1ΔC900.MYC.HIS3 
KHSY3536 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC1000.MYC.HIS3 
KHSY3539 ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/ lys2ΔBgl, hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1ΔC900.MYC.HIS3 
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TABLE 2.S1 (continued) 
KHSY3543 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1ΔC800-blmΔN647.MYC.TRP1 
100
REFERENCES 
Bachrati, C. Z. and I. D. Hickson (2003). "RecQ helicases: suppressors of tumorigenesis 
and premature aging." Biochem J 374(Pt 3): 577-606. 
Bachrati, C. Z. and I. D. Hickson (2008). "RecQ helicases: guardian angels of the DNA 
replication fork." Chromosoma 117(3): 219-233. 
Barakat, A., M. Ababou, R. Onclercq, S. Dutertre, E. Chadli, N. Hda, A. Benslimane and 
M. Amor-Gueret (2000). "Identification of a novel BLM missense mutation (2706T>C) in 
a Moroccan patient with Bloom's syndrome." Hum Mutat 15(6): 584-585. 
Bennett, R. J., M. F. Noirot-Gros and J. C. Wang (2000). "Interaction between yeast 
sgs1 helicase and DNA topoisomerase III." J Biol Chem 275(35): 26898-26905. 
Bernstein, D. A. and J. L. Keck (2005). "Conferring substrate specificity to DNA 
helicases: role of the RecQ HRDC domain." Structure 13(8): 1173-1182. 
Bernstein, K. A., E. Shor, I. Sunjevaric, M. Fumasoni, R. C. Burgess, M. Foiani, D. 
Branzei and R. Rothstein (2009). "Sgs1 function in the repair of DNA replication 
intermediates is separable from its role in homologous recombinational repair." EMBO J 
28(7): 915-925. 
Bischof, O., S. H. Kim, J. Irving, S. Beresten, N. A. Ellis and J. Campisi (2001). 
"Regulation and localization of the Bloom syndrome protein in response to DNA 
damage." Journal of Cell Biology 153(2): 367-380. 
Bjergbaek, L., J. A. Cobb, M. Tsai-Pflugfelder and S. M. Gasser (2005). "Mechanistically 
distinct roles for Sgs1p in checkpoint activation and replication fork maintenance." Embo 
J 24(2): 405-417. 
Brosh, R. M., Jr., J. L. Li, M. K. Kenny, J. K. Karow, M. P. Cooper, R. P. Kureekattil, I. 
D. Hickson and V. A. Bohr (2000). "Replication protein A physically interacts with the 
Bloom's syndrome protein and stimulates its helicase activity." J Biol Chem 275(31): 
23500-23508. 
Chaganti, R. S., S. Schonberg and J. German (1974). "A manyfold increase in sister 
chromatid exchanges in Bloom's syndrome lymphocytes." Proc Natl Acad Sci U S A 
71(11): 4508-4512. 
Chang, M., M. Bellaoui, C. Zhang, R. Desai, P. Morozov, L. Delgado-Cruzata, R. 
Rothstein, G. A. Freyer, C. Boone and G. W. Brown (2005). "RMI1/NCE4, a suppressor 
of genome instability, encodes a member of the RecQ helicase/Topo III complex." 
EMBO J 24(11): 2024-2033. 
Chenna, R., H. Sugawara, T. Koike, R. Lopez, T. J. Gibson, D. G. Higgins and J. D. 
Thompson (2003). "Multiple sequence alignment with the Clustal series of programs." 
Nucleic Acids Res 31(13): 3497-3500. 
101
Chiolo, I., W. Carotenuto, G. Maffioletti, J. H. Petrini, M. Foiani and G. Liberi (2005). 
"Srs2 and Sgs1 DNA helicases associate with Mre11 in different subcomplexes 
following checkpoint activation and CDK1-mediated Srs2 phosphorylation." Mol Cell Biol 
25(13): 5738-5751. 
Cobb, J. A., L. Bjergbaek and S. M. Gasser (2002). "RecQ helicases: at the heart of 
genetic stability." FEBS Lett 529(1): 43-48. 
Davies, S. L., P. S. North, A. Dart, N. D. Lakin and I. D. Hickson (2004). 
"Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-
phase arrest." Molecular and Cellular Biology 24(3): 1279-1291. 
Dosztanyi, Z., V. Csizmok, P. Tompa and I. Simon (2005). "IUPred: web server for the 
prediction of intrinsically unstructured regions of proteins based on estimated energy 
content." Bioinformatics 21(16): 3433-3434. 
Dosztanyi, Z., V. Csizmok, P. Tompa and I. Simon (2005). "The pairwise energy content 
estimated from amino acid composition discriminates between folded and intrinsically 
unstructured proteins." J Mol Biol 347(4): 827-839. 
Duno, M., B. Thomsen, O. Westergaard, L. Krejci and C. Bendixen (2000). "Genetic 
analysis of the Saccharomyces cerevisiae Sgs1 helicase defines an essential function 
for the Sgs1-Top3 complex in the absence of SRS2 or TOP1." Mol Gen Genet 264(1-2): 
89-97. 
Dutertre, S., M. Ababou, R. Onclercq, J. Delic, B. Chatton, C. Jaulin and M. Amor-
Gueret (2000). "Cell cycle regulation of the endogenous wild type Bloom's syndrome 
DNA helicase." Oncogene 19(23): 2731-2738. 
Ellis, N. A., J. Groden, T. Z. Ye, J. Straughen, D. J. Lennon, S. Ciocci, M. Proytcheva 
and J. German (1995). "The Bloom's syndrome gene product is homologous to RecQ 
helicases." Cell 83(4): 655-666. 
Foiani, M., G. Liberi, S. Piatti and P. Plevani (1999). Saccharomyces cerevisiae as a 
model system to study DNA replication. Eukaryotic DNA Replication. A Practical 
Approach. S. Cotterill. Oxford, UK, Oxford University Press: 185-200. 
Foucault, F., C. Vaury, A. Barakat, D. Thibout, P. Planchon, C. Jaulin, F. Praz and M. 
Amor-Gueret (1997). "Characterization of a new BLM mutation associated with a 
topoisomerase II alpha defect in a patient with Bloom's syndrome." Hum Mol Genet 
6(9): 1427-1434. 
Frei, C. and S. M. Gasser (2000). "The yeast Sgs1p helicase acts upstream of Rad53p 
in the DNA replication checkpoint and colocalizes with Rad53p in S-phase-specific foci." 
Genes Dev 14(1): 81-96. 
Fricke, W. M. and S. J. Brill (2003). "Slx1-Slx4 is a second structure-specific 
endonuclease functionally redundant with Sgs1-Top3." Genes Dev 17(14): 1768-1778. 
102
Fricke, W. M., V. Kaliraman and S. J. Brill (2001). "Mapping the DNA topoisomerase III 
binding domain of the Sgs1 DNA helicase." J Biol Chem 276(12): 8848-8855. 
Gangloff, S., J. P. McDonald, C. Bendixen, L. Arthur and R. Rothstein (1994). "The 
yeast type I topoisomerase Top3 interacts with Sgs1, a DNA helicase homolog: a 
potential eukaryotic reverse gyrase." Mol Cell Biol 14(12): 8391-8398. 
Garcia-Rubio, M., S. Chavez, P. Huertas, C. Tous, S. Jimeno, R. Luna and A. Aguilera 
(2008). "Different physiological relevance of yeast THO/TREX subunits in gene 
expression and genome integrity." Mol Genet Genomics 279(2): 123-132. 
German, J., M. M. Sanz, S. Ciocci, T. Z. Ye and N. A. Ellis (2007). "Syndrome-causing 
mutations of the BLM gene in persons in the Bloom's Syndrome Registry." Hum Mutat 
28(8): 743-753. 
Gietz, R. D. and R. A. Woods (2006). "Yeast transformation by the LiAc/SS Carrier 
DNA/PEG method." Methods Mol Biol 313: 107-120. 
Guo, R. B., P. Rigolet, L. Zargarian, S. Fermandjian and X. G. Xi (2005). "Structural and 
functional characterizations reveal the importance of a zinc binding domain in Bloom's 
syndrome helicase." Nucleic Acids Res 33(10): 3109-3124. 
Hanada, K. and I. D. Hickson (2007). "Molecular genetics of RecQ helicase disorders." 
Cell Mol Life Sci 64(17): 2306-2322. 
Hand, R. and J. German (1975). "A retarded rate of DNA chain growth in Bloom's 
syndrome." Proc Natl Acad Sci U S A 72(2): 758-762. 
Hegde, S. P., M. H. Qin, X. H. Li, M. A. Atkinson, A. J. Clark, M. Rajagopalan and M. V. 
Madiraju (1996). "Interactions of RecF protein with RecO, RecR, and single-stranded 
DNA binding proteins reveal roles for the RecF-RecO-RecR complex in DNA repair and 
recombination." Proc Natl Acad Sci U S A 93(25): 14468-14473. 
Heo, S. J., K. Tatebayashi, I. Ohsugi, A. Shimamoto, Y. Furuichi and H. Ikeda (1999). 
"Bloom's syndrome gene suppresses premature ageing caused by Sgs1 deficiency in 
yeast." Genes Cells 4(11): 619-625. 
Hojo, E. T., P. C. van Diemen, F. Darroudi and A. T. Natarajan (1995). "Spontaneous 
chromosomal aberrations in Fanconi anaemia, ataxia telangiectasia fibroblast and 
Bloom's syndrome lymphoblastoid cell lines as detected by conventional cytogenetic 
analysis and fluorescence in situ hybridisation (FISH) technique." Mutat Res 334(1): 59-
69. 
Huber, M. D., M. L. Duquette, J. C. Shiels and N. Maizels (2006). "A conserved G4 DNA 
binding domain in RecQ family helicases." J Mol Biol 358(4): 1071-1080. 
Ira, G., A. Malkova, G. Liberi, M. Foiani and J. E. Haber (2003). "Srs2 and Sgs1-Top3 
suppress crossovers during double-strand break repair in yeast." Cell 115(4): 401-411. 
103
Ivancic-Bace, I., E. Salaj-Smic and K. Brcic-Kostic (2005). "Effects of recJ, recQ, and 
recFOR mutations on recombination in nuclease-deficient recB recD double mutants of 
Escherichia coli." J Bacteriol 187(4): 1350-1356. 
Janscak, P., P. L. Garcia, F. Hamburger, Y. Makuta, K. Shiraishi, Y. Imai, H. Ikeda and 
T. A. Bickle (2003). "Characterization and mutational analysis of the RecQ core of the 
bloom syndrome protein." J Mol Biol 330(1): 29-42. 
Jiao, R. J., C. Z. Bachrati, G. Pedrazzi, P. Kuster, M. Petkovic, J. L. Li, D. Egli, I. D. 
Hickson and I. Stagljar (2004). "Physical and functional interaction between the Bloom's 
syndrome gene product and the largest subunit of chromatin assembly factor 1." 
Molecular and Cellular Biology 24(11): 4710-4719. 
Johnson, F. B., D. B. Lombard, N. F. Neff, M. A. Mastrangelo, W. Dewolf, N. A. Ellis, R. 
A. Marciniak, Y. Yin, R. Jaenisch and L. Guarente (2000). "Association of the Bloom 
syndrome protein with topoisomerase IIIalpha in somatic and meiotic cells." Cancer Res 
60(5): 1162-1167. 
Killoran, M. P. and J. L. Keck (2008). "Structure and function of the regulatory C-
terminal HRDC domain from Deinococcus radiodurans RecQ." Nucleic Acids Res 36(9): 
3139-3149. 
Kitano, K., S. Y. Kim and T. Hakoshima (2010). "Structural basis for DNA strand 
separation by the unconventional winged-helix domain of RecQ helicase WRN." 
Structure 18(2): 177-187. 
Kitano, K., N. Yoshihara and T. Hakoshima (2007). "Crystal structure of the HRDC 
domain of human Werner syndrome protein, WRN." J Biol Chem 282(4): 2717-2728. 
Kitao, S., I. Ohsugi, K. Ichikawa, M. Goto, Y. Furuichi and A. Shimamoto (1998). 
"Cloning of two new human helicase genes of the RecQ family: biological significance of 
multiple species in higher eukaryotes." Genomics 54(3): 443-452. 
Kitao, S., A. Shimamoto, M. Goto, R. W. Miller, W. A. Smithson, N. M. Lindor and Y. 
Furuichi (1999). "Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson 
syndrome." Nat Genet 22(1): 82-84. 
Langland, G., J. Kordich, J. Creaney, K. H. Goss, K. Lillard-Wetherell, K. Bebenek, T. A. 
Kunkel and J. Groden (2001). "The Bloom's syndrome protein (BLM) interacts with 
MLH1 but is not required for DNA mismatch repair." J Biol Chem 276(32): 30031-30035. 
Lee, J. W., R. Kusumoto, K. M. Doherty, G. X. Lin, W. Zeng, W. H. Cheng, C. von 
Kobbe, R. M. Brosh, Jr., J. S. Hu and V. A. Bohr (2005). "Modulation of Werner 
syndrome protein function by a single mutation in the conserved RecQ domain." J Biol 
Chem 280(47): 39627-39636. 
104
Lee, S. K., R. E. Johnson, S. L. Yu, L. Prakash and S. Prakash (1999). "Requirement of 
yeast SGS1 and SRS2 genes for replication and transcription." Science 286(5448): 
2339-2342. 
Liu, Z., M. J. Macias, M. J. Bottomley, G. Stier, J. P. Linge, M. Nilges, P. Bork and M. 
Sattler (1999). "The three-dimensional structure of the HRDC domain and implications 
for the Werner and Bloom syndrome proteins." Structure 7(12): 1557-1566. 
Longtine, M. S., A. McKenzie, 3rd, D. J. Demarini, N. G. Shah, A. Wach, A. Brachat, P. 
Philippsen and J. R. Pringle (1998). "Additional modules for versatile and economical 
PCR-based gene deletion and modification in Saccharomyces cerevisiae." Yeast 
14(10): 953-961. 
Lonn, U., S. Lonn, U. Nylen, G. Winblad and J. German (1990). "An abnormal profile of 
DNA replication intermediates in Bloom's syndrome." Cancer Res 50(11): 3141-3145. 
Miyajima, A., M. Seki, F. Onoda, M. Shiratori, N. Odagiri, K. Ohta, Y. Kikuchi, Y. Ohno 
and T. Enomoto (2000). "Sgs1 helicase activity is required for mitotic but apparently not 
for meiotic functions." Mol Cell Biol 20(17): 6399-6409. 
Miyajima, A., M. Seki, F. Onoda, A. Ui, Y. Satoh, Y. Ohno and T. Enomoto (2000). 
"Different domains of Sgs1 are required for mitotic and meiotic functions." Genes Genet 
Syst 75(6): 319-326. 
Mohaghegh, P., J. K. Karow, R. M. Brosh Jr, Jr., V. A. Bohr and I. D. Hickson (2001). 
"The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases." 
Nucleic Acids Res 29(13): 2843-2849. 
Morimatsu, K. and S. C. Kowalczykowski (2003). "RecFOR proteins load RecA protein 
onto gapped DNA to accelerate DNA strand exchange: a universal step of 
recombinational repair." Mol Cell 11(5): 1337-1347. 
Morozov, V., A. R. Mushegian, E. V. Koonin and P. Bork (1997). "A putative nucleic 
acid-binding domain in Bloom's and Werner's syndrome helicases." Trends Biochem Sci 
22(11): 417-418. 
Mullen, J. R., V. Kaliraman and S. J. Brill (2000). "Bipartite structure of the SGS1 DNA 
helicase in Saccharomyces cerevisiae." Genetics 154(3): 1101-1114. 
Myung, K., A. Datta, C. Chen and R. D. Kolodner (2001). "SGS1, the Saccharomyces 
cerevisiae homologue of BLM and WRN, suppresses genome instability and 
homeologous recombination." Nat Genet 27(1): 113-116. 
Nair, K. R. (1940). "Table of confidence intervals for the median in samples from any 
continuous population." Sankhya(4): 551-558. 
105
Ooi, S. L., D. D. Shoemaker and J. D. Boeke (2003). "DNA helicase gene interaction 
network defined using synthetic lethality analyzed by microarray." Nat Genet 35(3): 277-
286. 
Peng, K., S. Vucetic, P. Radivojac, C. J. Brown, A. K. Dunker and Z. Obradovic (2005). 
"Optimizing long intrinsic disorder predictors with protein evolutionary information." J 
Bioinform Comput Biol 3(1): 35-60. 
Ralf, C., I. D. Hickson and L. Wu (2006). "The Bloom's syndrome helicase can promote 
the regression of a model replication fork." J Biol Chem 281(32): 22839-22846. 
Rockmill, B., E. J. Lambie and G. S. Roeder (1991). "Spore enrichment." Methods 
Enzymol 194: 146-149. 
Saffi, J., H. Feldmann, E. L. Winnacker and J. A. Henriques (2001). "Interaction of the 
yeast Pso5/Rad16 and Sgs1 proteins: influences on DNA repair and aging." Mutat Res 
486(3): 195-206. 
Sanz, M. M., M. Proytcheva, N. A. Ellis, W. K. Holloman and J. German (2000). "BLM, 
the Bloom's syndrome protein, varies during the cell cycle in its amount, distribution, 
and co-localization with other nuclear proteins." Cytogenetics and Cell Genetics 91(1-4): 
217-223. 
Schmidt, K. H. and R. D. Kolodner (2004). "Requirement of Rrm3 helicase for repair of 
spontaneous DNA lesions in cells lacking Srs2 or Sgs1 helicase." Mol Cell Biol 24(8): 
3213-3226. 
Schmidt, K. H., V. Pennaneach, C. D. Putnam and R. D. Kolodner (2006). "Analysis of 
gross-chromosomal rearrangements in Saccharomyces cerevisiae." Methods Enzymol 
409: 462-476. 
Schmidt, K. H., J. Wu and R. D. Kolodner (2006). "Control of translocations between 
highly diverged genes by Sgs1, the Saccharomyces cerevisiae homolog of the Bloom's 
syndrome protein." Mol Cell Biol 26(14): 5406-5420. 
Selak, N., C. Z. Bachrati, I. Shevelev, T. Dietschy, B. van Loon, A. Jacob, U. Hubscher, 
J. D. Hoheisel, I. D. Hickson and I. Stagljar (2008). "The Bloom's syndrome helicase 
(BLM) interacts physically and functionally with p12, the smallest subunit of human DNA 
polymerase delta." Nucleic Acids Res 36(16): 5166-5179. 
Sharma, S., J. A. Sommers, L. Wu, V. A. Bohr, I. D. Hickson and R. M. Brosh, Jr. 
(2004). "Stimulation of flap endonuclease-1 by the Bloom's syndrome protein." J Biol 
Chem 279(11): 9847-9856. 
Sinclair, D. A., K. Mills and L. Guarente (1997). "Accelerated aging and nucleolar 
fragmentation in yeast sgs1 mutants." Science 277(5330): 1313-1316. 
106
Torres, J. Z., S. L. Schnakenberg and V. A. Zakian (2004). "Saccharomyces cerevisiae 
Rrm3p DNA helicase promotes genome integrity by preventing replication fork stalling: 
viability of rrm3 cells requires the intra-S-phase checkpoint and fork restart activities." 
Mol Cell Biol 24(8): 3198-3212. 
Ui, A., Y. Satoh, F. Onoda, A. Miyajima, M. Seki and T. Enomoto (2001). "The N-
terminal region of Sgs1, which interacts with Top3, is required for complementation of 
MMS sensitivity and suppression of hyper-recombination in sgs1 disruptants." Mol 
Genet Genomics 265(5): 837-850. 
Versini, G., I. Comet, M. Wu, L. Hoopes, E. Schwob and P. Pasero (2003). "The yeast 
Sgs1 helicase is differentially required for genomic and ribosomal DNA replication." 
EMBO J 22(8): 1939-1949. 
von Kobbe, C., N. H. Thoma, B. K. Czyzewski, N. P. Pavletich and V. A. Bohr (2003). 
"Werner syndrome protein contains three structure-specific DNA binding domains." J 
Biol Chem 278(52): 52997-53006. 
Ward, J. J., J. S. Sodhi, L. J. McGuffin, B. F. Buxton and D. T. Jones (2004). "Prediction 
and functional analysis of native disorder in proteins from the three kingdoms of life." J 
Mol Biol 337(3): 635-645. 
Watt, P. M., E. J. Louis, R. H. Borts and I. D. Hickson (1995). "Sgs1: a eukaryotic 
homolog of E. coli RecQ that interacts with topoisomerase II in vivo and is required for 
faithful chromosome segregation." Cell 81(2): 253-260. 
Wu, L., C. Z. Bachrati, J. Ou, C. Xu, J. Yin, M. Chang, W. Wang, L. Li, G. W. Brown and 
I. D. Hickson (2006). "BLAP75/RMI1 promotes the BLM-dependent dissolution of 
homologous recombination intermediates." Proc Natl Acad Sci U S A 103(11): 4068-
4073. 
Wu, L., K. L. Chan, C. Ralf, D. A. Bernstein, P. L. Garcia, V. A. Bohr, A. Vindigni, P. 
Janscak, J. L. Keck and I. D. Hickson (2005). "The HRDC domain of BLM is required for 
the dissolution of double Holliday junctions." Embo J 24(14): 2679-2687. 
Wu, L., S. L. Davies, N. C. Levitt and I. D. Hickson (2001). "Potential role for the BLM 
helicase in recombinational repair via a conserved interaction with RAD51." J Biol Chem 
276(22): 19375-19381. 
Wu, L. and I. D. Hickson (2006). "DNA helicases required for homologous 
recombination and repair of damaged replication forks." Annu Rev Genet 40: 279-306. 
Yamagata, K., J. Kato, A. Shimamoto, M. Goto, Y. Furuichi and H. Ikeda (1998). 
"Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 
mutant: implication for genomic instability in human diseases." Proc Natl Acad Sci U S A 
95(15): 8733-8738. 
107
Yankiwski, V., R. A. Marciniak, L. Guarente and N. F. Neff (2000). "Nuclear structure in 
normal and Bloom syndrome cells." Proceedings of the National Academy of Sciences 
of the United States of America 97(10): 5214-5219. 
Yu, C. E., J. Oshima, Y. H. Fu, E. M. Wijsman, F. Hisama, R. Alisch, S. Matthews, J. 
Nakura, T. Miki, S. Ouais, G. M. Martin, J. Mulligan and G. D. Schellenberg (1996). 
"Positional cloning of the Werner's syndrome gene." Science 272(5259): 258-262. 	
108
 
 
 
 
 
CHAPTER THREE: 
GENETIC CHARACTERIZATION OF RECQL5 IN SACCHAROMYCES CEREVISIAE 
AND IDENTIFICATION OF BINDING PARTNERS USING A YEAST TWO-HYBRID 
SCREEN 
 
Note to reader: Unpublished data. Experiments were designed by Kristina H. Schmidt 
and Salahuddin Syed. Experiments were performed by Salahuddin Syed. 
  
INTRODUCTION  
 RecQL5 is a RecQ like helicase found in humans, but has no known attributed 
genetic disease. It contains 19 exons and encodes three isoforms, RecQL5α, RecQL5β 
and RecQL5ɣ [1]. In human tissues RecQL5 isoforms are expressed with high 
abundance in the testes [1]. Of the three isoforms RecQL5α and RecQL5ɣ are found in 
the cytoplasm whereas RecQL5β is found in the nucleus [2]. RecQL5α and RecQL5ɣ 
lack a substantial amount of homology to the other RecQ homologs (Figure 1). Although 
all the isoforms of RecQL5 have a conserved helicase domain, only RecQL5β contains 
ATPase activity [3, 4]. This activity is insufficient to unwind D-loops, G-quadruplexes, 
and Holliday junctions [3, 4]. However, in the presence of ssDNA binding protein and 
RPA, RecQL5β can unwind forked duplexes [5]. The inability to efficiently unwind DNA 
may be due to the fact that RecQL5β does not have a winged-helix motif, which is 
present in RecQL1 and WRN and has been shown to be important for DNA unwinding 
[6, 7]. We used RecQL5β in this study because it is the only isoform that has been 
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observed to possess enzymatic activity and is abundantly found in humans and mice 
[8].  
 RecQL5 has several protein-protein interactions involved in DNA repair, such as 
Rad51, PCNA, Topo3α, Topo3β, the MRN complex, and Pol II [2, 9-14]. RecQL5 is 
found at DSBs, but for a shorter time compared to BLM and WRN, suggesting that the 
biochemical properties of RecQL5 are important for its activity [15]. In the presence of 
HU or UV light, Mre11 recruits RecQL5 to the site of damage and co-localizes with the 
MRN complex and has been implicated in regulating the exonuclease activity of MRN 
during end resection [12]. RecQL5 has a KIX domain on its C terminus distal to the 
RQC domain, which is required for resistance to DNA damaging agents and binding to 
DSBs [16]. In addition to having a role at DSBs, RecQL5 has a role during HR as an 
anti-recombinase and inhibits the formation of D-loops by removing Rad51 from ssDNA 
[17]. It has also been shown that RecQL5 interacts with phosphorylated RPBI, a subunit 
of Pol II, which indicates elongation of transcripts, implicating RecQL5 in transcription 
[16]. 
 Mouse embryonic fibroblast cell lines deficient for RecQL5 show increased sister 
chromatid exchanges (SCEs), elevated number of broken chromosomes, and 
quadriradials [9]. Cells deficient for RecQL5 are sensitive to CPT and it has been 
suggested that this is due to an inability to restart stalled forks [18]. Although defects in 
RecQL5 have not been associated with a known human disease, mice lacking RecQL5 
have a higher incidence of cancer, including lymphomas and lung adenocarcinoma [19]. 
To further characterize the function of RecQL5, human RecQL5 cDNA was expressed 
using the SGS1 promoter and overexpressed to assess its ability to complement sgs1∆ 
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defects. Additionally, we performed a yeast two-hybrid screen using the human testis 
library to identify pathways, in DNA repair, which RecQL5 functions in, thus shedding 
light on its cellular role. 
 
MATERIALS AND METHODS 
 Yeast transformation and targeted gene disruption 
 Modifications to the yeast genome are carried through a lithium acetate mediated 
transformation [20]. Cells are grown overnight in liquid YPD media until they reach 
saturation and then diluted into 25 ml of YPD media for an initial OD of 0.2. The cells 
are grown to an OD of 0.8 and then centrifuged for 2 minutes at 2000 rpm, washed with 
dH2O, and centrifuged once more to remove any residual YPD. They are then re-
suspended in 100mM LiAc and centrifuged for 30 seconds at 14000 rpm. The cells are 
re-suspended in 240µl of 100mM LiAc and spread equally amongst 4 eppindorf tubes. 
The tubes are centrifuged for 1 minute at 14000 rpm and the following reagents are 
added sequentially: 50% PEG, 36µl of 1M LiAc, 75µl of DNA, and 5µl of boiled and 
snap-cooled salmon sperm DNA. The pellet is loosely re-suspended using a toothpick 
and vortexed for 1 min at high speed. The cells are then incubated at 30ºC for 30 min 
followed by heat shocking for 15 min at 42ºC. Cells are then centrifuged at 7000 rpm for 
1 min and the pellet re-suspended in 100 µl of dH2O and plated on selective media 
corresponding to the type of mutation that is being introduced into the cell. Cells were 
grown for 2-3 days at 30ºC and colonies were re-streaked onto new plates and grown 
for another 2 days at 30ºC followed by freezing at -80ºC. The transformations were 
verified by isolating genomic DNA from positives followed by PCR confirmation. 
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 Cloning of plasmid DNA using homologous recombination in yeast 
DNA of interest is amplified by PCR using primers that share 50-nt homology 
upstream and downstream of the plasmid of interest and 20-nt homology to the DNA. 
The plasmid of interest is linearized using two different restriction enzymes to reduce re-
ligation events. Transformations were performed in strain KHSY2331 (Appendix C), 
which is deficient for non-homologous end joining (lig4∆). Lig4, DNA Ligase 4, is 
important for resolution of NHEJ by ligating the ends of a double strand break. The 
purpose of using this strain is to minimize the possibility that the plasmid of interest will 
re-circularize by NHEJ and to force it to use HR to integrate the amplicon into the 
plasmid. During the transformation 50-100 ng of linearized plasmid DNA is combined 
with 10-75 µl of PCR product and the experiment is carried out using the same method 
as that found in the “yeast transformation and targeted gene disruption” section. Cells 
are plated on media that selects for the plasmid of interest and plasmid DNA is 
extracted using the QIAprep Miniprep Kit (QIAGEN). 
 
 Colony PCR 
 Colony PCR is a method that allows for verification of a large quantity of E. coli 
transformants for integration of a plasmid of interest. After the plasmid is transformed 
into E. coli, the colonies are re-streaked onto agar LB plates supplemented with the 
appropriate antibiotic for selection and incubated overnight at 37ºC. A small quantity of 
cells are then inoculated into 100 µl of sterile water and boiled at 100ºC for 10 min in an 
Applied Biosystems PCR GeneAmp 9700 Thermocycler. The samples are then 
112
centrifuged at 14000 rpm for 2 minutes and 2 µl of the top layer is used as a template 
for PCR.  
 
Fluctuation assay 
GCR rates were determined using a method previously described [21]. In order 
to assess overexpression of RecQL5 on accumulating GCRs we modified the assay 
such that strains containing a GAL1 promoter were incubated on YPD agar plates for 
three days and a single colony was cultured in liquid YP-Galactose (yeast extract 10 
g/L, peptone 20 g/L, 2% galactose) instead of YPD. The strains were allowed to reach 
saturation and the cultures were spread on synthetic complete agar plates containing 5-
FOA (1 g/L), canavanine (60 mg/L), and galactose instead of dextrose. 
 
Plasmid construction 
RECQL5β cDNA was obtained from Open Biosystems in vector pCMV-SPORT6. 
In order to integrate RECQL5 in S. cerevisiae, a selectable marker was integrated 
downstream of the cDNA. A HIS3MX6 cassette, in plasmid pRS303, was used [22]. 
Using PCR, HIS3MX6, was amplified and cloned into vector pCR2.1-TOPO (Invitrogen). 
The PCR primers anneal upstream and downstream to the HIS3MX6 cassette and 
contain a 5’ XhoI restriction site. The RECQL5 cDNA in pCMV-SPORT6 (pKHS265) 
contains an XhoI restriction site at the 3’ end. The plasmids containing RECQL5 and 
HIS3MX6 were digested using XhoI and HIS3MX6 was ligated into the pCMV-SPORT6 
plasmid using DNA Ligation Kit Ver. 2.1 (Takara) per manufacturer instructions. The 
resulting ligated products were introduced into electro-competent E. coli cells and 
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selected for on LB agar plates (Tryptone 10 g/L, Yeast extract 5 g/L, and NaCl 5 g/L) 
supplemented with 100 µg/ml of Chloramphenicol (CMP). Using colony PCR E. coli 
transformants were tested for the presence of HIS3MX6 cassette using primers 1032R 
and 1676F that anneal to RECQL5 and HIS3MX6. Plasmid DNA from positive 
transformants was isolated using QIAGEN’s QIAprep Spin Miniprep Kit (per 
manufacturers directions). The plasmid DNA was further confirmed for integration of 
RECQL5 with the HIS3MX6 cassette using restriction digestion with HindIII to determine 
the relative orientation of RECQL5 in respect to HIS3MX6. Three isolates were obtained 
containing RECQL5 linked to HIS3MX6 (pKHS671, pKHS672, pKHS673).  
For yeast two-hybrid, a bait plasmid (pKHS392, Appendix D) containing a GAL4 
DNA binding domain (DBD) was linearized by double restriction enzyme digestion using  
PvuII and NotI. Using PCR, RECQL5 cDNA was amplified with primers 1672F and 
1673R that share 50-nt homology, upstream and downstream of the bait plasmid and 
20-nt homology to RECQL5. Transformation was carried out in KHSY2331 in order to 
use homologous recombination to integrate the amplicon into the plasmid. 
Transformants were selected for on SC-Trp and genomic DNA was isolated from these 
positive transformants. Genomic DNA was introduced into electrocompetent E. coli cells 
using a MicroPulse device (BioLab). Plasmid DNA was isolated and RECQL5 was 
sequenced completely to ensure mutations were not introduced in-frame with the DNA 
binding domain and the strain was saved as pKHS525. 
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 Yeast strain construction 
To integrate RECQL5 at the SGS1 locus, RECQL5.HIS3MX6 (pKHS671) was 
used and PCR was performed using primers 1911F and 1912R that anneal upstream of 
RECQL5 and downstream of HIS3MX6 cassette. The primers also contain 50-
nucleotide homology, upstream and downstream of the SGS1 locus. The PCR product 
RECQL5.HIS3MX6 was transformed into yeast strain KHSY1633 (sgs1::kanMX6) using 
a LiAc-mediated transformation method [23]. KHSY1633 has SGS1 replaced with 
kanMX6, which confers resistance to G418-sulfate (Alexis Biochemicals). In order to 
isolate RECQL5.HIS3MX6, transformants were picked by plating on agar lacking 
histidine (SC-His). To determine if kanMX6 was replaced by RECQL5.HIS3MX6, PCR 
was performed using primers 1143F and 1680R, which are specific to RECQL5 and a 
sequence upstream of the SGS1 locus. To ensure that this process was not mutagenic 
RECQL5 cDNA was amplified by PCR from colonies that had RECQL5.HISMX6 
integrated into KHSY1633 and the amplicon was sent out for sequencing using primers 
1674F, 1675F, 1676F, 1677F, 1678F, 1679F, and 1680R. Three independent isolates 
(KHSY3777, KHSY3778, KHSY3779) were obtained without any mutations and were 
used for further characterization. 
In order to verify protein expression of RecQL5 a myc-epitope tag was fused to 
the 3’ end of RECQL5 in the strain containing RECQL5.HIS3MX6 (KHSY3777). A 
13MYC.TRP1 cassete was amplified by PCR from plasmid pFA6a.13MYC.TRP1 
(pKHS230, Appendix D) [24]. The myc-epitope was amplified using primers 1911F and 
1912R that share 50-nt homology with the 3’ end of RECQL5 and downstream of 
HIS3MX6. The PCR amplicon was transformed into the strain containing 
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RECQL5.HIS3MX6 (KHSY3777) using standard LiAc-mediated transformation [23]. 
Transformants were selected for integration of 13MYC.TRP1 on synthetic complete 
agar minus tryptophan (SC-Trp). Integration of the myc-epitope was verified by PCR 
using primers 1678F and 2455R, which anneal to the myc epitope and RECQL5. 
Positive transformants were saved as KHSY5172, KHSY5173, and KHSY5174 
(Appendix C). 
To overexpress RecQL5 a galactose inducible promoter was added upstream of 
RECQL5. To achieve this, TRP1.PGAL1 was amplified by PCR using plasmid 
pFA6a.TRP1.PGAL1 (pKHS236, Appendix D). Primers 1850F and 1851R were used to 
amplify the plasmid and share 50-nt homology upstream of RECQL5 and 5’ of the cDNA 
so that the native SGS1 promoter can be replaced. The amplicon was transformed into 
a strain containing RECQL5.HIS3MX6 (KHSY3777) using LiAc-mediated transformation 
[23] and positive transformants were selected for on SC-Trp agar plates. To determine if 
the GAL1 promoter was integrated, PCR was performed using primers 1045F and 
1680R, which anneal upstream of the GAL1 promoter and internal to RECQL5 in order 
to obtain TRP1.PGAL1.RECQL5.HIS3MX6 and three isolates (KHSY3827, KHSY3828, 
KHSY3829) were confirmed and saved. To verify protein expression a myc epitope tag 
was added to the 3’ end of RECQL5 in KHSY3827. A 13MYC.kanMX6 cassete was 
amplified by PCR from plasmid pFA6a.13MYC.kanMX6 (pKHS229, Appendix D) [24]. 
The myc-epitope was amplified using primers 1911F and 1912R that share 50-nt 
homology with the 3’ end of RECQL5 and downstream of kanMX6. The PCR amplicon 
was transformed into the strain containing TRP1.PGAL1.RECQL5.HIS3MX6 (KHSY3827) 
using standard LiAc-mediated transformation [23]. Transformants were selected for 
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integration of 13MYC.kanMX6 on SC-G418 plates and integration of the myc-epitope 
was verified by PCR using primers 1678F and 2455R that anneal to the myc epitope 
and RECQL5. Positive transformants were saved as KHSY5175, KHSY5176, and 
KHSY5177 (Appendix C). 
To generate a Sgs1-RecQL5 chimeric protein the entire RECQL5 cDNA was 
used. RECQL5.HIS3MX6 (KHSY3777) was amplified by PCR and the amplicon was 
transformed into KHSY802 at the SGS1 locus (wildtype, Appendix C). The primers for 
this PCR were designed so that 50-nt would anneal to SGS1 in order to retain its N 
terminal 1-647 residues and its native promoter. Positive transformants were selected 
for on SC-His for the presence of RECQL5.HIS3MX6. These isolates were tested by 
PCR for further confirmation that a chimeric protein was generated using primers 1257F 
and 1680R that anneal to the 5’ end of SGS1 and internal to RECQL5. Primer 
combinations were used to ensure that the SGS1 N terminal sequence and RECQL5 
would be amplified and the entire ORF was sent out for sequencing to ensure that 
mutations were not incorporated using the following primers: 1256F, 1257F, 1258F, 
1259F, 1260F, 1261F, 1262F, 1674F, 1675F, 1676F, 1677F, 1678F, 1679F, 1680R. 
Positive candidates were saved as KHSY5178, KHSY5179, and KHSY5180 (Appendix 
C). To verify protein expression of the Sgs1-RecQL5 chimeric protein a myc epitope 
was added to the C terminus of Sgs1-RecQL5 using plasmid pFA6a.13MYC.TRP1 
(pKHS230, Appendix D) [24]. Positive transformants were saved as KHSY5181, 
KHSY5182, and KHSY5183 (Appendix C). 
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 Analyzing protein expression by western blot  
 An overnight culture of cells was diluted to an OD600 = 0.2 in YPD and allowed to 
grow to an OD600 = 0.5. Protein was extracted using the trichloroacetic acid method 
using ~3.5 x 107 cells to confirm expression of the myc epitope tagged strains. The TCA 
extract was analyzed on a 10% polyacrylamide gel, transferred to PVDF membrane 
(Bio-Rad), and then analyzed with anti-c-myc monoclonal antibody (9E10, Covance 
Research Products). Myc tagged proteins were visualized by chemoluminescence (ECL 
Plus, GE Healthcare). To induce RECQL5 cDNA under the control of a GAL1 promoter 
media was supplemented with 2% galactose or 1% sucrose/1% galactose instead of 2% 
dextrose. 
 
Yeast two-hybrid screen 
 This screen utilized the Clontech Matchmaker Gold Yeast Two-Hybrid System 
and the Clontech Mate and Plate Human Testis cDNA library. For our yeast two-hybrid 
screen, we used yeast strain AH109 (KHSY3130, Appendix C), which we obtained from 
the Clontech Matchmaker Gold Yeast Two-Hybrid System. This strain possess four 
different reporter genes, which allow for varying degrees of stringency (Figure 3.7). 
pKHS525 containing RECQL5 was transformed into AH109 (Appendix C) using 
standard LiAc-mediated transformation. Protein from yeast strain AH109 containing 
RecQL5 was isolated by TCA extraction and verified by Western blot analysis. The 
membrane was incubated with anti-DBD monoclonal antibody (Santa Cruz) and three 
isolates were found to express RecQL5 (KHSY5184, KHSY5185, KHSY5186).  
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 The bait strain (KHSY5184) was inoculated and cultured overnight in 100 ml of 
SC-Trp liquid media until it reached an optical density of 0.6. The culture was 
centrifuged and divided into eight aliquots and 600 ng of plasmid DNA (Clontech Mate 
and Plate Human Testis cDNA Library) was transformed using standard LiAc-mediated 
transformation and plated on SC-Leu-Trp and SC-Leu-Trp-His+3AT. SC-Leu-Trp plates 
were incubated for 2 days at 30ºC and SC-Leu-Trp-His+3AT plates were incubated for 14 
days at 30ºC. To exclude false positives, colonies that appeared on SC-Leu-Trp-His+3AT 
were re-streaked on new SC-Leu-Trp-His+3AT plates and incubated for two days. These 
colonies were re-suspended in 40% glycerol and saved at -80ºC for further analysis. 
Western blot was performed on positive candidates using anti-AD monoclonal antibody 
(Santa Cruz). It is important to note that the molecular weight of the activation domain is 
30 kDa and for this reason candidates that are larger than 30 kDa were excluded. 
 For manual verification of interactions between RecQL5 and candidates identified 
through yeast two-hybrid, colonies that were saved for further analysis were spotted 
onto SC-Leu-Trp, SC-Leu-Trp-His, and SC-Leu-Trp-His+3AT. Using candidates that grow 
on all three plates, plasmids from these positives were rescued. The rescued AD 
plasmids were introduced into the bait strain (KHSY5184) containing RecQL5 using 
standard LiAc transformation. Positives were spotted onto SC-Leu-Trp, SC-Leu-Trp-His, 
and SC-Leu-Trp-His+3AT to determine if interaction is reproducible. 
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RESULTS 
Expression of human RecQL5 cDNA in S. cerevisiae does not complement 
sgs1∆ defects 
Cells lacking Sgs1 are not resistant to DNA-damaging agents hydroxyurea (HU) 
and methyl methanesulfonate (MMS) and have increased gross-chromosomal 
rearrangements (GCRs) [25, 26]. RecQ-like helicases are conserved across species 
and share many of the functional domains so it is possible that RecQ-like helicases from 
different species may be able to complement each others functions. In order to assess 
RecQL5’s ability to suppress sgs1∆ defects we placed RECQL5 cDNA in-frame with the 
start codon of SGS1 in order to regulate RecQL5 expression similar to that of Sgs1. 
Protein expression of RecQL5 was determined through Western blot analysis from 
yeast strain KHSY5172 (Figure 3.3). RecQL5 was unable to suppress the sensitivity on 
HU and MMS seen in an sgs1∆ cell and was unable to suppress the accumulation of 
GCRs (Figure 3.4 and Table 3.2).  
Next, we explored the possibility that a single copy of RECQL5 was insufficient to 
suppress sgs1∆ defects, and overexpressed RecQL5 in a sgs1∆  strain (KHSY5175). In 
order to do this, the SGS1 promoter was replaced with a GAL1 promoter and 
overexpression of RecQL5 was verified by probing for a myc epitope tag on the C 
terminus of RecQL5 (Figure 3.3). Overexpression of RecQL5 was unable to suppress 
the sensitivity on HU and MMS, nor was it able to suppress the accumulation of GCRs 
(Figure 3.4 and Table 3.2). 
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Sgs1-RecQL5 chimera is unable to suppress defects observed in the 
 absence of Sgs1 
The N terminus of Sgs1 does not possess any catalytic activity but interacts with 
Top3, Top2, Srs2, and Rad16 [27-33]. RECQL5 is unable to complement sgs1∆ defects 
and this may be because it lacks a conserved N terminal region found in other RecQ-
like helicases. We have previously shown that an N-terminal fragment of Sgs1 
expressed by the sgs1∆C800 allele can suppress HU sensitivity seen in a BLM 
overexpressing cell suggesting Sgs1 and BLM have a functional relationship [34]. The 
Sgs1-BLM chimeric protein was able to suppress defects seen in a sgs1∆ cell [34]. To 
test if RecQL5 can suppress defects of a sgs1∆ cell with addition of the N terminal 
region of Sgs1 (Sgs1 1-647), we fused this region to RecQL5 to produce a Sgs1-
RecQL5 chimera. Protein expression of Sgs1-RecQL5 was confirmed through Western 
blot (Figure 3.3), probing for a myc epitope. The Sgs1-RecQL5 chimera was unable to 
suppress sensitivity to HU and MMS, nor was it able to suppress the accumulation of 
GCRs seen in an sgs1∆ strain (Figure 3.4 and Table 3.2). 
 
Yeast two-hybrid screen using human testis cDNA library to determine 
novel RecQL5 interacting partners 
There are ten known RecQL5 interacting partners to date: Fen1, TopoIIa, 
TopoIIIα/β, PCNA, WRN, Rad51, Mre11, Nbs1, Rad50, RnaPII, SWI/SNF, and PARP-1 
[2, 7, 10-12, 15, 17, 35-41]. These interacting partners have all been discovered through 
either pull down assays or proteomic analysis. To date a comprehensive screen was not 
performed to identify RecQL5 interacting proteins. So we set out to perform a yeast two-
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hybrid screen using the human testis cDNA library since RecQL5 is abundantly 
expressed in the testis [1]. Using the Clontech Matchmaker Gold Yeast Two-Hybrid 
system we were screened approximately 1.5 million transformants. Transformants that 
grew on SC-His, SC-Leu, and SC-Trp indicate a interaction with RecQL5 and these 
isolates were frozen for further analysis. The potential positive transformants were 
spotted once more on selective media for further stringency and validation. From this 
additional test we obtained 61 positive transformants that may be potential RecQL5 
interacting partners. These transformants were then set up for TCA protein extraction 
and Western blot was performed using an antibody against the activating domain. We 
decided to exclude any protein bands less than 30kDa because that is indicative of the 
activating domain (Figure 3.9). Through this exclusion we pursued 36 candidates that 
have a high likelihood of interaction with RecQL5. Lastly, we performed a manual test 
and spotted the transformants on selective media to confirm interaction and determined 
isolates 1 and 10 to express interacting proteins of RecQL5 (Figure 3.10). This test was 
to ensure that there is a positive interaction between the bait and prey and not a result 
of auto-activation by the prey plasmid. For this purpose, the prey plasmid, expressing  
RecQL5 interacting protein, was isolated and transformed into strain KHSY3989 
(reporter strain with empty bait plasmid) and a strain expressing RecQL5 (KHSY5184), 
and then spotted on the following selective media: SC-Leu-Trp, SC-Leu-Trp-His, SC-
Leu-Trp-His+3AT. Growth on SC-Leu-Trp suggests presence of both bait and prey 
plasmids. Growth on SC-Leu-Trp-His plates has lower stringency for selection of 
protein-protein interaction and growth on SC-Leu-Trp-His+3AT has the highest stringency 
because of the presence of 3AT (3-Amino-1,2,3-triazole), which is a competitive 
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inhibitor of the HIS3 gene and is utilized to isolate strong protein-protein interactions. Of 
the 36 transformants that were tested only two were able to activate the reporter genes 
(Figure 3.10). To determine the identity of these isolates, the cDNA insert in the prey 
plasmid was isolated from yeast and primer F1975, that binds upstream of the cDNA 
insert was used to sequence the prey plasmid. The sequences were analyzed using 
NCBI BLAST and isolate 1 and 10 (Figure 3.10) were found to be UBE2I and HLP2 
respectively.  
 
DISCUSSION 
 BLM and WRN, human RecQ-like helicases, have been studied in depth in a 
yeast system, but RecQL5 had not been investigated in a similar fashion, so this study 
sets out to functionally characterize RecQL5 in order to better understand its cellular 
function. We hypothesized that RecQL5, being a RecQ-like helicase, could suppress 
defects seen in an sgs1∆ cell. We found that cells expressing RecQL5 under control of 
the native SGS1 promoter were as sensitive as an sgs1∆ cell on both HU and MMS, 
were unable to suppress this sensitivity when overexpressed, and could not suppress 
the accumulation of GCRs. The inability of RecQL5 to suppress the defects of an sgs1∆ 
cell may be due to the fact that RecQL5 lacks a long N terminal region found in Sgs1, 
which is important for protein-protein interaction with Top2, Top3, Srs2, and Rad16 [26, 
27, 33, 42-44]. The absence of this N terminus may prevent Top3 from localizing to 
sites of damage, resulting in toxic intermediates that cannot be resolved without the 
combined function of the RecQ helicase and topoisomerase. It has been shown that an 
Sgs1-BLM chimera can suppress defects seen in an sgs1∆ cell because it regains the 
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important N terminal functions of Sgs1 so we fused the long N terminal region of Sgs1 
to RecQL5 to determine if retaining these functions could suppress defects similar to a 
Sgs1-BLM chimera [34]. We exposed cells expressing the chimeric protein to DNA 
damaging agents HU and MMS and also assessed its ability to suppress accumulation 
of GCRs and found that the Sgs1-RecQL5 chimeric protein was unable to suppress 
these defects suggesting a separation of function between this helicase and BLM. The 
inability to complement may be because the fusion protein lacks the HRDC domain. 
Removing the HRDC domain in BLM has been shown to reduce its ability to unwind 
double Holliday junctions, and both BLM and WRN are unable to recognize damage 
induced by MMS and mitomycin C in the absence of the HRDC domain [45, 46]. 
Considering RecQL5 lacks an HRDC domain, it is possible that it is unable to respond 
to DNA damage because it cannot recognize these structures. Additionally, looking at 
protein disorder, RecQL5 is distinct from BLM because its C terminus is disordered [34]. 
Disordered regions have been associated with protein-protein interactions so it is 
possible that the C terminus of RecQL5 mediates interactions with proteins involved in 
DNA repair, but inability to recognize DNA substrates may be inhibitory to its function. 
 A useful approach to understand the cellular mechanisms in which RecQL5 
functions is to identify proteins it interacts with. Through yeast two-hybrid screen of a 
human testis cDNA library we identified strong interaction with Hlp2 and Ube2I (Figure 
3.10). Human Hlp2 is an ATP-dependent RNA helicase that is part of the DEAD box 
family of helicases [47, 48]. The homolog in S. cerevisiae, Ded1, is an essential gene, 
which has ATP-dependent RNA helicase activity and plays a role in translation initiation 
[49]. Ded1 has been shown to displace protein complexes from RNA and is capable of 
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RNA duplex unwinding [49]. Proteomics studies have shown that RecQL5 can associate 
with Pol II through its KIX domain, providing a role for RecQL5 in transcription [16]. 
Further evidence has indicated that in the absence of RecQL5, DSBs accumulate 
during replication as a result of the transcription machinery converging with the 
replication fork [15]. The interaction between RecQL5 and Hlp2 may suggest a role for 
RecQL5 apart from DNA metabolism.  
Ube2I is a SUMO-conjugating enzyme that is important in regulating DNA repair, 
the stress response, and cell cycle progression [50-54]. In S. cerevisiae UBE2I is 
essential and is required for cell viability and defects in this gene result in abnormal 
chromosome segregation [55]. Ube2I has also been shown to interact with transcription 
factor AP-2 [56]. AP-2 belongs to a transcription factor family that is involved in 
regulating genes that have a role in differentiation including ERBB2, a proto-oncogene, 
and has functions during embryonic development [57, 58].  Ube2I has been shown to 
associate with this transcription factor and down-regulate its activity by protein-protein 
interaction and post-translational modification [56]. Since Ube2I has such diverse roles 
in the cell, RecQL5 may target Ube2I to damage in the cell so that it can regulate 
proteins involved in repair [59].  
 It will be important to confirm the interaction with endogenous proteins in human 
cells by co-immunoprecipitation. It is possible that Hlp2 and Ube2I interact with the 
unstructured C terminal half of RecQL5. By creating systematic deletions to the C 
terminus of RecQL5, we can narrow the site of interaction and may be able to identify if 
the KIX domain and SRI domain have a role in this interaction. Better understanding the 
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role of novel interacting proteins, such as Ube2I and Hlp2 with RecQL5 will give us 
better insight into the molecular mechanism by which RecQL5 functions.  
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FIGURES AND TABLES 
Table 3.1. Primers used in this study 
Primer ID Name Sequence 
1031F HIS3-5'Chk TCGAGTGCTCTATCGCTAGGGGACC 
1032R HIS3-3'Chk AGTGCGTTCAAGGCTCTTGCGGTTG 
1045F SGS1Confirm GGTTGATATACCAGCCAGCA 
1143F SGS1-5'Chk CTGGGTGATCATTGGTGATA 
1144R SGS1-3'Chk GCACACCACAATATGTCGTG 
1256F SGS1 SEQ1 ATGGTGACGAAGCCGTCACA 
1257F SGS1 SEQ2 GTATAGGCAAACAGCTCGAA 
1258F SGS1 SEQ3 ACTGTGACCCTCCTGTAATA 
1259F SGS1 SEQ4 GTTCCCTCAAATGGCCAAAA 
1260F SGS1 SEQ5 GAGGAAGACGATTTTGATGA 
1261F SGS1 SEQ6 GAAGTCTTTAAACTGCCTGG 
1262F SGS1 SEQ7 CTGCAAGTGAACAAGTCAGA 
1263F SGS1 SEQ8 GCAGACAATGATCCAGAAGG 
1264F SGS1 SEQ9 GCTGACTGGAAAAATGGAGA 
1265F SGS1 SEQ10 GATCAAGCGAGGATCATGAA 
1266F SGS1 SEQ11 CCGAGGTCACTACAGAGGAA 
1267R SGS1 SEQ12R TAACCATTTGTGCTCCCTTC 
1268R SGS1 SEQ13R CTTGAAGGCGGATCACCTCT 
1672F POBD2 RECQL5 F AAGATACCCCACCAAACCCAAAAAAAGAGATCGAATTCCAGCTGACCACCATGAGCAGCCACCATACCAC 
1673R POBD2 RECQL5 R CTACGATTCATAGATCTCTGCAGGTCGACGGATCCCCGGGAATTGCCATGTCATCTCTGGGGGCCACACA 
1674F RECQL5 SEQ F 1 ATGAGCAGCCACCATACCAC 
1675F RECQL5 SEQ F 2 AGCCACCCCACAGGTCCAAG 
1676F RECQL5 SEQ F 3 TCTATTACTCCAGGAATGAC 
1677F RECQL5 SEQ F 4 CCAGATGAGAACTGTCCCCT 
1678F RECQL5 SEQ F 5 GAGCCGGCCCTGTGGCCTCC 
1679F RECQL5 SEQ F 6 AGAACCCAGAGAGCCAGCCT 
1680R RECQL5 SEQ R 1 AATGAGCTTCATCCACCACC 
1697R RECQL5 R TCATCTCTGGGGGCCACACA 
1850F R5   F ATTATTGTTGTATATATTTAAAAAATCATACACGTACACACAAGGCGGTAATGAGCAGCCACCATACCAC 
1851R R5   R TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTATTTTTCTACTCTTCATCTCTGGGGGCCACACA 
1911F R5 HIS3 F TTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGCCAAGCTTGCATGCCATGAGCAGCCACCATACCAC 
1912R R5 HIS3 R CCAAGCTCTTAAAACGATAACTTCGTATAATGTATGCTATACGAAGTTATTCATCTCTGGGGGCCACACA 
1913R R5 HIS3 KI R TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTATTTTTCTACTCTATTCGAGCTCGGTACCCGGG 
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Table 3.1 (continued) 	
1975F pact2ADF ACCACTACAATGGATGATGT 
2454F MycChkF CAGAAACTGATCTCTGAAGA 
2455R MycChkR TCTTCAGAGATCAGTTTCTG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
128
Table 3.2. Rate of accumulating Gross Chromosomal Rearrangements (GCRs) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain GCR Rate 
(Canr 5-FOAr × 10− 10) 
95% CI 
(Canr 5-FOAr × 10− 10) 
Wildtype 1.1 <1-6.2 
Δsgs1 251 80-310 
RECQL5 187 40-200 
Pgal.RECQL5 96 71-264 
sgs1ΔC800.RECQL5 110 47-250 
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Figure 3.1. RecQ-like helicases 
Domain structures of RecQ-like helicases from Saccharomyces cerevisiae and Homo 
sapiens. RecQL5β lacks the N terminal region present in Sgs1, WRN, BLM, and 
RecQL4, but still contains a conserved helicase domain and partial RQC domain. In 
addition to these domains RecQL5β possess a KIX domain and a SRI domain not 
present in any of the other RecQ-like helicases. For this study RecQL5β was used 
instead of RecQL5α and RecQL5ɣ because of its localization to the nucleus and 
implicated roles in DNA repair. 
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Figure 3.2. Construction of a chimeric protein containing the N terminal region of 
Sgs1 and full length RecQL5β 
Protein disorder was determined using IUPred algorithm. Data points above 0.5 indicate 
a disordered residue and data points below 0.5 indicate ordered residues. N terminal 
region of Sgs1, residues 1-647 were fused to RecQL5. 
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 Figure 3.3. Expression of RecQL5 at the endogenous SGS1 locus 
RECQL5 was integrated into a strain deficient for SGS1 and a myc epitope tag was 
added to the C terminus. Protein was extracted using standard TCA extraction and run 
on a 10% SDS-PAGE gel and transferred to a PVDF membrane before visualization 
with ECL Plus (GE Healthcare). RecQL5 was probed by using anti-myc (COVANCE) 
antibody. In order to overexpress RecQL5, a GAL1 promoter was added to the N 
terminus of RecQL5 while maintaining the myc epitope tag at the C terminus and 
expression was verified using anti-myc antibody (COVANCE). The N terminus of SGS1 
was fused to RecQL5 and expression verified using anti-myc antibody (COVANCE). 
 
 
 
 
 
 
MW 
(kDa) 
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 Figure 3.4. RecQL5 does not suppress the defects seen in a sgs1∆ strain 
Exponentially growing haploid cells were spotted on YPD media in the presence and 
absence of DNA damaging agent hydroxyurea. Expressing RecQL5 from the native 
SGS1 promoter, overexpressing, or generating a chimeric Sgs1-RecQL5 protein were 
as sensitive as the sgs1∆ strain. 
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 Figure 3.5. Expression of RecQL5 from bait plasmid containing a DNA binding 
domain 
Cells were grown to an OD600 = 0.5 in SC-Trp media and protein was extracted using 
standard TCA extraction. Sample was loaded on a 10% SDS-PAGE gel and transferred 
to a PVDF membrane (Bio-Rad) then probed with anti-DBD monoclonal antibody (Santa 
Cruz). Protein was visualized using ECL Plus (GR Healthcare). RecQL5β is 
approximately 109kDa and all three independent isolates produced similar expression 
and were therefore used for the yeast two-hybrid. 
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 Figure 3.6. Schematic of yeast two-hybrid using a testis cDNA library to find 
RecQL5 interacting proteins 
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Figure 3.7. Strain AH109 (Clontech) with the four reporter constructs 
Strain AH109 used in the Clontech Matchmaker Gold Yeast Two-Hybrid System 
containing the four reporter constructs. HIS3 and ADE2 contain GAL1 and GAL2 
promoter elements and an upstream activating sequence. LacZ and MEL1 contain a 
MEL1 UAS promoter element, which is a GAL4 response gene. The reporter genes in 
this strain allow for a high level of stringency to determine RecQL5 interacting proteins 
when using the human testis cDNA library. 
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Figure 3.8. Positive candidates identified in the yeast two-hybrid system using 
human testis cDNA library against RecQL5 
Colonies that show a noticeable growth on SC-Leu-Trp-His+3AT were saved for protein 
extraction and further analysis. 
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Figure 3.9. Western blot analysis of candidates identified in yeast two-hybrid 
using a human testis cDNA library for RecQL5 interacting proteins 
Positive transformants from the yeast two-hybrid screen were grown to an OD600 = 0.5 
in SC-Leu-Trp media and protein was extracted using standard TCA extraction to 
confirm the expression of the activating domain and cDNA ORF from the testis library. 
TCA extractions were run on 10% SDS-PAGE gels and transferred to a PVDF 
membrane (Bio-Rad) and probed with anti-AD monoclonal antibody (Santa Cruz). 
Protein was visualized using ECL Plus (GE Healthcare). The activating domain within 
the plasmid containing the cDNA is approximately 30kDa. For this study candidates that 
are greater than 30kDa are circled and were utilized for further analysis. 
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 Figure 3.10. Manual verification of RecQL5 interacting proteins 
Positive candidates from yeast two-hybrid were evaluated for expression using an 
activating antibody and candidates larger than 30kDa were used for further evaluation 
are shown above. Genomic DNA from candidates larger than 30kDa was isolated and 
transformed into E. coli in order to isolate the plasmid containing the cDNA. The isolated 
plasmid was transformed into a strain containing the bait plasmid with RECQL5 
(KHSY5184) and a strain with an empty bait vector (KHSY3989) in order to ensure that 
the interaction observed was not a byproduct of the prey plasmid self-activating. The 
candidates were spotted on SC-Leu-Trp, to select for presence of both plasmids and on 
SC-Leu-Trp-His+3AT, to select for activation of the HIS3 reporter gene with 3AT allowing 
for an extra level of stringency. The images on the left are of candidates grown on SC-
Leu-Trp and the images on the right are of candidates grown on SC-Leu-Trp-His+3AT. 
From 36 candidates tested only two reproduced as positives, Ube2I and Hlp2. 
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CHAPTER FOUR: 
NOVEL ROLE OF RRM3 IN CONTROLLING DNA SYNTHESIS IS SEPARABLE 
FROM ITS HELICASE-DEPENDENT ROLE IN AVOIDANCE OF REPLICATION 
FORK PAUSING 
 
Note to reader: Unpublished data. Experiments were designed by Kristina H. Schmidt 
and Salahuddin Syed. Experiments were performed by Salahuddin Syed. 
 
ABSTRACT 
 In response to replication stress cells activate the DNA Damage checkpoint, 
induce DNA repair pathways, increasing nucleotide levels, and inhibit late origin firing.  
Here, we report that Rrm3 controls DNA synthesis during replication stress and normal 
S phase. This novel Rrm3 function is independent of its established role as an 
ATPase/helicase in facilitating replication fork progression through polymerase blocking 
obstacles; instead the new functional domain maps to residues 186-212 that are also 
critical for binding Orc5 of the origin recognition complex. Deletion of this domain is 
lethal to cells lacking the replication checkpoint mediator Mrc1 and leads to mutations 
upon exposure to the replication stressor hydroxyurea, but not upon induction of 
alkylating DNA damage. Using quantitative mass spectrometry and genetic analysis, we 
find that the chromatin remodeler Rdh54 and Rad5-depenent error-free DNA damage 
bypass act as independent mechanisms on DNA lesions that arise when Rrm3 catalytic 
activity is disrupted whereas these mechanisms are dispensable for DNA damage 
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tolerance when the replication function is disrupted, indicating that the DNA lesions 
generated by the loss of each Rrm3 function are distinct. Although both lesion types 
activate the DNA-damage checkpoint, we find that the resultant increase in nucleotide 
levels is not sufficient for continues DNA synthesis under replication stress. Together, 
our findings suggest a role of Rrm3, via its Orc5-binding domain, in restricting DNA 
synthesis that is genetically and physical separable from its established catalytic role in 
facilitating fork progression through replication blocks. 
 
INTRODUCTION 
The replication machinery constantly at risk of encountering obstacles such as 
protein-DNA complexes, DNA secondary structures, transcribing RNA polymerases, 
and DNA damage, which can block fork progression. If these structures cannot 
immediately be resolved the paused fork may eventually collapse as replisome 
components become irretrievably inactivated.  
The 5’ to 3’ DNA helicase Rrm3 is a member of the Pif1 family, which is 
conserved from yeast to humans (Azvolinsky, Dunaway et al. 2006). Saccharomyces 
cerevisiae RRM3 was first discovered as a suppressor of recombination between 
tandem arrays and ribosomal DNA (rDNA) repeats (Keil and McWilliams 1993). Without 
Rrm3, extrachromosomal rDNA circles accumulate, suggesting a role in maintaining 
rDNA stability, and cells accumulate recombination intermediates at stalled replication 
forks, suggesting that Rrm3 facilitates DNA unwinding and the removal of protein blocks 
from DNA to help fork convergence during replication termination (Ivessa, Zhou et al. 
2000, Ivessa, Zhou et al. 2002, Ivessa, Lenzmeier et al. 2003, Fachinetti, Bermejo et al. 
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2010). Additionally, replication fork pausing has been observed in the absence of Rrm3 
at centromeres, telomeres, tRNA genes, the mating type loci, inactive origins of 
replication, and RNA polymerase II-transcribed genes (Keil and McWilliams 1993, 
Ivessa, Zhou et al. 2002, Ivessa, Lenzmeier et al. 2003). 
The mechanism by which Rrm3 aids fork progression is poorly understood, but it 
is thought that Rrm3 facilitates replication through protein blocks and may also be able 
to remove RNA transcripts (Ivessa, Lenzmeier et al. 2003, Stamenova, Maxwell et al. 
2009). Within each rRNA coding region are two intergenic spacers that contain 
termination (Ter) sites that are bound by the replication terminator protein Fob1 to 
promote fork arrest in order to prevent unscheduled transcription (Kobayashi, Nomura 
et al. 2001, Kobayashi 2003, Mohanty and Bastia 2004). Ter function also requires the 
intra-S phase checkpoint proteins Tof1 and Csm3, which form a complex with the 
replisome and antagonize Rrm3 function (Mohanty, Bairwa et al. 2006, Mohanty, Bairwa 
et al. 2009). It is thought that Rrm3 removes Fob1 and other non-histone proteins from 
DNA before the replication fork encounters them. This ability of Rrm3 to promote 
replication fork progression is dependent on its catalytic activity (Ivessa, Zhou et al. 
2000). Further supporting a role of Rrm3 in fork progression are synthetic fitness 
defects or lethality between rrm3Δ and mutations that disrupt genes involved in 
maintaining the integrity of stalled forks, including rad53Δ, mec1Δ, srs2Δ, sgs1Δ, mrc1Δ, 
and rtt101Δ (Ivessa, Lenzmeier et al. 2003, Schmidt and Kolodner 2004, Torres, 
Schnakenberg et al. 2004, Luke, Versini et al. 2006).  
Rrm3 possesses an N-terminal PCNA-interacting motif, associates with the 
replication fork in vivo and is hyperphosphorylated by Rad53 under replication stress 
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(Schmidt, Derry et al. 2002, Azvolinsky, Dunaway et al. 2006, Rossi, Ajazi et al. 2015). 
The replication damage that arises in the absence of Rrm3 causes constitutive, 
Mec3/Mec1/Rad9-dependent activation of the checkpoint kinase Rad53 (Ivessa, 
Lenzmeier et al. 2003, Schmidt and Kolodner 2006, Rossi, Ajazi et al. 2015). As a 
result, Dun1 kinase is activated, leading to degradation of the ribonucleotide reductase 
(RNR) inhibitor Sml1 and an increase in the dNTP pool (Zhao and Rothstein 2002, Poli, 
Tsaponina et al. 2012). This increased dNTP pool has been associated with enhanced 
DNA synthesis in hydroxyurea (HU) in chromosome instability mutants (Poli, Tsaponina 
et al. 2012).  
Here we show that cells lacking Rrm3 fail to inhibit DNA replication in the 
presence of HU-induced replication stress and that this failure is not caused by the 
increased dNTP pool resulting from constitutive DNA-damage checkpoint activation. 
This novel function of Rrm3 is independent of its ATPase/helicase activity and, thus, 
distinct from Rrm3’s established catalytic role in facilitating fork progression through 
replication blocks. Instead, we have identified dependency on a novel functional domain 
in the Rrm3 N-terminus that we find is critical for binding the Orc5 subunit of the origin 
recognition complex (ORC), suggesting that Rrm3 may control DNA synthesis by 
controlling origin activity. Quantitative mass spectrometry and genetic analyses further 
implicate Rad5-dependent error-free DNA damage bypass and Rdh54 translocase as 
novel repair mechanisms for DNA lesions that result from inactivating the catalytic 
activity of Rrm3, whereas the same DNA repair factors are dispensable when the Orc5-
binding domain is disrupted, leading us to conclude that the types of DNA lesions that 
result from the inactivation of the two independent Rrm3 functions are distinct.  
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RESULTS 
 SILAC-based proteomics to identify the cellular response to replication fork 
 pausing 
In the absence of Rrm3 cells accumulate replication pause sites at the rDNA 
locus, in tRNA genes and at centromeric regions, as well as many other sites 
throughout the genome (Ivessa, Zhou et al. 2002, Ivessa, Lenzmeier et al. 2003, Torres, 
Schnakenberg et al. 2004). To identify DNA metabolic pathways that deal with stalled 
forks, we sought to identify proteins whose association with chromatin changed in the 
absence of Rrm3 using stable isotope labeling by amino acids in cell culture (SILAC)-
based quantitative mass spectrometry (Ong, Blagoev et al. 2002, Ong and Mann 2006). 
We extracted the chromatin fraction from nuclei purified from a mixture of wildtype and 
rrm3Δ cells grown in the presence of heavy- or light-labeled arginine and lysine, 
respectively (Figures 1A and 1B). Across chromatin fractions from three biological 
replicates we identified 490 peptides from 137 different proteins, with the abundance of 
11 proteins changing significantly in at least two out of the three replicates (Figure 1C). 
The largest change in chromatin association was a 5.1-fold increase (p<0.001) of Rad5, 
which belongs to the SWI/SNF family of ATPases and defines an error-free pathway for 
bypassing replication-blocking DNA lesions (Torres-Ramos, Prakash et al. 2002, 
Gangavarapu, Haracska et al. 2006, Blastyak, Pinter et al. 2007, Ortiz-Bazan, Gallo-
Fernandez et al. 2014). The increase in Rad5 was followed by smaller, but significant, 
increases for Top2 (1.9-fold, p<0.01), a type II topoisomerase that is important for the 
decatenation of replication intermediates, and Rdh54 (1.8-fold, p<0.01), a chromatin 
remodeler with a role in homologous recombination that is still largely unclear. Like 
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Rad5, Rdh54 is a member of the SWI/SNF family of ATPases; it possesses translocase 
activity on double-stranded (ds) DNA and has been shown to be capable of modifying 
DNA topology, especially in chromatinized DNA (Petukhova, Sung et al. 2000, Chi, 
Kwon et al. 2006, Shah, Zheng et al. 2010). We observed significant decreases in 
chromatin association for the Rsc1 subunit of the chromatin-structure-remodeling (RSC) 
complex (2-fold, p<0.01), the Mcm4 subunit of the minichromosome maintenance 
(MCM) replicative DNA helicase (1.9-fold, p<0.01), and the catalytic subunit Hda1 of the 
histone deacetylase (HDAC) complex (1.7-fold, p<0.01).  
Upon treatment with HU, which induces replication stress by reducing the 
nucleotide pool, Rdh54 abundance in the chromatin fraction of the rrm3Δ mutant 
increased the most (2.6-fold, p<0.01) whereas the histone deacetylase Set3 and the 
Rsc9 subunit of the RSC chromatin remodelling complex saw the largest decreases 
(2.7-fold, p<0.05) (Figures 1D and 1E). The complete list of proteins that underwent 
significant changes in the HU-treated or untreated rrm3Δ mutant, including the FANCM-
related Mph1 helicase, the recombination factor Mgm101, and the cohesion 
components Smc1, Smc3 and Scc3, is provided in Supplemental Table S1.  
 
 Rad5 and Rdh54 independently act on DNA lesions that arise in the 
 absence of Rrm3 
Rrm3 helicase is required to prevent excessive replication fork pausing at 
protein-bound sites, possibly by acting as a protein displacement helicase (Ivessa, Zhou 
et al. 2002). The role of Rdh54 as a chromatin remodeler (Kwon, Seong et al. 2008, 
San Filippo, Sung et al. 2008) and the fork reversal activity of Rad5 suggest that they 
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are recruited to chromatin to recover forks that are blocked due to the lack of Rrm3 or to 
substitute for Rrm3 in preventing fork pausing. We therefore examined the effect of 
deleting RAD5 and RDH54 in the rrm3Δ mutant on genome stability and sensitivity to 
DNA damage and replication stress. We found synergistic increases in DNA damage 
sensitivity in the rrm3Δ rad5Δ and rrm3Δ rdh54Δ mutants (Figure 2A). The negative 
genetic interaction between rrm3Δ and rad5Δ was particularly strong; both single 
mutants were no more sensitive to HU than wildtype, but the double mutant failed to 
form colonies on 100 mM HU and grew very poorly even on 20 mM HU. In contrast to 
HU, the rad5Δ mutant was extremely sensitive to methyl methanesulfonate (MMS), and 
deleting RRM3 led to a further, synergistic increase in MMS sensitivity. Inactivation of 
the ATPase activity of Rrm3 (rrm3-K260A/D) caused the same DNA-damage sensitivity 
in the rad5Δ mutant as an RRM3 deletion (Figure 2B). We also identified a negative 
genetic interaction between rrm3Δ and rdh54Δ, which was especially strong on MMS. 
The increase in DNA-damage sensitivity of rdh54Δ cells upon deletion of RRM3 
extended to diploid cells (Figure 2G), suggesting that the lesions generated in the 
absence of Rrm3 are substrates for recombination between homologous chromosomes 
that is controlled by Rdh54. Even though the rrm3Δ rad5Δ mutant was hypersensitive to 
MMS and HU, deletion of RDH54 caused further synergistic increases in sensitivity to 
both DNA damaging agents, suggesting that Rad5 and Rdh54 define important 
pathways for dealing with DNA lesions that arise in the absence of Rrm3, and that they 
perform (at least some) independent roles.  
In addition to structure-specific helicase activity, Rad5 also possesses a RING 
motif associated with ubiquitin ligase activity that plays a role in polyubiquitination of 
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PCNA (Johnson, Henderson et al. 1992, Johnson, Prakash et al. 1994, Ulrich and 
Jentsch 2000, Hoege, Pfander et al. 2002). Disrupting the ubiquitin-ligase activity (rad5-
Ub) or ubiquitin ligase and ATPase activity (rad5-Ub-ATPase), had the same effect on 
the MMS and HU sensitivity of wildtype cells (Figure 2B), consistent with a previous 
report (Gangavarapu, Haracska et al. 2006). In the rrm3Δ mutant, however, disrupting 
both activities caused significantly greater DNA damage sensitivity than disrupting either 
activity (rrm3Δ rad5-Ub, rrm3Δ rad5-ATPase), indicating that the ATPase/helicase and 
ubiquitin ligase activities of Rad5 contribute independently to repair of DNA lesions that 
arise in the absence of Rrm3. 
Although Rad5 and Rdh54 chromatin association increased most in the absence 
of Rrrm3 (Figure 1E), gross-chromosomal rearrangements (GCRs) did not accumulate 
at higher rates in the rrm3Δ rad5Δ or rrm3Δ rdh54Δ mutants compared to the single 
mutants, even after exposure to HU and MMS (Table 1). However, disruption of both, 
Rad5 and Rdh54, in the rrm3Δ mutant caused significantly higher chromosome 
instability than disruption of a single pathway, especially upon exposure to HU or MMS, 
underlining the independent contributions of Rdh54 and Rad5-mediated repair 
mechanisms to genome stability and DNA damage tolerance in the absence of Rrm3.  
Whereas rdh54Δ and rad5Δ cells moved through an undisturbed cell cycle with 
similar kinetics as wildtype cells, rrm3Δ cells were delayed in progressing through S 
phase (Figure 2C), consistent with previous observations (Ivessa, Zhou et al. 2002, 
Schmidt and Kolodner 2004). We find that this accumulation of rrm3Δ cells in S phase 
was enhanced when RDH54 or RAD5 were deleted. To examine progression of rrm3Δ 
rad5Δ and rrm3Δ rdh54Δ cells through S phase under replication stress, we released α-
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factor arrested cells from G1 in the presence of hydroxyurea and trapped them in G2/M 
with nocodazole. After 140 minutes, virtually all wildtype cells had reached 2C DNA 
content, whereas rrm3Δ and rdh54Δ entered S phase similarly to wildtype cells, but then 
slowed down significantly (Figure 2D, 100 minute time point). When we combined rrm3Δ 
and rdh54Δ mutations, this slowdown was so severe that most cells still had near 1C 
DNA content 100 minutes after release from G1 arrest. Similarly, rad5Δ rrm3Δ cells 
were delayed in reaching 2C DNA content in HU (Figure 2E). However, all mutants 
were able to recover from a 2-hour arrest in 100 mM HU and resume the cell cycle 
normally (Supplemental Figure S1). When we examined the ability of cells arrested in 
G2/M with nocodazole to complete mitosis and reach G1 phase we found that a 
significant number of wildtype cells had reached G1 after 20 minutes, whereas virtually 
all rrm3Δ, rad5Δ and rrm3Δ rad5Δ cells remained arrested in mitosis (Figure 2F). 
Together, these findings indicate that Rad5 and Rdh54 facilitate the progression of 
rrm3Δ cells through S phase, both in the presence and in the absence of HU, and that in 
the absence of Rrm3, cells accumulate DNA damage that impairs mitosis.     
In addition to Rad5 and Rdh54, which exhibited the most significant increases in 
chromatin association in the absence of Rrm3 (Figure 1E), we tested DNA damage 
sensitivity of cells that lacked Rrm3 in combination with other nonessential factors 
revealed in the proteome screen (Figures 1C and 1D), including Mgm101, Hda1, Set3, 
and Mph1. Whereas deletions of MGM101, HDA1 or SET3 had no effect on DNA 
damage sensitivity of wildtype or rrm3Δ cells (Supplemental Figure S2), deletion of 
MPH1 caused synergistic increases in HU and MMS sensitivity of the rrm3Δ mutant 
(Supplemental Figure S3), consistent with our previous finding (Schmidt, Viebranz et al. 
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2010). In the absence of Mph1, rrm3Δ cells progressed very slowly through an 
undisturbed cell cycle and accumulated in G2/M when they were released from a 2-hour 
incubation in 100 mM HU (Supplemental Figures 3B and 3C). When cells were released 
from HU arrest into media with 40 mM HU and α-factor, virtually all wildtype cells and 
the single mutants had been trapped in G1 after 60 minutes (with a slight S-phase delay 
in the mph1Δ mutant), whereas the majority of rrm3Δ mph1Δ cells accumulated in S 
phase, never forming a majority peak at 1C DNA content in the 120-minute time course 
(Supplemental Figure S3D). These findings implicate Mhp1 as another crucial factor for 
overcoming spontaneous and DNA-damage-induced replication-blocking lesions. 
Together these findings suggest error-free DNA lesion bypass, implicated by Rad5 and 
Mph1, and homologous recombination, implicated by Rdh54, as two mechanisms that 
can act independently on blocked replication forks. 
 
 A novel function of Rrm3 in controlling DNA replication maps to the N-
 terminal tail and is independent of Rrm3 catalytic activity 
All functions of the Rrm3 helicase known to date are dependent on its 
ATPase/helicase activity. During our analysis of cell cycle progression, however, we 
observed that cells with a deletion of RRM3 continue to replicate DNA in the presence 
of HU, similar to a rad53Δ checkpoint mutant, whereas the helicase-defective rrm3-
K260A and rrm3-K260D mutants maintained near 1C DNA content after 2 hours in HU, 
similar to wildtype (Figures 3B and 3C). This observation suggested the presence of a 
previously unknown, ATPase/helicase-independent function of Rrm3 in DNA replication. 
Since this replication defect was independent of the ATPase/helicase activity located in 
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the ordered C-terminal domain of Rrm3 (residues 250-723), we explored a possible 
involvement of the 230-residue, disordered N-terminal tail (Figure 3A, Supplemental 
Figure S4A). The only motifs previously identified in this tail are a putative PCNA-
interacting peptide (PIP) box between residues 35-42 (Schmidt, Derry et al. 2002) and a 
cluster of phosphorylated residues between S85 and S92 (Rossi, Ajazi et al. 2015). 
Deletion or mutation of the PIP-box (rrm3-ΔN54, rrm3-FFAA) had no effect on DNA 
replication in HU, whereas deletion of the entire N-terminal tail (rrm3-ΔN230) caused the 
same replication defect as deleting RRM3 (rrm3Δ) (Figure 3D). By constructing a series 
of N-terminal truncations (Figure 3A and 3D) we determined that deletion of up to 186 
residues, which include the PIP-box and the phosphorylation site, was able to maintain 
the wildtype replication phenotype in HU (Figures 3D and 3E), whereas deletion of 212 
residues caused the same replication defect as rrm3-ΔN230, thus narrowing down the 
critical functional site for control of DNA replication to the 26 residues between residues 
186-212. The importance of this region for controlling DNA replication was limited to 
HU, and not observed when cells were exposed to the alkylating agent methane 
methylsulfonate (Supplementary Figure S4B). 
Deletion of RRM3 or inactivation of its ATPase/helicase activity was recently 
reported to partially suppresses the HU hypersensitivity of the rad53Δ mutant (Rossi, 
Ajazi et al. 2015). We obtained the same findings, but also observed that the rrm3-
ΔN212 allele does not act as a suppressor (Figure 3J), indicating that this rrm3-∆N212 
codes for a functional ATPase/helicase. This is also supported by the finding that a 
introduction of the K260A mutation in rrm3-ΔN212 allele suppressed HU hypersensitivity 
of the rad53Δ mutant to the same extent as the rrm3-K260A allele (Figure 3J). Still, the 
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Rad53 checkpoint kinase was constitutively activated in the rrm3-ΔN212 mutant just like 
in the ATPase/helicase-defective rrm3-K260A/D mutants, and Rad53 activation in both 
mutants was dependent on the mediator of the DNA damage checkpoint Rad9 (Figures 
3G and 3I).    
Through degradation of the ribonucleotide reductase (RNR) inhibitor Sml1, the 
nucleotide pool increases upon Rad53 activation, and this correlates with enhanced fork 
progression (Poli, Tsaponina et al. 2012). However, we found that the rrm3 mutants that 
continued DNA replication in HU (rrm3Δ, rrm3ΔN212) and the rrm3 mutant that 
maintained 1C DNA content (rrm3-K260D) had a constitutively increased nucleotide 
pool (Figure 3F), indicating that the continued DNA replication in HU seen in the rrm3-
ΔN212 mutant could not be explained by a larger nucleotide reservoir prior to its 
depletion by HU addition. In fact, we estimate that in the rrm3Δ and rrm3Δ-N212 
mutants the peak of cells with 1C DNA content had progressed nearly 40% toward 2C 
DNA content after 2 hours in HU (Figure 3H), and continued to progress (Supplemental 
Figure S4C), whereas wildtype cells, the helicase-dead rrm3 mutants, and rrm3Δ-N186 
mutant had progressed less than 10%.  
Together, these findings indicate a novel function of Rrm3 in the control of DNA 
replication and prevention of S phase damage, which maps to residues 186-212 of the 
N-terminal tail and does not require Rrm3’s established activity as an ATPase/DNA 
helicase. 
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 Residues of Rrm3 required for control of DNA replication are critical for 
 Orc5 binding 
Long disordered tails, such as the N-terminal 230 residues of Rrm3, which 
extend from its structured catalytic core, typically serve as sites for protein binding and 
posttranslational modification (Gsponer and Babu 2009). The phenotype of the rrm3-
ΔN212 allele in the rad53Δ mutant indicates that it encodes a proficient 
ATPase/helicase, raising the possibility that the replication defect of this allele is caused 
by loss of a protein-binding site. Because deletion of the putative PIP-box (Schmidt, 
Derry et al. 2002) and the recently identified phosphorylation site (Rossi, Ajazi et al. 
2015) did not impair the ability of Rrm3 to control DNA replication, we explored the 
possibility that Orc5, an ATP-binding subunit of the origin recognition complex (ORC), 
binds to the N-terminal tail of Rrm3. An interaction between the two full-length proteins 
had previously been identified in a yeast-two-hybrid screen (Matsuda, Makise et al. 
2007). When we combined ORC5 with the various rrm3 truncation alleles in a yeast 
two-hybrid assay, we found that deletion of 186 residues did not diminish Orc5 binding 
to Rrm3, in the presence or absence of MMS or HU, whereas deletion of 212 or 230 
residues eliminated binding (Figure 4A). These findings show that the same site of 
Rrm3 that controls DNA replication is required for a physical interaction with Orc5 and 
raise the possibility that Rrm3 may control DNA replication by affecting origin activity.  
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 Differential requirements of Rrm3 function in controlling DNA replication 
 and ATPase/helicase activity in cells lacking Rad5, Rdh54, Mph1 or 
 replication checkpoint factors Mrc1 and Tof1  
 To investigate the link between Rrm3 functions and DNA replication, we first 
examined the replication checkpoint. Replication mutants exhibit strong genetic 
interactions with Mrc1/Claspin, which acts as a mediator of the replication stress 
checkpoint – a Rad9-independent pathway of the intra-S-phase checkpoint (Alcasabas, 
Osborn et al. 2001, Katou, Kanoh et al. 2003, Osborn and Elledge 2003, Suter, Tong et 
al. 2004, Xu, Boone et al. 2004). Mrc1 is also a component of normal replication forks, 
which is loaded at origins of replication and stays associated with the replisome 
(Alcasabas, Osborn et al. 2001, Osborn and Elledge 2003, Szyjka, Viggiani et al. 2005, 
Tourriere, Versini et al. 2005). Mrc1, like Rrm3, is required for efficient replication 
(Naylor, Li et al. 2009). The function of Mrc1 in DNA replication is essential for the 
viability of cells lacking Rrm3 (Szyjka, Viggiani et al. 2005) whereas Mrc1 
phosphorylation on SQ and TQ sites linked to its checkpoint function is dispensable 
(Schmidt and Kolodner 2006). However, the role of this functional interaction between 
Rrm3 and Mrc1 in DNA replication has remained unclear. We therefore tested if the 
ability of Rrm3 to control DNA replication was required for the viability of the mrc1Δ 
mutant. For this purpose, we transformed diploids heterozygous for the mrc1Δ and 
rrm3Δ mutations with plasmids expressing N-terminal truncations of Rrm3 and analyzed 
the viability of meiotic products. Figure 4B shows that the rrm3-ΔN186 allele supported 
viability of the rrm3Δ mrc1Δ mutant as effectively as the wildtype RRM3 allele, whereas 
the helicase-dead alleles and the rrm3-ΔN212 allele were as ineffective as the null allele 
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(empty vector). Thus the helicase activity of Rrm3 is not sufficient for viability of the 
mrc1Δ mutant; Rrm3’s new N-terminal domain for controlling DNA replication is also 
required.  
In addition to Mrc1, Tof1 promotes normal progression of the replication fork; 
however, in contrast to Mrc1, its requirement for fork progression appears more limited, 
assisting primarily replication through non-histone protein complexes with DNA 
(Hodgson, Calzada et al. 2007). TOF1 deletion was not lethal in the rrm3Δ mutant and 
neither single mutant was hypersensitive to HU or MMS. The combined loss of Rrm3 
and Tof1, however, caused a synergistic increase in DNA-damage sensitivity (Figure 
4C). Identical to the functional requirements in the absence of Mrc1 both, the 
ATPase/helicase activity of Rrm3 and the Orc5 binding domain, were required for 
growth in the presence of DNA damage and replication stress in the absence of Tof1.  
In contrast to mrc1Δ and tof1Δ mutants, we found that only the ATPase/helicase 
activity of Rrm3 was required for the suppression of HU and MMS hypersensitivity of the 
rad5Δ, rdh54Δ, and mph1Δ mutants (Figures 4D – 4F, Figure 2B). The N-terminal tail, 
including its function in controlling DNA replication, was dispensable, with the rrm3-
ΔN212 allele exhibiting wildtype phenotypes in rad5Δ, rdh54Δ, and mph1Δ mutants 
(Figures 4D – 4F).  
Together, these findings suggest two separable functions of Rrm3 in DNA 
replication. First, an ATPase/helicase-dependent function that promotes fork 
progression through protein-DNA complexes, which if disrupted (rrm3-K260A/D) causes 
aberrant replication intermediates that can be rescued by Rad5, Rdh54 or Mph1 
mechanisms. Second, an N-terminal function that controls DNA replication, possibly 
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mediated by Rrm3’s physical interaction with ORC, which if disrupted (rrm3-ΔN212) 
requires the replication checkpoint factors Mrc1 and Tof1 for viability and DNA damage 
survival. These differential requirements of factors involved in DNA repair and DNA 
damage tolerance pathways in the rrm3-ΔN212 and rrm3-K260A/D mutants also 
suggests that the types of DNA lesions that accumulate upon inactivation of the two 
Rrm3 functions are different, but both lead to dependence on Mrc1 for survival and both 
are sufficient for constitutive activation of the DNA-damage checkpoint. 
 
 Requirement of the Orc5-binding domain of Rrm3 for suppression of HU-
 induced mutations, but not MMS-induced mutations and gross-
 chromosomal rearrangements  
If Rrm3 is important for the response to replication stress, cells lacking the 
catalytic activity of Rrm3 or its Orc5-binding domain may be prone to accumulating 
mutations at higher rates than wildtype cells. To test this, we measured forward 
mutation rates at the CAN1 locus and the accumulation of GCRs on chromosome V in 
the presence and absence of HU or MMS (Table 2). Two-fold (ung1Δ) to 50-fold 
(rad27Δ) increases in CAN1 forward mutation rates compared to wildtype have 
previously been reported for numerous DNA metabolism mutants (Huang, Rio et al. 
2003). Deletion of RRM3 or disruption of its ATPase activity caused a significant 
increase in spontaneous CAN1 mutations. Of the truncation alleles, which encode 
catalytically active rrm3 mutants, rrm3Δ-N186 was indistinguishable from wildtype 
whereas rrm3Δ-N212 caused a small, but significant, increase in the CAN1 mutation 
rate in untreated cells and upon exposure to HU (Table 2). In contrast, expression of the 
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rrm3Δ-N212 allele had no effect on the CAN1 mutation rate if cells were treated with 
MMS, consistent with our observation that the rrm3-ΔN212 mutant exhibits a defect in 
controlling replication in HU, but not MMS. GCRs accumulated at increased rates in the 
rrm3Δ and rrm3-K260A/D mutants in the absence and presence of DNA damaging 
agents, but accumulated at wildtype levels in cells expressing N-terminal truncations 
under all conditions. These mutator phenotypes, albeit mild, reveal that Rrm3’s 
ATPase/helicase activity is required for the suppression of all tested mutation types 
induced by either HU or MMS, or in their absence, whereas the N-terminal site that 
controls DNA replication and binds Orc5 plays a role specifically in the suppression of 
spontaneous and HU-induced mutations, but not for the suppression of MMS-induced 
mutations, or GCRs under any conditions. 
 
DISCUSSION 
By quantifying changes in chromatin composition we have identified Rad5 and 
Rdh54 as novel factors that respond to increased replication fork stalling induced by the 
absence of Rrm3, and affirmed the importance of Mph1. These factors suggest that 
error-free post-replicative repair (PRR), implicated by Rad5 and Mph1, and HR, 
implicated by Rdh54, act on DNA polymerase blocking sites in the genome that arise in 
the absence of Rrm3. The N-terminal unstructured tail is entirely dispensable for this 
ATPase/helicase-dependent role of Rrm3 in facilitating fork progression. Instead, we 
have discovered that the N-terminal tail encodes a new function of Rrm3 – to control 
DNA replication. This function of Rrm3 is distinct from its established role as an 
ATPase/helicase, is not regulated by the previously identified phosphorylation cluster 
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(Rossi, Ajazi et al. 2015) or the PIP-box (Schmidt, Derry et al. 2002) and, in contrast to 
the ATPase/helicase activity, does not contribute to the HU hypersensitivity of the 
rad53Δ mutant.  
Based on changes in DNA content as measure by flow cytometry, we observed 
that wildtype cells maintained near 1C DNA content for 180 minutes after release from 
G1 phase into HU, whereas rad53∆, rrm3∆ and rrm3-∆N212 did so for only 60 minutes 
(Figure 3C, Supplemental Figure S4C). The extent of continuing DNA replication in the 
presence of HU, however, was not as pronounced in the rrm3 mutants as in the intra-S 
checkpoint-deficient rad53∆ mutant. Although the Rad9-dependent DNA-damage 
checkpoint is chronically activated in the rrm3-∆N212 mutant and, as a consequence, 
nucleotide levels are increased compared to wildtype cells and the rrm3-∆N186 mutant, 
the increased nucleotide levels are not the cause for the ability of the rrm3-∆N212 
mutant to continue DNA replication upon HU exposure because the rrm3-K260A/D 
mutants showed the same nucleotide level increase and DNA-damage checkpoint 
activation, but maintained a peak at 1C DNA content in HU. 
Therefore, considering Rrm3’s known function as an accessory ATPase/helicase 
that facilitates progression of the replication fork through obstacles, and its new function 
in controlling DNA synthesis reported here, we propose a model (Figure 5) where Rrm3 
performs two genetically and physically separable functions to deal with challenges 
during genome duplication: the N-terminal tail of Rrm3 plays a structural role in 
preventing untimely replication in the presence of replication stress (HU) and in normal 
S phase, whereas the C-terminal ATPase/helicase domain plays a catalytic role in 
preventing fork pausing. The site between residues 186 to 212, which is in a segment of 
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the N-terminal tail not previously assigned a function, is not only critical for restricting 
DNA replication, but also for binding Orc5, raising the possibility that Rrm3 may exert 
control over DNA replication by affecting origin activity; such a link would be consistent 
with a previously identified role of ORC in suppressing late-origin firing under replication 
stress (Shirahige, Hori et al. 1998). For example, Rrm3 could be recruited to pre-
replication complexes as they are assembled at origins during G1 by binding to the 
ATP-binding ORC subunit Orc5, which does not appear to play a role in the completion 
of S phase, or the remainder of the cell cycle (Bell and Dutta 2002, Labib 2010). There, 
Rrm3 could act as an inhibitor of ORC ATPase activity, which is required for loading of 
minichromosome maintenance (MCM) proteins and initiation of DNA replication 
(Bowers, Randell et al. 2004, Randell, Bowers et al. 2006). 
Instead of a global role in controlling origin activity, however, the wildtype level of 
HU sensitivity of rrm3Δ cells and the importance of Rrm3 for replicating through certain 
nonhistone-protein-bound regions suggest that Rrm3 may play a role at origins in 
specific loci, such as those in highly transcribed regions and regions with converging 
transcription, which are often late-firing (Soriano, Morafraile et al. 2014), rRNA and 
tRNA coding loci, or highly transcribed metabolic genes, where ORC has been found to 
be bound to the open reading frames, possibly to coordinate the timing of replication 
with transcription (Shor, Warren et al. 2009). The absence of Rrm3 from these regions 
could cause more wide-spread (untimely) origin firing early in S-phase and, thus, an 
overabundance of replication intermediates and, eventually, DNA lesions, causing 
constitutive activation of the DNA-damage checkpoint (Figure 5B). It has been proposed 
that the temporal separation of origins into early and late firing might be required to 
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prevent excessive accumulation of replication intermediates, such as ssDNA, that could 
activate the intra-S checkpoint (Shimada, Pasero et al. 2002). In rrm3Δ and rrm3-ΔN212 
mutants, a subset of regions whose replication may be controlled by Rrm3 to fire late 
could convert to firing early, so that in HU, when firing of late origins is inhibited in cells 
with a proficient intra-S checkpoint (Santocanale and Diffley 1998, Shirahige, Hori et al. 
1998), rrm3Δ and rrm3-ΔN212 mutants exhibit a DNA replication profile that is similar to 
that of the rad53Δ mutant.  
Inactivation of the ATPase/helicase activity does not affect Rrm3’s novel role in 
controlling DNA replication. Instead, it impairs Rrm3’s established function in facilitating 
fork progression through replication blocks, leading to the accumulation of DNA lesions 
that activate the DNA-damage checkpoint and increase formation of chromosome 
rearrangements and point mutations (Figure 5C). By identifying changes in chromatin 
composition combined with genetic assays we have identified Rad5 and Rdh54 as 
novel factors that contribute to the maintenance of genome stability in the absence of 
Rrm3’s ATPase/helicase activity. Rad5 defines an error-free pathway for the bypass of 
DNA polymerase blocking lesions (Nelson, Lawrence et al. 1996, Johnson, Prakash et 
al. 1999, Torres-Ramos, Prakash et al. 2002, Prakash, Johnson et al. 2005, 
Gangavarapu, Haracska et al. 2006, Ortiz-Bazan, Gallo-Fernandez et al. 2014). As a 
structure-specific DNA helicase, Rad5 is capable of regressing replication forks in vitro 
(Blastyak, Pinter et al. 2007). Such a regressed fork is thought to provide an alternative 
template for DNA synthesis, generating enough nascent DNA to eventually bypass the 
replication block. The increased association of Rad5 with chromatin in rrm3Δ cells and 
the severe synergistic interaction between rad5Δ and rrm3Δ deletions in HU-treated 
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cells suggest that some type of nascent strand annealing by Rad5 is involved in 
replication fork progression in rrm3Δ cells. Notably, we found that the ATPase activity of 
Rad5 and the RING motif involved in polyubiquitination of PCNA (Johnson, Henderson 
et al. 1992, Johnson, Prakash et al. 1994, Hoege, Pfander et al. 2002, Haracska, 
Torres-Ramos et al. 2004) make independent contributions to DNA damage tolerance in 
the absence of Rrm3. Evidence for a role of the ATPase activity of Rad5 in remodeling 
blocked replication forks has been obtained in vitro (Blastyak, Pinter et al. 2007) 
whereas a role of Rad5-dependent polyubiquitination of PCNA in activating HR-
dependent template switching has more recently been suggested (Minca and Kowalski 
2010). Evidence that these two Rad5 activities can function independently, albeit 
inefficiently, as we determined here in the rrm3Δ mutant, was also observed for bypass 
of MMS-induced lesions by sister-chromatid recombination (Minca and Kowalski 2010). 
Besides fork regression, Rad5 has also been implicated in DNA damage bypass 
by HR-dependent template switching between sister-chromatids (Minca and Kowalski 
2010) and the major HR factors Rad51, Rad52 and Rad54 as well as Sgs1 have been 
implicated in error-free DNA lesion bypass (Branzei, Sollier et al. 2006). It was therefore 
surprising that Rdh54, a chromatin remodeler that plays a major role in meiotic, but not 
mitotic, HR (Klein 1997, Shinohara, Shita-Yamaguchi et al. 1997, Holzen, Shah et al. 
2006), is recruited to chromatin when Rrm3 is absent - both in the presence and 
absence of HU. Rdh54 was only required in the absence of the ATPase/helicase activity 
of Rrm3, but not in the absence of the Orc5-binding domain, implicating Rdh54 in repair 
of DNA lesions that arise when Rrm3 cannot facilitate fork progression through 
replication blocks. Even though Rdh54 does not affect gene conversion repair of a DSB, 
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a role specifically in repair that involves template switches was recently reported 
(Tsaponina and Haber 2014), and could be related to its increased chromatin 
association and the DNA-damage hypersensitivity of the rrm3Δ rdh54Δ and rrm3-K260A 
rdh54Δ mutants.  
Although it is unknown how Rdh54 acts in template switching, its activities in vitro 
seem compatible with those that may be required to rescue a paused fork. Like Rad5 
and the human Rad5 ortholog, HTLF, Rdh54 is a dsDNA translocase of the SWI/SNF 
family (Petukhova, Sung et al. 2000, Chi, Kwon et al. 2006, Blastyak, Hajdu et al. 2010). 
In vitro, it can dislodge the HR factor Rad51 from dsDNA and introduces negative 
supercoiling into dsDNA that can cause strand separation (Petukhova, Sung et al. 2000, 
Chi, Kwon et al. 2006, Shah, Zheng et al. 2010). These Rdh54 activities could help to 
regulate repair at fork pause sites within Rad5-mediated pathways, such as fork 
regression/reversal or template switching, and in HR-mediated template switching 
events outside of Rad5 mechanisms. Whereas Rdh54 can remove proteins from dsDNA 
and remodel chromatinized DNA, an ability to remove bound proteins from DNA has not 
yet been shown for Rad5, and RecQ-like helicases are only capable of acting on forked 
DNA structures that are protein-free (Kwon, Seong et al. 2008, San Filippo, Sung et al. 
2008). The synergistic interactions between rad5Δ and rdh54Δ in the absence of RRM3 
clearly identify a role of Rdh54 outside of a Rad5 mechanism. In addition to facilitating 
template switching HR when error-free PRR is inactivated, Rdh54 could act in the 
avoidance of replication fork pausing in a manner similar to Rrm3 by removing certain 
proteins from dsDNA, such as shown for Rad51, which appears to have a tendency to 
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associate with nonrecombinogenic dsDNA (Chi, Kwon et al. 2006, Holzen, Shah et al. 
2006, Shah, Zheng et al. 2010).  
That the ATPase activity of Rrm3 is required in the absence of Rad5, Rdh54 and 
Mph1, whereas the role of Rrm3 in controlling DNA replication is dispensable strongly 
suggests that the types of DNA damage checkpoint activating DNA lesions in the rrm3-
K260A and rrm3-ΔN212 mutants are different, and that Rad5, Rdh54 and Mph1 act on 
DNA lesions that form when replication forks are unable to move through replication 
blocks, but not on DNA lesions that form during uncontrolled DNA replication. In 
contrast, Mrc1 and Tof1 were required for viability and DNA damage tolerance when 
either of the two Rrm3 activities was disrupted. Mrc1, the mediator of the replication 
stress checkpoint, mediates Rad53 phosphorylation specifically in response to 
replication fork pausing, leading to intra-S checkpoint activation and inhibition of late-
origin firing (Osborn and Elledge 2003, Crabbe, Thomas et al. 2010). That synthetic 
lethality between rrm3Δ and mrc1∆ is limited to those mrc1 alleles that cause DNA 
damage accumulation during S phase (Naylor, Li et al. 2009), whereas the checkpoint 
function of Mrc1 is dispensable (Schmidt and Kolodner 2006, Naylor, Li et al. 2009) 
suggests that the additive accumulation of S phase damage and slowing of S phase 
progression due to lack of both, Mrc1 and Rrm3, is lethal and suggests that uncontrolled 
replication in the rrm3-ΔN212 mutant also leads to S phase damage, consistent with our 
observation of Rad9-dependent activation of Rad53 (Figure 5B).  
Finally, the new N-terminal Rrm3 function in controlling DNA replication is 
separated from Rrm3’s established C-terminal function as an ATPase/helicase in 
facilitating fork progression by the differential requirement of Rad5, Rdh54 and Mph1 for 
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DNA lesion repair and by the different spontaneous and DNA-damage induced mutation 
spectra. This suggests that the N-terminal tail is neither involved in the recruitment of 
Rrm3 to active replication forks nor in facilitating fork progression through protein-bound 
sites, and that a separate replisome binding site is likely to be located in the 
ATPase/helicase domain. The accumulation of GCRs and point mutations in the 
ATPase/helicase mutant, spontaneously or induced by HU or MMS, could be indicative 
of DNA break formation as a result of replication fork stalling. In contract, the Orc5-
binding domain mutant did no accumulate GCRs under any conditions, suggesting 
wildtype levels of DNA breaks, including in HU and MMS, but increasingly formed point 
mutations. That these point mutations formed specifically in response to HU, but not 
MMS, suggests that they arise during the unscheduled DNA synthesis that occurs in 
this mutant in HU. 
In summary, this study has revealed a 26-resiude region in Rrm3 that is critical 
for a novel, ATPase-independent function of Rrm3 in preventing untimely DNA 
replication and for binding Orc5, which might be mechanistically linked. Genome-wide 
quantification of DNA synthesis in cells expressing the new rrm3 alleles will help to 
reveal any regions with increased origin activity and undergoing untimely DNA 
replication, and provide insight into the mechanism underlying continued DNA synthesis 
under replication stress and lethality with mrc1∆. That Rrm3 does not appear to have a 
homolog in multicellular eukaryotes, although the Pif1 family to which is belongs is 
conserved, might be an indication that Rrm3’s role in DNA replication is highly 
specialized to control replication and facilitate fork progression in genomic regions that 
are distinctively organized in yeast, such as its rDNA array, and to deal with the high 
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gene density imposed on its small genome that requires tight coordination between 
replication initiation and ongoing transcription. 
 
MATERIALS AND METHODS 
 Stable isotope labeling by amino acids in cell culture (SILAC) and isolation 
 of chromatin fraction 
For double isotope labeling of lysine and arginine, yeast strain KHSY5144 (lys2∆ 
arg4∆), was grown at 30ºC with vigorous shaking for at least ten generations in “heavy” 
medium (6.9 g/l yeast nitrogen base without amino acids (Formedium), 1.85 g/l amino 
acid dropout mixture without arginine and lysine (Kaiser formulation, Formedium), 2% 
glucose, 15 mg/l [13C6] L-arginine and 30 mg/l [13C6] or [13C6, 15N2] L-lysine). KHSY5143 
(lys2∆ arg4∆ rrm3Δ) was grown in “light” medium, containing 15 mg/l L-arginine and 30 
mg/l L-lysine at 30ºC with vigorous shaking.  
Chromatin was isolated using a method adapted from (Kubota, Stead et al. 
2012). Approximately 4 x 109 cells were re-suspended in 10 ml of 100 mM PIPES/KOH, 
pH 9.4, 10 mM dithio-treitol (DTT), 0.1% sodium azide, then incubated for 10 min at 
room temperature, followed by incubation in 10 ml of 50 mM KH2PO4/K2HPO4, pH 7.4, 
0.6 M Sorbitol, 10 mM DTT, containing 200 mg/ml Zymolyase-100T at 37ºC for 30 min. 
Spheroplasts were washed with 5 ml of cold wash buffer (20 mM KH2PO4/K2HPO4, pH 
6.5, 0.6 M Sorbitol, 1 mM MgCl2, 1 mM DTT, 20 mM beta-glycerophosphate, 1 mM 
phenyl-methylsulfonyl fluoride (PMSF), protease inhibitor tablets (EDTA free, Roche) 
and re-suspended in 5 ml of cold wash buffer. The suspension was overlaid onto 5 ml of 
7.5% Ficoll-Sorbitol cushion buffer (7.5% Ficoll, 20 mM KH2PO4/K2HPO4, pH 6.5, 0.6 M 
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sorbitol, 1 mM MgCl2, 1 mM DTT, 20 mM beta-glycerophosphate, 1 mM PMSF, 
protease inhibitor tablets) and spheroplasts were centrifuged through the cushion buffer 
at 5000 rpm for 5 min to remove proteases derived from Zymolyase. Pelleted 
spheroplasts were re-suspended in 200 ml of cold wash buffer and dropped into 18% 
Ficoll, 20 mM KH2PO4/K2HPO4, pH 6.5, 1 mM MgCl2, 1 mM DTT, 20 mM beta-
glycerophosphate, 1 mM PMSF, protease inhibitor tablets, 0.01% Nonidet P-40, with 
stirring. Unbroken cells were removed by two spins (5000 x g for 5 min at 4ºC). Nuclei 
were pelleted by centrifugation at 16,100 x g for 20 min and the cytoplasmic fraction 
removed. After washing in cold wash buffer, nuclei were re-suspended in 200 ml of EB 
buffer (50 mM HEPES/KOH, pH 7.5, 100 mM KCl, 2.5 mM MgCl2, 0.1 mM ZnSO4, 2 mM 
NaF, 0.5 mM spermidine, 1 mM DTT, 20 mM beta-glycerophosphate, 1 mM PMSF, 
protease inhibitor tablets) and lysed by addition of Triton X-100 to 0.25%, followed by 
incubation on ice for 10 min. Lysate was overlaid on 500 ml of EB buffer, 30% sucrose, 
0.25% Triton X-100, and centrifuged at 12,000 rpm for 10 min at 4ºC. The top layer was 
removed and the chromatin pellet was washed in 1 ml of EB buffer, 0.25% Triton X-100 
and centrifuged at 10,000 rpm for 2 min at 4ºC.  
 
 Sample preparation and LC-MS/MS 
The chromatin pellet was re-suspended in 40 µl of 1.5x Tris-Glycine SDS Sample 
Buffer and incubated for 2 min at 85ºC. DTT was added to a final concentration of 5 mM 
and incubated for 25 min at 56ºC. Iodoacetamide was added to 14 mM final 
concentration and incubated for 30 min at room temperature in the dark. DTT was 
added to a final concentration of 5 mM and incubated for 15 minutes at room 
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temperature in the dark. The protein mixture was diluted 1:5 in 25 mM Tris-HCl, pH 8.2, 
CaCl2 was added to a 1mM final concentration and trypsin was added to a 
concentration of 4-5 ng/µl, followed by incubation at 37ºC overnight. Trifluoroacetic acid 
was added to 0.4% final concentration and centrifuged at 2,500 x g for 10 min at room 
temperature. Peptides in the supernatant were desalted using reverse-phase tC18 
SepPak solid-phase extraction cartridges (Waters). The sample was eluted with 5 ml of 
50% acetonitrile (ACN) and lyophilized. The lyophilized product was re-suspended in 
0.1% formic acid prior to tandem mass spectrometric analysis on an LTQ Orbitrap XL 
(Thermo). Scans on the Orbitrap were obtained at a mass resolving power of 60000 at 
m/z 400 and top 10 abundant ions were selected for fragmentation in the LTQ ion trap. 
Further processing of the RAW files was done in MaxQuant version 1.5.3.30 (Cox and 
Mann 2008) against the Saccharomyces genome database (SGD). A database of 
known contaminants in MaxQuant was used as well as constant modification of cysteine 
by carbamidomethylation and variable modification of methionine oxidation. The first 
search tolerance was set at 20 ppm, then 8 ppm tolerance for the main search. 
Fragment ion mass tolerance was set to 0.5 Da and the minimum peptide length was 6 
amino acids. Unique and razor peptides were used for identification and the false 
discovery rate was set to 1% for peptides and proteins (Hochberg and Benjamini 1990, 
Cox and Mann 2008). Statistical analysis of the data was carried out using Perseus 
software using an approach by Benjamini and Hochberg (Benjamini, Drai et al. 2001).  
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 Yeast strains and plasmids 
 SILAC labeling and chromatin fractionation was performed using yeast strains 
from the same genetic background as KHSY5036 (MAT ɑ, ura3-52, trp1∆63, his3∆200).  
To determine resistance to DNA damaging agents and mutation assays, yeast strains 
from the same genetic background as KHSY802 were used (MAT ɑ, ura3-52, trp1∆63, 
his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3). Genes were deleted 
through homologous recombination and integration of a selectable marker (Gietz and 
Woods 2006). To generate more than one gene deletion or point mutation, random 
spore isolation was performed using diploid yeast strains heterozygous for the 
mutations. Point mutations were introduced into plasmids by site-directed mutagenesis 
and confirmed by sequencing. RRM3 N-terminal truncations were created in plasmid 
pKHS137 and plasmid pJG4-5* using HR-mediated integration in KHSY2331 (lig4Δ) 
and verified by sequencing. Yeast strains and plasmids from this study are listed in 
Tables S2 and S3, respectively. 
 
 Fluctuation assays 
GCR rates were determined as previously described (Schmidt, Pennaneach et 
al. 2006). To observe the effect of exposure of DNA damaging agents on GCR rates, 
cells were grown to OD600 = 0.5, placed into media containing the drug and cultured for 
2 hours at 30ºC. Cells were then inoculated in YPD and grown for 24 hours before being 
plated. Forward mutation rates were determined as described previously (Nair 1940, 
Lea and Coulson 1949, Reenan and Kolodner 1992). To obtain forward mutation rates 
and GCR rates after exposure to MMS and HU, cells were grown to OD600 = 0.5, 
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released into medium containing the drug and incubated for 2 hours at 30ºC. Cells were 
then placed into YPD and grown for 24 hours before being subjected to fluctuation 
analysis.  
 
 DNA damage sensitivity assay 
Cells were grown on either YPD or selective media to maintain plasmids (SC-Leu) 
to an OD600 = 0.5, serially diluted, and spotted on YPD or SC-Leu containing methyl 
methanesulfonate (Sigma Aldrich) or hydroxyurea (US Biological) at the indicated 
concentrations. Cell growth was recorded after 2 to 3 days of incubation at 30ºC. 
 
 DNA content analysis 
Cells were prepared for DNA content analysis as previously described (Nash, 
Tokiwa et al. 1988). Cells were washed and re-suspended in 70% ethanol for an hour at 
room temperature. The ethanol was removed and cells were re-suspended in 50 mM 
sodium citrate (pH 7), sonicated, washed in 50 mM sodium citrate (pH 7), and RNAse A 
was added to a final concentration of 250µg/ml. The cells were incubated overnight at 
37ºC, washed in 50 mM sodium citrate and Sytox green (Molecular Probes) was added 
to reach a 1µM final concentration. These cells were incubated in the dark for an hour 
and then subjected to FACS analysis using a BLD LSR II analyzer. Cell distribution was 
analyzed using FlowJo v8.3.3. 
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 Protein expression by western blot 
Cells were cultured in YPD to a final OD600 = 0.5 in YPD at 30ºC, arrested in G1 
with α-factor (15 µg/ml), and then released into pre-warmed YPD. Cells were harvested 
after 30 min, immediately put on ice and diluted to obtain equal cell number. Whole cell 
extracts were generated with 20% TCA as previously described (Kennedy, Daughdrill et 
al. 2013) and run on 10% SDS-PAGE for Western blot analysis. Phosphospecific Rad53 
antibody, EL7, was a gift from A. Pellicioli (FIRC Institute of Molecular Oncology 
Foundation, Milan, Italy). Antibody sc-6680 (SCBT) was used for Mcm2, ab34680 
(Abcam) for Adh1, ab46765 (Abcam) for histone H3, and RFA antibody AS07214 
(Agrisera) for Rfa1.  
 
 Determination of dNTP levels 
Cells grown to stationary phase were transferred to acidic media (pH 3.5) and 
grown to logarithmic phase. Cells were synchronized in G1 phase over two hours with 
the addition of 2 µg/ml alpha-factor (Genscript) every hour. Cells were washed twice 
with sterile water. 2.5×108 yeast cells were pelleted,  resuspended in 1 ml 60% 
methanol, and disrupted by 5 consecutive freeze and thaw cycles using liquid nitrogen 
and warm water, followed by incubation at -20ºC for 90 minutes, and boiling at 100ºC 
for 3 minutes. The lysate was centrifuged at 19000×g for 15 minutes and the 
supernatant frozen in liquid nitrogen. Methanol was evaporated in a SpeedVac (Thermo 
Scientific) and the residue was rehydrated in 100 µl Ultra-pure H2O (Invitrogen, GIBCO). 
Determination of cellular dNTP concentration was performed as earlier described 
174
(Desler, Munch-Petersen et al. 2007). Each extraction was performed at least in 
triplicate. 
 
 Yeast two-hybrid assay 
For yeast-two hybrid yeast strain EGY48 with a reporter plasmid was transformed with 
the bait vector (pEG202) and a prey vector (pJG4-5*). Cells were plated on synthetic 
complete media lacking histidine and tryptophan (SC-Trp-His). Positive transformants 
were selected and re-suspended in liquid SC-Trp-His media supplemented with 2% 
galactose and 1% raffinose, and cultured overnight at 30ºC. Cells were diluted to an 
OD600 =0.2, cultured to a final OD600 =0.8, and serially dilutions were spotted on SC-Trp-
His-Leu supplemented with either 2% glucose or 2% galactose in the presence or 
absence of hydroxyurea (HU) or methyl methanesulfonate (MMS). Pictures of cell 
growth were taken after 72 hours. 
 
 Analysis of meiotic products 
Diploids heterozygous for the desired mutant alleles (rrm3::TRP1, mrc1::HIS3) 
transformed with plasmid-borne alleles of RRM3 (linked to LEU2) were sporulated by 
nitrogen starvation in 0.1% potassium acetate for 5 days at 30ºC with vigorous shaking. 
Asci were incubated in the presence of 500 µg/ml of zymolase in 1M sorbitol for 20 min 
at 30ºC, enriched for meiotic products as previously described (Rockmill, Lambie et al. 
1991) and plated on nonselective media (YPD). After incubation for 2 days at 30ºC, 
colonies were spotted on SC-Leu media and 100 leu+ colonies genotyped further by 
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spotting on SC-Leu-Trp, SC-Leu-His, and SC-Leu-Trp-His to identify rrm3Δ, mrc1Δ and 
rrm3Δ mrc1Δ mutants, respectively, all harboring various plasmid borne RRM3 alleles. 
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FIGURES AND TABLES 
 
Figure 4.1. SILAC-based quantification of changes in chromatin association in 
cells lacking Rrm3. (A) Equal numbers of light-labeled (wildtype) and heavy-labeled 
(rrm3Δ) cells were mixed, nuclei isolated, and the chromatin fraction extracted and 
analyzed by tandem mass spectrometry using a hybrid linear ion trap-Orbitrap 
instrument. (B) Subcellular fractionation was verified by following the distribution of 
proteins in cytoplasmic (Cyto), nucleoplasm (NP), and chromatin (Ch) fractions during 
the enrichment procedure by Western blotting. Chromatin fractions were analyzed from 
three biological replicates in (C) the absence of hydroxyurea and (D) in the presence of 
hydroxyurea. (E) Merger of peptide quantification in the absence and presence of 
hydroxyurea. 
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 Figure 4.2. Rad5 and Rdh54 contribute independently to DNA lesion bypass/repair 
in cells lacking Rrm3. (A) Synergistic increases in DNA-damage sensitivity of rrm3Δ 
mutant lacking RAD5 and/or RDH54 were identified by spotting serial dilutions of 
exponentially growing cultures of the indicated mutants on MMS and HU. (B) Ubiquitin 
ligase and ATPase activities of Rad5 contribute independently to DNA damage 
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tolerance in the absence of Rrm3. The ATPase/helicase activity of Rrm3 is required for 
growth of the rad5Δ mutant under chronic exposure to HU or MMS. (C) Accumulation of 
rrm3Δ cells in S phase increases upon deletion of RAD5 or RDH54. Cells were 
synchronized in G1 phase with α-factor, released in YPD to resume the cell cycle, and 
DNA content analyzed by fluorescence-activated cell sorting every 20 minutes for 3 
hours.  (D-E) Deletion of RAD5 or RDH54 slows progression of rrm3Δ cells through S 
phase in the presence of HU. Cells were synchronized in G1 with α-factor, released into 
media containing 100 mM HU (rdh54Δ) or 40 mM HU (rad5Δ) and nocodazole (to trap 
cells in G2/M). DNA content was analyzed by fluorescence activated cell sorting every 
20 minutes for 3 hours. (F) rrm3Δ and rad5Δ mutations slow progression through 
mitosis to G1 phase. Cells were trapped in mitosis with nocodazole and released into 
media with α-factor. (G) Deletion of RRM3 increases DNA damage sensitivity of the 
diploid rdh54Δ mutant. Serial dilutions of exponentially growing cultures of diploids 
heterozygous or homozygous for rrm3Δ or rdh54Δ mutations were spotted on HU and 
MMS.  
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 Figure 4.3. A 26-residue region in the N-terminal tail of Rrm3 is required for the 
control of DNA replication under replication stress independently of 
ATPase/helicase activity. (A) Rrm3 consist of a ~230-residue disordered N-terminal 
tail and a ~400 residue ordered C-terminal ATPase/helicase domain.  A putative PCNA-
interaction motif (PIP) between residues 35-42 (Schmidt, Derry et al. 2002) and a 
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cluster of phosphorylated residues (P) between residues 85-95 (Rossi, Ajazi et al. 2015) 
are indicated by gray boxes in the disordered tail. N-terminal tail truncations (rrm3∆N54, 
rrm3∆N142, rrm3∆N186, rrm3∆N212, rrm3∆N230) and point mutations designed to 
inactivate the PIP box (rrm3-FFAA) and the Walker A motif of the helicase domain 
(rrm3-K260A, rrm3-K260D) were constructed. Point mutations are indicated by a red 
box. (B) DNA content analysis by fluorescence-activated cell sorting (FACS) of rrm3 
mutants shows continued DNA replication in rrm3Δ, rrm3-ΔN212 and rrm3-ΔN230 
mutants during a 2-hour incubation in 200 mM hydroxyurea, but maintenance of a peak 
at 1C DNA content for wildtype cells and the other rrm3 mutants. (C) Similar to 
checkpoint-deficient rad53Δ sml1Δ cells, rrm3Δ cells continue DNA replication in the 
presence of HU, but not MMS (Figure S2B). Cells were synchronized in G1 phase with 
α-factor and released into media containing 100 mM HU. DNA content was analyzed by 
FACS every 20 minutes for 2 hours after G1 release.  (D) Cells expressing an N-
terminal truncations of 212 residues continue DNA replication in the presence of 200 
mM HU whereas those expressing a 186-residue truncation or the ATPase/helicase-
dead mutant arrest with 1C DNA content like wildtype cells. Cells were synchronized in 
G1 with α-factor and released into 200 mM HU for 2 hours. Aliquots were removed prior 
to release from G1 and then every 20 minutes for 2 hours and DNA content analyzed by 
FACS. (E) Nucleotide pool, represented here by dTTP, is increased in rrm3Δ cells and 
in cells expressing the rrm3-ΔN212 truncation or the ATPase/helicase-dead rrm3-
K260A mutant, but not in cells expressing the shorter rrm3-ΔN186 truncation. (F) Rad53 
is constitutively activated in catalytically inactive rrm3Δ, rrm3-K260A and rrm3-K260D 
mutants, and in the rrm3-ΔN212 truncation mutant. Cells were arrested in G1 with α-
factor and Rad53 phosphorylation analyzed 30 min after release from arrest with a 
phospho-specific Rad53 antibody. Rad53 activation in rrm3 mutants correlates with an 
increased dNTP pool, but not with continued DNA synthesis in the presence of 
hydroxyurea. (G) DNA content in wildtype cells and rrm3 mutants in the presence of 
hydroxyurea was analyzed by FACS analysis and progression toward genome 
duplication (2n) estimated by setting the 1C peak of untreated wildtype cells to 0% and 
the 2C peak to 100%. (H) Rad53 phosphorylation in rrm3 mutants, irrespective of 
continued DNA replication in HU or catalytic activity, is Rad9-dependent. (I) Rrm3 
truncated by 212 N-terminal residues is an active ATPase/helicase. Deletion of RRM3 
or inactivation of its ATPase/helicase activity suppresses HU hypersensitivity of the 
rad53Δ sml1Δ mutant whereas the rrm3-ΔN212 allele does not, exhibiting wildtype 
ATPase/helicase activity.  
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 Figure 4.4. The N-terminal Rrm3 region that controls DNA replication is an Orc5-
binding site that is required for cell viability and DNA lesion avoidance in the 
absence of Mrc1/Tof1 but not in the absence of Rad5, Rdh54 or Mph1. (A) 
Residues 186-212 of Rrm3 are critical for physical interaction with origin recognition 
complex (ORC) subunit Orc5. Orc5 binding to wildtype Rrm3 and rrm3 mutants was 
assessed by yeast-two-hybrid analysis on media lacking leucine to identify cells 
expressing the LEU2 reporter gene upon bait-prey binding. Rrm3 truncated by 186 
residues binds Orc5, in the presence or absence of HU or MMS, whereas deletion of an 
additional 26 residues (rrm3-ΔN212) eliminates binding of Orc5. (B) Orc5-Rrm3 binding 
site is required for mrc1∆ viability. Diploids heterozygous for mrc1∆ and rrm3∆ 
mutations were transformed with plasmids expressing N-terminal truncations of Rrm3 
and 100 meiotic products that grew on SC-Leu media, indicating the presence of the 
plasmid-borne RRM3 alleles, were genotyped. Absence of meiotic products that grew 
on SC-Leu-Trp-His indicates synthetic lethality between the rrm3 allele and mrc1Δ. (C) 
Deletion of the Orc5-Rrm3 binding site increases DNA-damage senstivity of the tof1∆ 
mutant. (D-F) Requirement of the ATPase/helicase activity of Rrm3, but not the Orc5-
binding site, for suppression of HU and MMS hypersensitivity of rad5∆, rdh54Δ, and 
mph1∆ mutants.  
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 Figure 4.5. Rrm3 performs two genetically and physically separable functions 
during DNA replication. (A) Rrm3 controls DNA synthesis via residues 186-212 (green 
rectangle) in its disordered N-terminal tail (blue double line). The involvement of this 
region in Orc5 binding suggests that Rrm3 may control DNA synthesis by controlling 
origin activity to prevent untimely replication events during replication stress and during 
normal S phase, as indicated by constitutive checkpoint activation. Rrm3 assists in 
replication through nonhistone-protein-bound sites throughout the genome, including 
the rRNA coding region, and may also be needed in other highly transcribed regions 
and those with convergent transcription. Such regions often contain late-firing origins. 
Independently of its N-terminal tail, Rrm3 associates with the replisome and utilizes its 
ATPase/helicase activity (blue oval labeled H) to facilitate fork progression through 
replication blocks. (B) Deleting the Orc5-binding domain disrupts Rrm3’s function in 
controlling DNA synthesis, leading to untimely DNA synthesis and accumulation of point 
mutations in normal S-phase and in HU. Excessive accumulation of replication 
intermediates and ensuing DNA lesions are the most probable cause of intra-S 
checkpoint activation in these cells. Despite loss of the N-terminal function, the 
ATPase/helicase-dependent function of Rrm3 in fork progression through blockages is 
intact, suggesting that Rrm3 can be recruited to replisomes independently of the N-
terminal tail. (C) Disrupting the ATPase/helicase activity of Rrm3 maintains control over 
DNA synthesis timing, but forks are unable to progress through replication blocks, 
leading to DNA lesions that require Rad5, Rdh54, and Mph1 for bypass or repair and 
activate the intra-S checkpoint. In contrast to loss of the Orc5-binding site, GCRs form 
in addition to point mutations, indicating the formation of different types of DNA lesions 
in the ATPase/helicase mutant, most likely DNA breaks. 
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replication 
fork pausing fork  
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replisome  
stabilization  
Rdh54 fork pausing untimely 
replication 
untimely 
replication 
 
Error-free DNA lesion bypass 
(fork reversal, 
template switch HR) 
Rad5 
Rdh54 
Mph1 
excessive replication 
intermediates (ssDNA) & DNA lesions  
DNA lesions 
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 Figure 4.S1. Rad5 and Rdh54 are not required for S phase progression of rrm3Δ 
cells after release from 2 hour exposure to 100 mM HU.  
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 Figure 4.S2. Deletion of the nonessential HDA1, SET3, or MGM101 genes does not 
affect the DNA damage sensitivity of the rrm3Δ mutant. Chromatin association of 
Hda1 and Set3 significantly decreased in the absence of Rrm3 whereas Mgm101 
increased. Deletion of MGM101 resulted in the ‘petite’ phenotype. Serial dilutions of 
exponentially growing cultures of the indicated mutants were spotted on rich media 
containing 0.01% MMS or 100 mM HU, or no drug (YPD), followed by incubation for 2-3 
days at 30ºC. 
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 Figure 4.S3. Requirement of Mph1 for DNA repair and DNA replication in the 
absence of Rrm3. (A) Deletion of RRM3 causes a synergistic increase in DNA damage 
sensitivity of cells lacking the DNA helicase Mph1. Absence of Mph1 causes delayed S 
phase progression of rrm3Δ cells in the absence of DNA damaging agents (B), after 
release from HU into an undisturbed S phase (C), and, most severely, during chronic 
exposure to HU (D). 
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Figure 4.S4. The Rrm3 N-terminal tail controls DNA replication. (A) The N-terminal 
tail of Rrm3 is predicted to be unstructured. A disorder score of >0.5 indicates a 
disordered residue whereas a score <0.5 indicates a residue in a ordered region 
(Dosztanyi et al., 2005). (B) In contrast to HU, rrm3-ΔN212 and rrm3Δ mutants arrest 
with 1C DNA content when exposed to MMS. (C) 4 hour time course of rrm3Δ mutant 
released from G1 arrest into 100 mM HU.   
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Table 4.1. Effect of Deletions of RRM3, RAD5, RDH54  on Accumulation of Gross-
Chromosomal Rearrangements in the Presence or Absence of Genotoxic Agents 	
Genotype GCR rate 
(Canr 5-FOAr) 
(x 10-10) 
GCR rate 
(Canr 5-FOAr) 
(x 10-10) 
+HU 
GCR rate 
(Canr 5-FOAr) 
(x 10-10) 
+MMS 
 GCR Rate 
wildtype 1.1 (<1-6.1)  20 (9.6-35) 65 (55-75) 
rrm3∆ 14 (11-27) 139 (106-171) 97 (90-114) 
∆rad5 237 (220-271) 1477 (1300-1590) 928 (837-1020) 
∆rrm3 ∆rad5 260 (224-263) 1600 (1390-1680) 1040 (834-1220) 
∆rdh54 17 (11-27) 191 (144-212) 108 (87-135) 
∆rrm3 ∆rdh54 25 (14-54) 202 (194-224) 120 (99-266) 
∆rad5 ∆rdh54 263 (244-272) 1578 (1320-1710) 991 (907-1160) 
∆rrm3 ∆rad5 ∆rdh54 322 (278-419) 2446 (2140-2670) 1664 (1350-1810) 
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Table 4.2. Accumulation of Forward Mutations at CAN1 and Gross-chromosomal 
Rearrangements in Untreated rrm3 Mutants and after Treatment with Genotoxic 
Agents 
 
Genotype Can 
(x10-7) 
Can 
(x10-7) 
+HU 
Can 
(x10-6) 
+MMS 
 GCR rate 
(Canr 5-FOAr) 
(x 10-10) 
GCR rate 
(Canr 5-
FOAr) 
(x 10-10) 
+HU 
GCR rate 
(Canr 5-
FOAr) 
(x 10-10) 
+MMS 
 Mutation rate  GCR Rate 
Wildtype 1.6 (1.4-
1.9) 
2.3 (2.0-
2.8) 
1.9 (1.7-
2.3) 
 1.1 (<1-6.1)  20 (9.6-
35) 
65 (55-75) 
rrm3∆ 5.1 (4.3-
5.8) 
8.1 (7.4-
8.8) 
3.2 (2.8-
3.4) 
 14 (11-27) 139 (106-
171) 
97 (90-
114) 
rrm3-∆N186 1.9 (1.7-
2.3) 
2.5 (2.2-
2.9) 
2.3 (1.9-
2.4) 
 4.4 (<1-8.8) 43 (18-
47) 
56 (39-71) 
rrm3-∆N212 2.8 (2.6-
3.0) 
4.1 (4.0-
4.5) 
2.1 (2.0-
2.4) 
 4.5 (<1-13) 33 (17-
39) 
78 (63-92) 
rrm3-K260A 4.3 (4.0-
5.0) 
8.0 (7.9-
8.4) 
3.0 (2.7-
3.1) 
 14 (10-23) 158 (105-
201) 
93 (81-
117) 
rrm3-K260D 4.4 (4.3-
4.8) 
8.2 (7.6-
9.2) 
2.9 (2.7-
3.3) 
 18 (10-25) 132 (110-
170) 
97 (88-
113) 
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TABLE 4.S1. Proteins that undergo significant changes in cells lacking Rrm3 in 
the presence and absence of HU 	
Protein 
ID 
Fold 
Change 
-HU 
Description 
Rad5 5.1 RING domain-containing ubiquitin ligase involved in error 
free DDT 
Top2 1.9 Type II topoisomerase that catalyzes decatenation of DNA  
Rdh54 1.8 DNA-dependent ATPase activity, can supercoil and unwind 
DNA and promote D-loop formation and branch migration to 
promote HR 
Smc1 1.5 Subunit of the cohesin complex that associates with SMC3 
and is required for sister chromatid cohesion 
Sif2 1.5 Subunit of Set3C histone deacetylase complex 
Mgm101 1.4 Role in mitochondrial DNA recombinational repair and 
interstrand cross-link repair 
Smc3 1.3 Subunit of the cohesin complex that assicates with SMC1 
and is required for sister chromatid cohesion 
Irr1 1.3 Subunit of the cohesin complex, thought to close the 
cohesion ring 
Hda1 -1.7 Putative catalytic subunit of a class II histone deacetylase 
complex 
Mcm4 -1.9 Essential helicase component of heterohexameric MCM2-7 
complexes 
Rsc1 -2.0 Component of the RSC chromatin remodeling complex  		
Protein 
ID 
Fold 
Change 
+HU 
Description 
Rdh54 2.6 DNA-dependent ATPase activity, can supercoil and unwind 
DNA and promote D-loop formation and branch migration to 
promote HR 
Spt7 1.7 SAGA core component which may regulate Spt20 and Ada1, 
components of the SAGA complex. 
Ybp2 1.6 Central kinetochore associated protein 
Cdc28 1.6 Associates with six B-type cyclins to direct mitotic spindle 
assembly in S-phase and spindle function during mitosis 
Rpt4 1.6 ATPase of the 19S regulatory particle of the 26S 
proteasome. One of six ATPases of the regulatory particle, 
involved in degradation of ubiquitinated substrates 
Mgm101 1.5 Role in mitochondrial DNA recombinational repair and 
interstrand cross-link repair 
Mph1 1.4 3'-5' DNA helicase involved in error-free bypass of DNA 
lesions 
190
Table 4.S1 (continued) 	
Top2 1.4 Type II topoisomerase that catalyzes decatenation of DNA 
Rsc9 -1.9 Component of the RSC chromatin remodeling complex 
which targets genes regulated by stress 
Set3 -2.7 Component of the 7-subunit HDAC complex with a role in 
transcription 
Vps72 -2.7 Part of the SWR1 complex, exchanges histone variant H2AZ 
(Htz1p) for chromatin-bound histone H2A 
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Table 4.S2. Yeast Strains used in this study 
 
Strain Genotype 
EGY48[1] MATα ura3-52, trp1Δ63, his3Δ200, LexAop (x6)-LEU2 
KHSY304 MATα ura3-52, trp1Δ63, his3Δ200, rrm3::TRP1 
KHSY745 ura3-52/ura3-52, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
RRM3/rrm3::TRP1, MRC1/mrc1::HIS3 
KHSY802 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3 
KHSY1063 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1 
KHSY1065 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,  
RAD53/rad53::his3, SML1/sml1::G418, RRM3/rrm3::TRP1 
KHSY1133 ura3-52, lys2-801 amber, ade2-101 ochre, trp1-∆63, his3-∆200, leu2-∆1, rad9::G418, rrm3::URA3 
KHSY1157 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3 
KHSY1557 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, mph1::HIS3 
KHSY1713 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, mph1::HIS3 
KHSY2331 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, lig4::loxP-G418-loxP 
KHSY4570 MATa ura3-52, trp1Δ63, his3Δ200 
KHSY4743 ura3-52/ura3-52, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, 
RRM3/rrm3::TRP1 
KHSY5143 MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3 
KHSY5144 MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3, 
rrm3::TRP1 
KHSY5145 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rad5::HIS3 
KHSY5146 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, rad5::HIS3 
KHSY5147 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rdh54::HIS3 	
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Table 4.S2 (continued) 	
KHSY5148 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3 
KHSY5149 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rad5::HIS3 rdh54::G418 
KHSY5150 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3, 
rad5::TRP1 
  
KHSY5151 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, set3::HIS3 
KHSY5152 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, set3::HIS3 
KHSY5153 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, tof1::HIS3 
KHSY5154 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, tof1::HIS3 
KHSY5155 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, ies4::HIS3 
KHSY5156 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, ies4::HIS3 
KHSY5157 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, had1::HIS3 
KHSY5158 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, had1::HIS3 
KHSY5159 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, mgm101::HIS3 
KHSY5160 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, rrm3::TRP1, mgm101::HIS3 
KHSY5161 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, sml1::G418 
KHSY5162 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1 
KHSY5163 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, 
ade2Δ1, ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1, 
rad53::HIS3 	
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Table 4.S2 (continued) 	
KHSY5164 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3,  
rdh54::HIS3/rdh54::HIS3 
KHSY5165 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
rrm3::TRP1/rrm3::TRP1,  rdh54::HIS3/rdh54::HIS3 
KHSY5166 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
rrm3::TRP1/rrm3::TRP1 
KHSY5167 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
RRM3/rrm3::TRP1,  RDH54/rdh54::HIS3 
KHSY5168 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
RRM3/rrm3::TRP1 
KHSY5169 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
RDH54/rdh54::HIS3 
KHSY5170 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
RRM3/rrm3::TRP1,  rdh54::HIS3/rdh54::HIS3 
KHSY5171 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, 
his3∆200/his3∆200, lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, 
ade2∆1/ade2∆1, ade8/ade8. YEL069C::URA3/YEL069C::URA3, 
rrm3::TRP1/rrm3::TRP1,  RDH54/rdh54::HIS3 
 
1. Gyuris, J., et al., Cdi1, a human G1 and S phase protein phosphatase that 
associates with Cdk2. Cell, 1993. 75(4): p. 791-803. 
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TABLE 4.S3. Plasmids used in this study 
 
Plasmid Description Reference 
pRS315 CEN/ARS, LEU2 (Sikorski and Hieter 1989) 
pEG202 LexA bait plasmid, HIS3, 2µm (Estojak, Brent et al. 1995) 
pR5-19 CEN/ARS, LEU2, rad5-C914A/C917A (Pages, Bresson et al. 
2008) 
pR5-28 CEN/ARS,LEU2, RAD5 (Pages, Bresson et al. 
2008) 
pR5-30 CEN/ARS,LEU2, rad5-D681A/E682A (Pages, Bresson et al. 
2008) 
pJG4-5* GALI promoter-GAL4AD, TRP1, 2µm (Schmidt, Derry et al. 2002) 
pKHS124 pJG-4-5*-RRM3 (Schmidt, Derry et al. 2002) 
pKHS126 pEG202-RRM3 (Schmidt, Derry et al. 2002) 
pKHS133 pEG202-rrm3-∆N54 (Schmidt, Derry et al. 2002) 
pKHS135 pEG202-rrm3∆N230 (Schmidt, Derry et al. 2002) 
pKHS136 pRS315-rrm3-∆N54 this study 
pKHS137 pRS315-rrm3-∆N230 this study 
pKHS170 pRS315-RRM3 this study 
pKHS174 pRS315-rrm3-F41A/F42A this study 
pKHS183 pEG202-rrm3-F41A/F42A (Schmidt, Derry et al. 2002) 
pKHS644 pR5-30-rad5-
D681A/E682A/C914A/C917A 
this study 
pKHS645 pRS315-rrm3-N∆142 this study 
pKHS646 pRS315-rrm3-∆N186 this study 
pKHS647 pRS315-rrm3-∆212 this study 
pKHS648 pRS315-rrm3-K260A this study 
pKHS649 pRS315-rrm3-K260D this study 
pKHS650 pRS315-rrm3-D102P this study 
pKHS651 pRS315-rrm3-S605A this study 
pKHS652 pRS315-rrm3-S605D this study 
pKHS653 peg202-rrm3-∆N186 this study 
pKHS654 peg202-rrm3-∆N212 this study 
pKHS655 peg202-rrm3-∆N230 (Schmidt, Derry et al. 2002) 	
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Table 4.S3 (continued) 	
pKHS656 pJG4-5*-ORC5 this study 
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CHAPTER FIVE: 
IMPLICATIONS AND FUTURE DIRECTIONS 
 
IMPLICATIONS 
 DNA helicases are conserved amongst species and are enzymes that function to 
unwind DNA in several processes, including replication, DNA repair, and transcription. 
Defective helicases can lead to human genetic disorders with high incidence of genomic 
instability and predisposition to cancer. For example, mutations to XPB and XPD, can 
result in xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy [1-3]. 
Mutations to these genes result in defects during nucleotide excision repair and 
transcription [3]. Mutations to the RecQ family members in humans, BLM, WRN, and 
RECQL4 can result in Bloom syndrome, Werner syndrome, and Rothmund-Thomson 
syndrome [4-9] and these patients are characterized by having increased genomic 
instability and mutation rates [10-12]. If the integrity of the genome is not maintained 
from one generation to another, chromosomal defects may arise, which can result in 
cancer predisposition, developmental defects, and premature aging. Better 
understanding the role of these helicases in DNA repair may allow us to better develop 
therapeutic approaches to help individuals affected by these syndromes and allow for a 
better quality of life. 
 Here we investigated the role of RecQ-like helicases Sgs1, BLM and RecQL5 
using yeast as a model system. We also looked at a non-RecQ-like helicase, Rrm3, 
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which is involved in maintaining genome stability by promoting fork progression. 
 
FUTURE DIRECTIONS 
 Humanized yeast model for BLM characterization 
 In chapter two of this dissertation we were able to create a yeast model to study 
BLM function [13]. This humanized yeast model was used to study the functional impact 
of 27 variants in the C terminal region of BLM and with this approach we found nine new 
functionally defective BLM variants [13, 14]. Unlike the known Bloom syndrome, causing 
mutations that have been characterized biochemically, these new variants are 
uncharacterized and may be informative in better understanding BLM function [8]. Of 
the newly identified variants, three only partially impair BLM function, leading to a new 
class of BLM alleles that may have an impact on the risk for disease [14]. These new 
variants in BLM (R791C, P868L, G1120R) were evaluated in patient derived BLM 
deficient cells (GMO8505) to determine if they complement cellular defects [15]. These 
variants were tested for their ability to suppress sister chromatid exchanges, resistance 
to DNA damage, and ability to induce the DNA damage response [15]. Through these 
assays it was found that these variants produced defects similar to a Bloom syndrome 
cell, but these defects were less pronounced [15]. The implication for this study and 
discovery of these new variants is that individuals who possess these variants may 
have an increased risk for cancer or Bloom syndrome associated disorders. The next 
step is to biochemically characterize these variants and determine if they have defects 
in catalytic activity. For this, we will look at DNA binding, unwinding, and annealing 
activities of these variants. 
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 RQC domain of Sgs1 is critical in maintaining genome stability, whereas 
 the HRDC domain is dispensable 
 In chapter two of this dissertation we created systematic truncations to the C 
terminus of Sgs1 and found that impinging on the RQC domain was deleterious to the 
cell whereas removing the HRDC domain had no effect [13]. To further narrow down the 
requirement of the C terminus of Sgs1 we further truncated the region between Sgs1 
1147-1247 and found that deleting C terminal 260 amino acids resulted in sensitivity to 
DNA damaging agents HU and MMS and there was an accumulation of gross 
chromosomal rearrangements [13]. We looked at the possibility that the inability of the 
sgs1∆C260 mutant to resist DNA damaging agents was due to loss of protein-protein 
interaction. It has been shown previously that Rad51 interacts with the C terminus of 
Sgs1 but the precise location of this interaction has not been determined [16]. Using pull 
down experiments we have validated Sgs1-Rad51 interaction and isolated the 
interaction to regions 1187-1207 of Sgs1. We narrowed down the binding site to the 
flexible linker region between the winged helix and HRDC domains and have found 
important residues for binding. Generating a Sgs1F1197D mutant located within this 
region resulted in loss of interaction with Rad51. In contrast to the sgs1∆C260 
truncation, Sgs1F1197D was resistant to DNA damaging agents suggesting that loss of 
interaction with Rad51 is not important for conferring resistance but may be important 
for other functions of Sgs1, and that impinging on the RQC domain is deleterious to the 
cell. This interaction is being genetically characterized to see if this loss of interaction is 
important in combination with other DNA metabolic factors.  
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 Novel RecQL5 interaction with Ube2I and Hlp2  
 In this dissertation we looked at the human RecQ like helicase, RecQL5β, which 
has not been associated with a syndrome but defects in this helicase lead to increased 
levels of sister chromatid exchanges, broken chromosomes, and quadriradials [17, 18]. 
To better understand the molecular mechanism of this helicase we used yeast as a 
model system to investigate its ability to complement Sgs1 functions. We found that it is 
unable to perform functions of Sgs1 suggesting its role in the cell is different than its 
Sgs1 counterpart, BLM. We performed a yeast two-hybrid assay using the human testis 
cDNA library to gain better insight into functions of RecQL5 by determining proteins it 
interacts with. From this screen we found that Hlp2 and Ube2I showed strong 
interaction with RecQL5. Human Hlp2 is an ATP-dependent RNA helicase that belongs 
to the DEAD box family of helicases [19, 20]. Ube2I is a SUMO-conjugating enzyme 
that has several roles in regulating DNA repair [21]. To further investigate these 
interactions we will use two approaches.  
 Interaction will be tested first by performing co-immunoprecipitation of 
endogenous proteins or tagged protein. If interaction is verified then we will map the 
interaction domain of each protein by placing a stop codon using site-directed 
mutagenesis and evaluate this loss of interaction in cells. If the co-immunoprecipitation 
approach fails to work we will determine protein-protein interactions by mass 
spectrometry. For mass spectrometry, we will create a stable cell line expressing Flag-
tagged RecQL5 and immunoprecipitate tagged RecQL5 and isolate polypeptides for 
analysis by mass spectrometry. This approach will help confirm interaction of our 
proteins and may elucidate new candidates for further study. We will then perform a 
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reciprocal IP using antibodies against Hlp2 and Ube2I to determine if we can identify 
RecQL5. We will look for interaction with Rad51, PCNA, and the MRN complex as 
positive controls.  
 In addition to the helicase domain and RQC domain, RecQL5 also possess a KIX 
domain and SRI domain [22, 23]. The KIX domain is located between amino acids 540-
620 and the SRI domain is between 909-991 amino acids [23]. The KIX domain has 
been found in many Pol II transcriptional regulators and the SRI domain is found in the 
histone methyltransferase SetD2, which also has a role in transcription [22]. It is 
possible that RecQL5 interaction with Hlp2 may help regulate transcription and prevent 
head-on collisions between the replication and transcription machinery, resulting in 
fewer stalled forks [24].  
 To test if the interaction with Hlp2 is regulating transcription we can recreate 
mammalian RNAPII transcription using purified general transcription factors (GTFs), 
RNAPII, and template DNA with a adenovirus major late promoter. To determine if 
RecQL5 is inhibitory to transcription, we can add increasing concentration of RecQL5 
and observe the production of the transcript. After determining the site of Hlp2 
interaction we can create a point mutation abolishing this interaction and perform the 
same experiment to determine if interaction with Hlp2 is regulating transcription and 
should see more run-off transcripts if this interaction is important. Additionally, we can 
determine if this regulation is helicase dependent by generating point mutations 
inactivating the helicase activity of RecQL5 (D157A) and loss of protein-protein 
interaction. It will be interesting to see if RecQL5 has dual roles, one in maintaining 
genome stability by preventing head-on collisions between the replication and 
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transcription machineries and another in preventing chromosomal instability by using its 
helicase activity to reduce unwanted homologous recombination events through its 
ability to resolve D loops [25].  
 Unlike Hlp2, Ube2I is a SUMO-conjugating enzyme that can regulate DNA repair, 
the stress response, and cell cycle progression [21]. Since Ube2I has a more diverse 
role in cell compared to Hlp2, it is possible that RecQL5 may target Ube2I to sites of 
DNA damage so that it can regulate downstream proteins for repair. Determining the 
interaction site of this protein on RecQL5 will help determine if it interacts with any 
RecQL5 conserved domains. We can then create targeted point mutations to assess if 
loss of interaction with Ube2I contributes to some of the cellular defects in cells deficient 
for RecQL5. We can perform similar assays looking at the role of RecQL5-Ube2I 
interaction during transcription by assessing formation of run-off transcripts. It is more 
reasonable to assume that interaction with Ube2I is important for maintaining genome 
stability by regulating repair during replication, possibly by preventing sister chromatid 
exchanges. It has been shown previously in DT40 cells that deleting RecQL5-/- / BLM-/- 
resulted in higher SCE level than BLM-/- cells [26]. Introducing RecQL5 into RecQL5-/- / 
BLM-/- resulted in a level similar to BLM-/- cells [26]. Considering RecQL5 can suppress 
SCEs in this double mutant, we can look at the importance of interaction with Hlp2 and 
Ube2I in preventing SCEs. In addition to increased SCEs in the absence of RecQL5-/-, 
these cells also have increased sensitivity to camptothecin, a topoisomerase I inhibitor 
that blocks replication [26]. RecQL5-/- / BLM-/- cells have a synergistic increase in 
sensitivity to CPT, so we can look at RecQL5 interactions to see if they are important in 
suppressing this sensitivity. Through these experiments it will be possible to determine 
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the importance of these protein-protein interactions and better determine the molecular 
mechanism of RecQL5 in DNA repair.  
 
 New role for Rrm3 in controlling replication 
 In addition to RecQ like helicases we also looked at a non-RecQ like helicase, 
Rrm3, which is involved in promoting fork progression through protein-DNA complexes. 
Using quantitative mass spectrometry we were able to find two significant mechanisms 
that act on DNA lesions created in the absence of Rrm3 catalytic activity. Rdh54, is a 
chromatin remodeler, and Rad5 is involved in error-free DNA damage bypass, and both 
were significantly increased in our screen [27, 28]. In addition to this, we found a novel 
function for Rrm3 in controlling replication through residues 186-212 that interact with 
Orc5. In the absence of this region we observe that cells replicate much faster, and this 
is independent of activation of Rad53, suggesting Rrm3 is physically controlling the 
activity of origins where Orc5 is located.  
 To test if Rrm3 is controlling origin activity, we can perform an experiment where 
we probe for origins in specific loci where Rrm3 is thought to function such as highly 
transcribed regions, rRNA and tRNA coding loci, and highly transcribed metabolic 
genes [29, 30]. Using 2D gel electrophoresis we can probe for origins in cells lacking 
Rrm3 under replication stress to see if they have fired. Alternatively, we can use a 
genomics approach and perform NextGen sequencing to look at origins. This approach 
will reveal more detail because we can look at all origins and determine precisely where 
Rrm3 may play a role. To determine mechanistically how it controls replication we will 
look at the interaction sites between Rrm3 and Orc5. Orc5 is the ATP-binding subunit of 
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the origin recognition complex (ORC) and is an essential gene. We hypothesize that 
Rrm3 has a role in controlling origin activity by inhibiting Orc5 activity, possibly by 
preventing it from binding ATP and initiating replication. To validate this, we can use two 
approaches. First we can generate truncations to Orc5 keeping in mind not to disturb 
the ATP-binding subunit and locate the interaction site for Rrm3. Alternatively, we can 
perform an experiment where we pull down Rrm3 in yeast and analyze the sample 
using mass spectrometry and analyze the results to see which peptides from Orc5 
interact with Rrm3. 
 Through these approaches we can gain a better understanding of how the 
genome deals with stalled replication forks and replication stress. Determining where 
Rrm3 plays a role will help us better understand whether it has a global role in the cell 
or a more specific role in controlling replication. 
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ABSTRACT 
Rev3 polymerase and Mph1 DNA helicase participate in error-prone and error-
free pathways, respectively, for the bypassing of template lesions during DNA 
replication. Here we have investigated the role of these pathways and their genetic 
interaction with recombination factors, other nonreplicative DNA helicases, and DNA 
damage checkpoint components in the maintenance of genome stability, viability, and 
sensitivity to the DNA-damaging agent methyl methanesulfonate (MMS). We find that 
cells lacking Rev3 and Mph1 exhibit a synergistic, Srs2-dependent increase in the rate 
of accumulating spontaneous, gross chromosomal rearrangements, suggesting that the 
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suppression of point mutations by deletion of REV3 may lead to chromosomal 
rearrangements. While mph1Δ is epistatic to homologous recombination (HR) genes, 
both Rad51 and Rad52, but not Rad59, are required for normal growth of the rev3Δ 
mutant and are essential for survival of rev3Δ cells during exposure to MMS, indicating 
that Mph1 acts in a Rad51-dependent, Rad59-independent subpathway of HR-mediated 
lesion bypass. Deletion of MPH1 helicase leads to synergistic DNA damage sensitivity 
increases in cells with chl1Δ or rrm3Δ helicase mutations, whereas mph1Δ is hypostatic 
to sgs1Δ. Previously reported slow growth of mph1Δ srs2Δ cells is accompanied by 
G2/M arrest and fully suppressed by disruption of the Mec3-dependent DNA damage 
checkpoint. We propose a model for replication fork rescue mediated by translesion 
DNA synthesis and homologous recombination that integrates the role of Mph1 in 
unwinding D loops and its genetic interaction with Rev3 and Srs2-regulated pathways in 
the suppression of spontaneous genome rearrangements and in mutation avoidance. 
 
INTRODUCTION 
Nonreplicative DNA helicases play an important role in the maintenance of 
genome stability from bacteria to humans, most likely by affecting the formation and/or 
resolution of recombination intermediates and by facilitating replication fork progression 
through chromosomal regions with a propensity to adopt unusual DNA structures or 
those bound by proteins. In Saccharomyces cerevisiae, this group of DNA helicases 
includes the 3′-to-5′ helicases Sgs1 and Srs2 and the 5′-to-3′ DNA helicase Rrm3. In the 
absence of any two of these three helicases, unresolved recombination intermediates 
accumulate and lead to extremely slow growth that is fully suppressed by deletion of 
216
genes encoding early homologous recombination (HR) factors (Lee, Johnson et al. 
1999, Gangloff, Soustelle et al. 2000, Klein 2001, Fabre, Chan et al. 2002, Schmidt and 
Kolodner 2004, Torres, Schnakenberg et al. 2004). In the absence of Sgs1, cells exhibit 
increased rates of mitotic recombination, frequent chromosome missegregation, 
accumulation of extrachromosomal ribosomal DNA (rDNA) circles, and increased rates 
of gross chromosomal rearrangements (GCRs) involving nonhomologous chromosomes 
(Gangloff, McDonald et al. 1994, Watt, Louis et al. 1995, Sinclair, Mills et al. 1997, 
Yamagata, Kato et al. 1998, Mullen, Kaliraman et al. 2000, Myung, Datta et al. 2001, 
Schmidt and Kolodner 2006, Schmidt, Wu et al. 2006). Based on the increased 
crossover frequency during HO endonuclease-induced double-strand breaks (DSBs) in 
cells lacking Sgs1, it has also been proposed that Sgs1 may function in decatenation of 
Holliday junctions (HJs) to yield noncrossovers (Ira, Malkova et al. 2003, Lo, Paffett et 
al. 2006). Like Sgs1, Srs2 acts to favor noncrossover outcomes during DSB repair but 
appears to act earlier than Sgs1 in regulating recombination outcomes through its ability 
to dislodge Rad51 from recombinogenic 3′ overhangs, thereby promoting a 
noncrossover synthesis-dependent single-strand annealing (SDSA) pathway (Ira, 
Malkova et al. 2003, Robert, Dervins et al. 2006, Prakash, Satory et al. 2009). In 
contrast, Rrm3 has not been implicated in DNA repair but is thought to be important for 
avoidance of recombination substrate formation by removal of DNA protein complexes 
in certain chromosomal locations, such as chromosome ends and replication fork 
barriers at the rDNA locus, thus facilitating replication fork progression (Ivessa, Zhou et 
al. 2002, Ivessa, Lenzmeier et al. 2003). 
In addition to Sgs1, Rrm3, and Srs2, the yeast genome encodes two other 
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nonreplicative DNA helicases with proposed functions in DNA repair, Mph1 and Chl1. 
Mph1 possesses 3′-to-5′ helicase activity, and its ATPase activity requires a relatively 
long fragment of single-stranded DNA (ssDNA) (≥40 nucleotides [nt]) for full activity in 
vitro (Prakash, Krejci et al. 2005). Mph1 is also necessary for resistance to the DNA 
damaging agents methyl methanesulfonate (MMS) and 4-nitroquinoline-1-oxide (4-
NQO) and suppresses spontaneous mutations toward canavanine resistance (Entian, 
Schuster et al. 1999, Schurer, Rudolph et al. 2004). The modest mutator phenotype of 
the mph1Δ mutant is enhanced by additional mutations in base excision repair (apn1Δ 
and apn2Δ) and is suppressed by mutations in translesion DNA synthesis (TLS) (rev3Δ) 
(Scheller, Schurer et al. 2000, Schurer, Rudolph et al. 2004). These findings, in 
combination with the observation of an epistatic relationship between mph1Δ and 
homologous recombination mutations, have led to the proposal that Mph1 may act in 
Rad52-dependent, error-free bypassing of DNA lesions (Schurer, Rudolph et al. 2004). 
Like the 3′-to-5′ DNA helicases Sgs1 and Srs2, Mph1 was recently shown to affect 
crossover frequency during repair of an HO endonuclease-induced DNA DSB, favoring 
noncrossovers as the outcome (Prakash, Satory et al. 2009). The authors showed that 
Mph1 can unwind intermediates of homologous recombination in vitro, specifically D 
loops that are thought to form early during homologous recombination when a 
homoduplex is invaded by a Rad51 filament. While Srs2 has been shown to be able to 
disassemble Rad51 filaments in vitro, it does not appear to possess Mph1's ability to 
dissociate D loops once they have formed (Krejci, Van Komen et al. 2003, Veaute, 
Jeusset et al. 2003). 
Although Chl1 has been shown to be required for the establishment of sister 
218
chromatid cohesion, a possible role in DNA repair by homologous recombination has 
also been proposed (Shiratori, Shibata et al. 1999, Holloway 2000, Petronczki, Chwalla 
et al. 2004, Ogiwara, Ui et al. 2007). While Chl1 possesses a conserved helicase 
domain, helicase activity has so far been shown only for its putative human homolog, 
hCHLR1 (Hirota and Lahti 2000). 
To further elucidate the functional interaction between nonreplicative DNA 
helicases and DNA repair pathways, we generated a series of mutants with 
combinations of mph1Δ, chl1Δ, rrm3Δ, srs2Δ, and sgs1Δ mutations and mutations in 
translesion DNA synthesis (TLS), base excision repair (BER), homologous 
recombination (HR), and DNA damage checkpoints. In addition to synthetic fitness 
defects due to aberrant HR and checkpoint activation, we identified epistatic and 
synergistic relationships with regard to fitness, the accumulation of gross chromosomal 
rearrangements (GCRs), and sensitivity to DNA damage. We propose that Mph1 
functions in a Rad51-dependent, Rad59-independent pathway of HR for DNA lesion 
bypass and interacts genetically with REV3 in the suppression of gross chromosomal 
rearrangements. 
 
RESULTS 
 Translesion DNA synthesis suppresses GCR accumulation in mph1∆ cells 
Deletion of MPH1 has been shown to cause an increase in spontaneous base 
substitutions at CAN1, which can be suppressed by disrupting error-prone translesion 
DNA synthesis (Schurer, Rudolph et al. 2004). To determine how spontaneous DNA 
lesions are processed if they cannot be bypassed by Mph1 or TLS, we deleted MPH1 
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and REV3 in a yeast strain that has been modified to allow the detection of gross 
chromosomal rearrangements, such as translocations, large deletions, and de novo 
telomere additions (Kolodner, Putnam et al. 2002, Schmidt, Pennaneach et al. 2006). 
We found that the rev3Δ mph1Δ mutant showed a statistically significant increase in the 
GCR rate over that of the single mutants, as indicated by the nonoverlapping 95% 
confidence intervals (α < 0.05) for the median GCR rates (Table 2). This may indicate 
that the avoidance of point mutations by deletion of the error-prone DNA polymerase 
Rev3 occurs at the expense of increased formation of chromosomal rearrangements, 
suggesting that as long as Rev3 is present, spontaneous DNA lesions in the mph1Δ 
mutant are preferentially taken care of by TLS, whereas an alternative repair pathway 
preferentially utilized in the rev3Δ mph1Δ mutant is prone to GCR formation. To test the 
possibility that Srs2, a DNA helicase that has been shown to regulate homologous 
recombination by disrupting recombinogenic Rad51-filaments (Krejci, Van Komen et al. 
2003, Veaute, Jeusset et al. 2003), may channel DNA lesions into this alternative DNA 
repair pathway, we determined the effect of an srs2Δ mutation on GCR formation in the 
rev3Δ mph1Δ mutant and found that GCR formation was eliminated (Table 2). That the 
viability of the rev3Δ mph1Δ mutant was significantly reduced upon introduction of the 
srs2Δ mutation (Fig. 1A) is consistent with previous reports of reduced fitness for the 
mph1Δ srs2Δ mutant (Tong, Evangelista et al. 2001, Tong, Lesage et al. 2004, 
Prakash, Satory et al. 2009) and suggests that spontaneous DNA lesions in the rev3Δ 
mph1Δ mutant may become substrates for homologous recombination pathways that 
need to be regulated by Srs2 to prevent cell death. In contrast to the mph1Δ mutant, the 
rev3Δ mutant does not require Srs2 for normal growth (Fig. 1A). 
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To test whether slow growth of the mph1Δ srs2Δ and rev3Δ mph1Δ srs2Δ 
mutants was due to increased G2/M arrest or to slowed progression through S phase 
resulting from impaired DNA lesion bypass, cell cycle profiles were obtained (Fig. 2A) 
and the fraction of cells in each cell cycle phase from three independent cultures was 
quantified (Fig. 2B). We found that the mph1Δ srs2Δ and rev3Δ mph1Δ srs2Δ mutants 
showed increased arrest in G2/M compared to the corresponding single and double 
mutants, but the mutations lacked any discernible affect on S phase. That the fraction of 
cells in S phase was largely unaffected indicates that impairment of DNA lesion bypass 
does not hinder the timely completion of genome replication but may instead cause the 
formation of DNA structures that later in the cell cycle impair progress through mitosis. 
Deletion of RAD51, which had previously been shown to improve colony growth 
of the mph1Δ srs2Δ mutant and other DNA helicase double mutants (Lee, Johnson et 
al. 1999, Gangloff, Soustelle et al. 2000, Klein 2001, Fabre, Chan et al. 2002, Schmidt 
and Kolodner 2004, Torres, Schnakenberg et al. 2004, Prakash, Satory et al. 2009), 
abolished the G2/M arrest of mph1Δ srs2Δ cells and allowed them to progress through 
the cell cycle as did the srs2Δ single mutant (Fig. 3A). In addition to disrupting 
homologous recombination, we found that disruption of the DNA damage checkpoint 
clamp by MEC3 deletion also improved growth of the mph1Δ srs2Δ mutant (Fig. 1A) 
and had the same effect on viability and cell cycle progression as the deletion of RAD51 
(Fig. 3). In contrast, introduction of a rev3Δ mutation into the mph1Δ srs2Δ mutant did 
not affect growth (Fig. 1A) but led to a small increase in the fraction of G2/M-arrested 
cells (Fig. 2). Similarly, sensitivity of the mph1Δ srs2Δ mutant to MMS was aggravated 
further by a rev3Δ mutation but was alleviated by a rad51Δ mutation (Fig. 4). In the 
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presence of MMS, rev3Δ mph1Δ srs2Δ cells emerged only after incubation for >72 h. 
This strong synergistic increase in MMS sensitivity of the triple mutant compared to that 
of any of the double mutants suggests that all three genes mediate independent 
pathways for survival in the presence of DNA damage. Taken together, these findings 
suggest that deleting the error-prone DNA polymerase Rev3 in mph1Δ cells while 
effectively avoiding points mutations causes the appearance of a different mutation 
type, i.e., gross chromosomal rearrangements, which activates the DNA damage 
checkpoint in G2/M and causes cell death if Srs2 is not present to regulate HR-
dependent DNA lesion bypass. 
 
Suppression of genome rearrangements by srs2∆ depends on functional 
 DNA damage checkpoint 
Genome instability in cells lacking Sgs1 helicase is suppressed by the DNA 
damage checkpoint, as demonstrated by synergistic GCR rate increases upon 
introduction of the mec3Δ, rad24Δ, mec1Δ, rad53Δ or rad9Δ mutation into the sgs1Δ 
mutant (Schmidt, Wu et al. 2006). As demonstrated by overlapping 95% confidence 
intervals, no statistically significant changes in the GCR rate of the mph1Δ mutant were 
observed upon introduction of checkpoint mutations (mec3Δ and mec1Δ) (Table 2), 
suggesting that the DNA damage checkpoint is not required for the suppression of 
GCRs in the mph1Δ mutant. However, when we introduced the mec3Δ mutation into the 
mph1Δ srs2Δ mutant, which itself exhibited wild-type levels of GCRs, the GCR rate 
increased to that of the mph1Δ mec3Δ mutant (Table 2), thus suggesting that, in 
contrast to the case with the rev3Δ mph1Δ and mph1Δ mutants, GCR formation in 
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checkpoint-deficient mutants is not dependent on Srs2. Similarly, the GCR rate of the 
mec3Δ mutant did not change upon introduction of an srs2Δ mutation. This ability of the 
srs2Δ mutation to suppress GCR formation in checkpoint-proficient cells but not in 
checkpoint-deficient cells suggests that the Mec3 checkpoint detects the aberrant HR 
intermediates that form in the absence of Srs2, leading to G2/M arrest and avoidance of 
GCRs, whereas in the absence of the checkpoint, these aberrant HR intermediates go 
on to form GCRs. 
 
Lack of Rev3 and Mph1 causes synergistic GCR rate increase in new GCR 
 strain susceptible to duplication-mediated rearrangements 
Putnam et al. (Putnam, Hayes et al. 2009) recently showed that the rate of GCR 
accumulation depends significantly on chromosomal features in the breakpoint region. 
For example, while GCRs in the standard GCR strain background (RDKY3615) are due 
largely to single-copy-sequence-mediated rearrangements, GCRs in a newly designed 
strain (RDKY6678) are duplication mediated due to the presence of imperfect homology 
between the HXT13-DSF1 sequence in the breakpoint region on chromosome V and 
sequences on chromosomes IV, X, and XIV (Putnam, Hayes et al. 2009). This new 
GCR strain accumulates chromosomal rearrangements at an increased rate compared 
to that for the standard GCR strain, with wild-type cells having a 56-fold-higher GCR 
rate than the standard strain (Putnam, Hayes et al. 2009). To assess the effect of DNA 
lesion bypass defects on GCR formation in this new strain, rev3Δ, mph1Δ, srs2Δ, and 
mec3Δ mutations were introduced into RDKY6678 (Table 3). Consistent with our 
observations with the standard GCR strain background (Table 2), the rev3Δ mph1Δ 
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double mutant exhibited a synergistic GCR rate increase compared to results for the 
mph1Δ and rev3Δ single mutants. Interestingly, the significantly greater synergistic 
effect of combining the rev3Δ and mph1Δ mutations in the new GCR strain background 
(Table 3; 167-fold increase over rates for the RDKY6678 wild type) compared to results 
with the standard GCR strain background (Table 2, 16-fold increase over rates for the 
RDKY3615 wild type) indicates that alternative pathways utilized for DNA lesion bypass 
in the rev3Δ mph1Δ mutant may be more prone to duplication-mediated than to single-
copy-sequence mediated genome rearrangements. As in the standard GCR strain 
(Table 2), deletion of SRS2 in the new GCR strain led to a significant decrease in the 
GCR rate of the rev3Δ mph1Δ mutant to the level of the srs2Δ mutant, suggesting that 
viable GCR formation depends on the antirecombinase Srs2 despite the different 
breakpoint regions in the two GCR strain backgrounds and the different GCR types that 
are likely to arise from them. The fact that deletion of SRS2 did not cause a GCR rate 
increase in the mph1Δ mec3Δ mutant in the standard GCR background (Table 2) but 
led to a significant GCR rate increase in the new GCR background (Table 3) is likely 
due to the greater requirement of Srs2 for GCR suppression in the new GCR strain 
background (Table 3, srs2Δ: 26-fold increase over wild-type level) than in the standard 
GCR strain (Table 2, srs2Δ: 0.6-fold increase over wild-type level). 
 
 Genetic interactions between MPH1 and other DNA helicases 
 Negative genetic interactions between any two of the DNA helicases Sgs1, Srs2, 
and Rrm3 have previously been shown to be caused by the accumulation of aberrant 
intermediates of homologous recombination (Gangloff, Soustelle et al. 2000, Ooi, 
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Shoemaker et al. 2003, Schmidt and Kolodner 2004, Torres, Schnakenberg et al. 2004). 
Since such a negative, HR-dependent genetic interaction has now also been 
established between mph1Δ and srs2Δ, we tested mph1Δ mutants with deletions of 
other confirmed or putative DNA helicase genes (sgs1Δ, rrm3Δ, and chl1Δ) for growth 
defects, GCR accumulation, and sensitivity to MMS. We observed that unlike the case 
with the mph1Δ srs2Δ mutant, the meiotic products of diploids heterozygous for the 
mph1Δ mutation and either the sgs1Δ, rrm3Δ, or chl1Δ mutation grew normally. In 
addition to a synergistic increase in sensitivity to MMS for the mph1Δ srs2Δ mutant 
(Banerjee, Smith et al. 2008), we also identified synergistic increases in sensitivity for 
the mph1Δ rrm3 and mph1Δ chl1Δ mutants but not for the mph1Δ sgs1Δ mutant, which 
appeared as sensitive as the sgs1Δ single mutant (Fig. 5). This indicates that Mph1, 
Chl1, Rrm3, and Srs2 contribute independently to survival during exposure to MMS, 
while Mph1 appears to be hypostatic to Sgs1. Since Schurer et al. (Schurer, Rudolph et 
al. 2004) reported a synergistic increase in mitotic homologous recombination at three 
markers for the mph1Δ sgs1Δ mutant and therefore suggested that Mph1 may play an 
antirecombinogenic role in the sgs1Δ mutant, we tested whether Mph1 also interacted 
with Sgs1 or other DNA helicases in the suppression of GCRs. However, we found that 
the mph1Δ sgs1Δ mutant accumulates GCRs at the same rate as the sgs1Δ mutant, 
indicating no genetic interaction between MPH1 and SGS1 in the suppression of 
chromosomal rearrangements (Table 2). Deletion of MPH1 also failed to induce 
significant changes in the accumulation of GCRs in srs2Δ, chl1Δ, and rrm3Δ mutants, 
as indicated by the overlap between 95% confidence intervals (Table 2). 
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 Rad52/Rad51, but not Rad59, are essential for DNA damage tolerance and 
 normal growth in the absence of translesion DNA synthesis 
Although the rev3Δ mph1Δ mutant exhibits a synergistic increase in the GCR 
rate and in sensitivity to MMS, it grows unimpaired in the absence of MMS, with a 
doubling time indistinguishable from that of the single mutants (Fig. 1B). However, 
sporulation of diploids heterozygous for the rev3Δ and rad52Δ mutations revealed 
slower growth for the rev3Δ rad52Δ mutant that was unaffected by deletion of MPH1 
(Fig. 1B). That the rev3Δ rad52Δ mutant does grow, albeit slowly, could mean that 
spontaneous DNA lesions needing to be bypassed during DNA replication are rare 
and/or that alternative, yet minor, pathways for lesion bypass exist in addition to HR and 
TLS. To distinguish between these possibilities, the ability of the HR-deficient rev3Δ 
mutant to grow in the presence of MMS was assessed (Fig. 4). While the rev3Δ mutant 
was no more sensitive than wild-type cells, consistent with previous findings (Schurer, 
Rudolph et al. 2004), the rev3Δ rad52Δ mutant was significantly more sensitive than the 
rad52Δ mutant. In fact, not a single colony emerged in repeated experiments, even after 
a >72-h incubation time on 0.001% MMS, for strains lacking both REV3 and RAD52, 
lending support to the proposal that besides HR and TLS, no other pathways exist in 
yeast for the bypassing of induced DNA lesions. To determine whether Rad51- or 
Rad59-dependent branches of homologous recombination are essential for rev3Δ 
survival, the viability of spores obtained from diploids heterozygous for rev3Δ and either 
the rad51Δ or rad59Δ mutation was assessed, revealing normal growth for the rev3Δ 
rad59Δ mutant while the rev3Δ rad51Δ mutant grew slowly (Fig. 1B). Moreover, the 
rev3Δ rad59Δ mutant was no more sensitive than the single mutants, whereas the 
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rev3Δ rad51Δ mutant could not form any colonies in the presence of MMS (Fig. 4), 
similar to the case with the rev3Δ rad52Δ mutant. Thus, although rev3Δ exhibits 
synergistic increases in sensitivity to MMS when combined with mph1Δ, mph1Δ srs2Δ, 
rad52Δ, or rad51Δ, the normal growth of the rev3Δ mph1Δ mutant as opposed to the 
impaired growth of the rev3Δ rad51Δ and rev3Δ rad52Δ mutants suggests that in 
addition to Mph1-dependent HR, other, Mph1-independent, Rad51-dependent HR 
pathways exist for DNA lesion bypass. 
 
DISCUSSION 
We have investigated genetic interactions between genes involved in DNA lesion 
bypass (MPH1 and REV3), homologous recombination (RAD52, RAD51, RAD59, and 
SRS2), and the DNA damage checkpoint (MEC3 and MEC1) with regard to fitness, 
MMS sensitivity, and suppression of genome instability. We find that suppression of 
point mutations that arise in an mph1Δ mutant as a result of the error-prone Rev3 
polymerase replicating across a template lesion results in the appearance of GCRs. 
This finding may suggest that mutations are not actually avoided but are simply shifted 
toward a different mutation type. Synergistic GCR rate increases in two strain 
backgrounds, each designed to accumulate different GCR spectra (Putnam, Hayes et 
al. 2009), demonstrate that REV3 and MPH1 interact genetically to suppress various 
types of spontaneous GCRs but are especially effective at suppressing GCRs in the 
newly designed GCR strain background. For this new GCR strain, Putnam et al. 
(Putnam, Hayes et al. 2009) determined that GCRs accumulate largely as a result of 
nonallelic homologous recombination (NAHR) between DNA sequences in the 
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breakpoint region on chromosome V and similar regions on chromosomes IV, X, and 
XIV. Hence, the greater synergistic GCR rate increase identified here in this new GCR 
background compared to that for the standard GCR strain suggests greater roles for 
MPH1 and REV3 in the suppression of such NAHR-mediated GCRs than in the 
suppression of single-copy-sequence-mediated rearrangements. The requirement of 
Srs2, which regulates the outcomes of HR by antagonizing strand invasion, for the 
formation of viable chromosomal rearrangements further supports a prominent role of 
HR in the formation of GCRs when Mph1 and Rev3 are absent for DNA lesion bypass. 
We further show that the negative genetic interaction between the mph1Δ and srs2Δ 
mutations, coupled with accumulation of cells in G2/M and further exacerbation of the 
G2/M arrest by disruption of REV3, is suppressed by disrupting the DNA damage 
checkpoint. Synergism in MMS sensitivity was observed for mph1Δ mutants lacking 
CHL1, RRM3, SRS2, or REV3, whereas epistasis was observed for mph1Δ mutants 
lacking RAD52, RAD51, or SGS1. Combined with our observation that the rev3Δ mutant 
required RAD51 and RAD52 but not RAD59 or MPH1 for normal growth, this suggests 
that Rev3 (TLS) and RAD51 (HR) are the two pathways for bypass of spontaneous 
DNA lesions, with Mph1 defining only one Rad51 subpathway. While the rad51Δ 
mutation appeared to suppress MMS sensitivity of the mph1Δ srs2Δ mutant to the level 
exhibited by a rad51Δ single mutant, the rev3Δ mutation led to a further synergistic 
increase, suggesting that Mph1, Srs2, and Rev3 contribute to bypass and/or repair of 
induced DNA lesions independently. 
Our observation of suppression of the G2/M arrest of the mph1Δ srs2Δ mutant by 
mec3Δ, in addition to the recently reported suppression by rad51Δ (Prakash, Satory et 
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al. 2009), suggests that cells lacking Mph1 and Srs2 are overwhelmed with HR 
intermediates that do not impair S phase but activate the DNA damage checkpoint prior 
to mitosis. That Srs2 is essential for normal growth in the absence of Mph1 could mean 
that DNA lesions, normally bypassed by the Mph1 pathway, will enter another HR 
pathway that is potentially lethal if it is not regulated by Srs2. According to recent 
findings by Prakash et al. (Prakash, Satory et al. 2009), Srs2, Mph1, and Sgs1 
independently promote noncrossover pathways during mitotic DSB repair. They suggest 
that Srs2 diverts DNA lesions away from crossover events that can result from double 
Holliday junction (dHJ) resolution into the noncrossover SDSA pathway by preventing 
second-strand invasion. Accumulation of dHJs due to the absence of Srs2 could 
overwhelm resolution pathways, especially when alternative pathways for DNA lesion 
bypass, such as TLS, are absent. In addition to its ability to inhibit crossover formation 
during repair of an HO-induced DSB, Mph1 has also been reported to unwind D loops in 
vitro (Prakash, Satory et al. 2009). It has therefore been proposed that Mph1 promotes 
SDSA and may reverse strand invasion events before they can form dHJs. Thus, the 
overall burden of lesions that are committed to HR pathways and could potentially go on 
to form dHJs would be expected to increase in the absence of Mph1 and even further 
when Rev3 is also absent. 
Recent findings suggest how FANCM, a human homolog of Mph1, could perform 
a role in error-free bypass of DNA lesions. FANCM is part of the eight-component 
Fanconi anemia core complex, which is involved in the repair of intrastrand cross-links 
and is associated with Fanconi anemia (Joenje and Patel 2001, Niedzwiedz, Mosedale 
et al. 2004, Kennedy and D'Andrea 2005, Mathew 2006, Wang 2007). FANCM can 
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branch migrate three- and four-way junctions and, like Mph1, unwind D loops (Gari, 
Decaillet et al. 2008, Gari, Decaillet et al. 2008). Combining these two activities, it has 
been proposed that FANCM may stall and remodel replication forks to promote repair of 
an approaching DNA lesion, thus preventing the fork from encountering the lesion and 
collapsing (Gari, Decaillet et al. 2008). Without FANCM, forks would collapse, leading to 
broken chromatids and increased gross chromosomal rearrangements, both hallmarks 
of Fanconi cells (Thompson, Hinz et al. 2005). 
The recruitment of Srs2 to the replisome when PCNA becomes sumoylated in 
the presence of DNA damage (Pfander, Moldovan et al. 2005) and the ability of the 
human Mph1 homolog FANCM to remodel replication forks in vitro lead us to propose a 
model in which Mph1 and Srs2 perform their roles in recombination directly at the fork to 
restart replication after encountering a DNA lesion (Fig. 6). Based on the slow growth of 
Rad52/Rad51-deficient rev3Δ cells and the inability of the rev3Δ rad52Δ and rev3Δ 
rad51Δ mutants to form any colonies in the presence of MMS, we propose that in wild-
type cells, DNA lesions may be bypassed by either Rev3-mediated TLS or Rad51-
dependent HR, with Mph1 being involved in only one subpathway of Rad51-dependent 
HR. Rev3-mediated TLS is prone to errors but not GCR formation, while properly 
regulated HR pathways, including the Mph1 pathway, are error free. Mph1 may act at a 
stalled replication fork by unwinding the leading strand from its template, a scenario 
which has been suggested to resemble unwinding of a D loop (Gari, Decaillet et al. 
2008). Mediated by HR proteins, the leading strand may then anneal with the lagging 
strand, forming a chicken foot (Fig. 6, structure A), or invade the sister chromatid, 
forming a D loop (Fig. 6, structure B), followed by DNA synthesis at the 3′ end. Based 
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on the ability of Mph1 to reverse D loops in vitro, it also seems possible that Mph1 acts 
to resolve these HR intermediates. For example, Mph1 could unwind the D loop formed 
by HR proteins after limited DNA synthesis or dissolve the chicken-foot structure by 
reverse branch migration. Reannealing of the daughter strands with their templates 
would then result in error-free bypass of the DNA lesion in the template strand and 
resumption of replication. While FANCM has been shown to migrate three- and four-
way junctions in vitro (Gari, Decaillet et al. 2008, Gari, Decaillet et al. 2008), as 
proposed in this model, this remains to be determined for Mph1. The recent report of a 
physical interaction between Mph1 and RPA (Banerjee, Smith et al. 2008) could 
suggest that Mph1 is recruited to stalled replication forks via RPA-bound regions of 
ssDNA that are generated when the replication machinery stalls at a lesion in the 
template. While Mph1 can unwind 40 bp by itself, it requires RPA to unwind duplexes 
that are 100 bp and fails on those that are 500 bp (Prakash, Krejci et al. 2005). This 
rather modest helicase activity could ensure that Mph1 does not expose unnecessarily 
large regions of ssDNA at stalled forks while at the same time being sufficiently strong 
to unwind the leading strand from its template needed for D-loop/chicken-foot formation 
and/or to reverse HR-mediated invasion of the sister chromatid. Moreover, the ATPase 
activity of Mph1 requires a relatively long stretch of ssDNA (≥40 nt) for full activation in 
vitro (Prakash, Krejci et al. 2005), which could help to ensure that Mph1 is active only 
on replication forks that have stalled because they are likely to contain longer regions of 
ssDNA than unperturbed forks. In our model, Srs2 is recruited to damaged replication 
forks to suppress dHJ formation, thereby promoting Mph1-mediated fork rescue. Such a 
role for Srs2 at the replication fork is consistent with recent findings (Liberi, Chiolo et al. 
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2000, Pfander, Moldovan et al. 2005). Hence, in the absence of Srs2, an increasing 
number of forks would enter dHJ pathways for rescue, overwhelming dHJ resolution 
pathways and leading to aberrant and/or unresolved intermediates and eventually G2/M 
arrest. This accumulation of srs2Δ cells in G2/M accelerates as more DNA lesions 
become substrates for dHJ pathways upon elimination of Mph1 and Rev3. Unresolved 
or aberrant DNA structures may not be the only cause for Mec3-dependent cell cycle 
arrest of mph1Δ srs2Δ cells. According to findings by Prakash et al. (Prakash, Satory et 
al. 2009), HR intermediates during DSB repair are increasingly resolved as crossovers 
when Srs2 and Mph1 are absent, possibly due to increased HR and impairment of 
single-strand annealing pathways, such as SDSA. Thus, not only is increased dHJ 
formation likely to overwhelm dHJ resolution pathways, it is also likely to increase the 
number of crossovers, which could be dangerous for haploid mitotic cells and contribute 
to diminished cell proliferation. Although formation and unwinding of D-loop-like 
structures could be envisaged at replication forks and the recently proposed role of 
Mph1 in SDSA repair of DSBs could be likened to reversing chicken-foot/D-loop 
structures at stalled forks, it remains to be tested whether Mph1 can branch migrate 
three- or four-way junctions to reverse these HR intermediates and does indeed 
function at the replication fork. 
 
MATERIALS AND METHODS 
 Yeast strains and media 
All strains used in this study are derived from Saccharomyces cerevisiae strain 
S288C and are listed in Table 1. For GCR rate measurements, desired gene deletions 
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were introduced into KHSY802 (MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2Bgl hom3-
10 ade2Δ1 ade8 hxt13::URA3), RDKY5027 (MATα ura3-52 trp1Δ63 his3Δ200 leu2Δ1 
lys2Bgl hom3-10 ade2Δ1 ade8 hxt13::URA3), or RDKY6678 (MATa ura3-52 leu2Δ1 
trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 can1::hisG yel072w::CAN1/URA3 
iYEL072::hph) by HR-mediated integration of PCR products by the lithium acetate 
method (Gietz and Woods 2006). All haploid strains, including single mutants, for GCR 
rate measurements, growth analysis, and fluorescence-activated cell sorting (FACS) 
were obtained by sporulating diploids heterozygous for the desired mutation(s). Spores 
were genotyped on selective media or by PCR. For tetrad dissection, desired mutations 
were introduced by HR-mediated integration of PCR fragments in the strain background 
RDKY2666 (MATa ura3-52 trp1Δ63 his3Δ200) or RDKY2664 (MATα ura3-52 trp1Δ63 
his3Δ200). Media for propagating strains have been previously described (Chen, 
Umezu et al. 1998). 
 
GCR analysis 
GCR rates were determined exactly as previously described (Schmidt, 
Pennaneach et al. 2006). Initially, GCR rates were derived from 10-ml cultures of two or 
three independent strain isolates. For mutants with low GCR rates, up to 75 cultures, 
ranging from 10 to 50 ml in volume, were analyzed per mutant. To determine the 
statistical significance of differences between median GCR rates, 95% confidence 
intervals (α < 0.05) for all median GCR rates were calculated according to the method of 
Nair (Nair 1940). GCR rates were measured in the standard GCR strain background 
RDKY3615 and a modified GCR strain background, RDKY6678 (both strains were 
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kindly provided by Richard Kolodner, University of California—San Diego). In 
RDKY3615, the CAN1 gene is in its wild-type location on chromosome V and a URA3 
cassette was used to replace the HXT13 gene on chromosome V (Schmidt, 
Pennaneach et al. 2006, Putnam, Hayes et al. 2009). In RDKY6678, the CAN1 gene is 
deleted (can1::hisG) and a URA3/CAN1 cassette is inserted into YEL072W, located 
telomeric of HXT13 on chromosome V (Putnam, Hayes et al. 2009). 
 
Tetrad analysis 
Diploids were sporulated in 1% potassium acetate for 5 days at 30°C, washed, 
digested with zymolase (500 µg/ml in 1 M sorbitol), and dissected on yeast extract-
peptone-dextrose (YPD) agar plates using a micromanipulator mounted on an Axioskop 
40 microscope (Zeiss). The YPD plates were incubated for 2 days at 30°C and 
photographed. 
 
 Doubling time measurement 
Overnight cultures of independent isolates were diluted in 5 ml of YPD to an 
optical density at 600 nm (OD600) of 0.1 to 0.2, and the OD600 was measured in 60-
min or 120-min intervals for 6 to 8 h. Doubling times are reported in minutes and are 
presented as the average doubling time of two or three independent strains for each 
genotype, with error bars showing the standard deviations. 
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DNA content analysis 
Cells were grown overnight at 30°C in YPD medium. Cultures were diluted in 
YPD to an OD600 of 0.2, and incubation was continued until cultures reached an 
OD600 of 0.6 to 0.8. Cells were then fixed in 70% ethanol for 1 h at room temperature 
and sonicated in 50 mM sodium citrate (pH 7). The cells were washed once in 50 mM 
sodium citrate (pH 7), and RNase A was added to a final concentration of 250 µg/ml. 
After overnight incubation at 37°C, the cells were washed twice in 50 mM sodium 
citrate. To stain the DNA, Sytox green (Molecular Probes) was added to a final 
concentration of 1 µM and the cells were incubated in the dark at room temperature for 
1 h immediately prior to fluorescence-activated cell sorting (FACS) on a BD LSR II 
analyzer. The distribution of cells throughout the cell cycle phases was quantified with 
the FlowJo v8.3.3 software program. The mean obtained from measurements of at least 
three cultures and standard deviation are reported for every strain. 
 
MMS sensitivity 
Overnight cultures were diluted in YPD to an OD600 of 0.2 and grown at 30°C to 
an OD600 of 0.6. A series of 10-fold dilutions was prepared for every yeast culture, and 
5 µl was spotted on YPD and on YPD containing the appropriate levels of MMS. Colony 
growth was recorded after 24 h, 48 h, and 72 h of incubation at 30°C. The 48-h time 
point is shown. 
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FIGURES AND TABLES 
 
Figure A.1. Genetic interactions between rev3Δ, mph1Δ, srs2Δ, and HR mutations 
were assessed by testing the fitness of mutants. (A) Tetrads from diploids 
heterozygous for rev3Δ, mph1Δ, and srs2Δ; mph1Δ, srs2Δ, and rad51Δ; or mph1Δ, 
srs2Δ, and mec3Δ were dissected on rich medium and genotyped by spotting on 
selective medium or by PCR to determine the presence of gene deletions. In contrast to 
the mph1Δ mutant, the rev3Δ mutant does not require SRS2 for normal growth. 
Deletion of MEC3 or disruption of HR rescues the slow growth of the mph1Δ srs2Δ 
mutant. (B) Doubling times of mutant strains and appropriate controls in rich medium 
(YPD) are shown with standard deviations. Cells lacking Rev3 require Rad51 and 
Rad52 but not Rad59 for normal growth, and these growth defects are unaffected by 
Mph1. 
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Figure A.2. Effect of rev3Δ and srs2Δ mutations on cell cycle progression of cells 
lacking Mph1. Asynchronous cultures were grown to mid-log phase, fixed, and stained 
with Sytox green to measure DNA content by FACS. (A) Cell cycle profiles reveal that 
mph1Δ srs2Δ cells accumulate in G2/M phase, which is enhanced further by a rev3Δ 
mutation. (B) Quantification of cell fractions in G1, S, and G2/M phases, determined by 
FACS analysis of three cell cultures for each strain, using FlowJo v8.3.3. Error bars 
indicate the standard deviations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
237
 Figure A.3. The G2/M arrest of mph1Δ srs2Δ cells is suppressed by disrupting 
homologous recombination or the DNA damage checkpoint. Cell cycle profiles (A) 
and quantification (B) of the fractions of cells in G1, S, and G2/M phases show that the 
rad51Δ and mec3Δ mutations are equally effective at decreasing cell accumulation in 
G2/M, showing an increase in the fraction of cells in G1. Neither mutation affects the 
fraction of cells in S phase. The DNA content of Sytox green-stained cells from at least 
three mid-log-phase cultures of every strain was analyzed by FACS. 
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 Figure A.4. Effect of mutations affecting translesion DNA synthesis and 
homologous recombination on sensitivity to MMS. Tenfold dilutions of exponentially 
growing cultures were spotted on YPD (viable cell count) or YPD containing 0.001% or 
0.005% MMS. Colony growth after 48 h (and 72 h for selected mutants) of incubation at 
30°C is shown. 
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 Figure A.5. Effect of an mph1Δ mutation on MMS sensitivity of mutants lacking 
various other confirmed (Sgs1, Rrm3, and Srs2) or putative (Chl1) DNA helicases. 
Tenfold dilutions of exponentially growing cultures were spotted on YPD or YPD 
containing 0.01% or 0.005% MMS. Colony growth after 48 h of incubation at 30°C is 
shown. 
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 Figure A.6. Model for the role of Mph1 in the maintenance of genome stability. 
DNA lesions arise spontaneously during DNA replication and are bypassed by an error-
free, Mph1-mediated, noncrossover pathway of homologous recombination (HR). Mph1 
may unwind the leading strand from its template, suggested to resemble a D loop (Gari, 
Decaillet et al. 2008), followed by Rad51/52-mediated chicken-foot formation (A) and 
then resolution by reverse branch migration. A D-loop structure could also form when 
the leading strand switches template (B), and Mph1 could dissolve this D loop by 
reverse branch migration. In the absence of Mph1, lesions are bypassed by error-prone, 
Rev3-mediated TLS or they are channeled by Srs2 into alternative bypass pathways 
that can result in GCRs. If TLS is disrupted in the mph1Δ mutant, point mutations from 
TLS are avoided, but GCRs arise as a consequence of aberrant repair, most likely 
nonallelic HR. In the absence of both Mph1 and Srs2, cells accumulate at G2/M and 
lose viability due to Rad51-mediated accumulation of dHJs and Mec3-mediated 
checkpoint activation. In the absence of the checkpoint, cells continue through the cell 
cycle in the presence of DNA lesions. The dotted line emerging from Srs2 indicates that 
Srs2 tightly regulates the levels of dHJ formation at paused replication forks by inhibiting 
Rad51-mediated strand invasion. 
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TABLE A.1. Saccharomyces cerevisiae strains used in this study 
Strain Genotype 
RDKY3615a MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 
RDKY2666a MATa ura3-52 trp1Δ63 his3Δ200 
RDKY2664a MATα ura3-52 trp1Δ63 his3Δ200 
RDKY6678a MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph 
RDKY6795a MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph mph1::HIS3 
KHSY883 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rad51::HIS3 
KHSY1258 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rad52::HIS3 
KHSY1399 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rrm3::kanMX6 
KHSY1557 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 mph1::HIS3 
KHSY1561 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 chl1::HIS3 
KHSY1598 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rad52::HIS3 mph1::HIS3 
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TABLE A1.1 (continued) 
KHSY1600 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 sgs1::TRP1 mph1::HIS3 
KHSY1630 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 sgs1::TRP1 
KHSY1702 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 srs2::kanMX6 mph1::HIS3 
KHSY1713 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rrm3::TRP1 mph1::HIS3 
KHSY1725 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 chl1::HIS3 mph1::HIS3 
KHSY1872 MATa/α ura3-52/ura3-52 trp1Δ63/trp1Δ63 his3Δ200/his3Δ200 
MPH1/mph1::HIS3 SRS2/srs2::TRP1 
KHSY1878 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 mec3::kanMX6 mph1::HIS3 
KHSY1889 MATa/α ura3-52/ura3-52 trp1Δ63/trp1Δ63 his3Δ200/his3Δ200 
MPH1/mph1::HIS3 MRE11/mre11::URA3 
KHSY1894 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 mph1::HIS3 mec1::HIS3 sml1::TRP1 
KHSY1932 MATa/α ura3-52/ura3-52 trp1Δ63/trp1Δ63 his3Δ200/his3Δ200 
MPH1/mph1::URA3 SRS2/srs2::HIS3 MEC3/mec3::TRP1 
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TABLE A1.1 (continued) 
KHSY1935 MATa/α ura3-52/ura3-52 trp1Δ63/trp1Δ63 his3Δ200/his3Δ200 
MPH1/mph1::HIS3 SRS2/srs2::TRP1 RAD51/rad51::kanMX6 
KHSY1954 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rev3::TRP1 
KHSY1957 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 apn1::TRP1 
KHSY1970 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 apn1::TRP1 mph1::HIS3 
KHSY1976 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rev3::TRP1 mph1::HIS3 
KHSY2020 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rad51::HIS3 srs2::kanMX6 mph1::HIS3 
KHSY2038 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 mec3::HIS3 srs2::kanMX6 mph1::TRP1 
KHSY2226 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rev3::TRP1 srs2::kanMX6 mph1::HIS3 
KHSY2416 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rev3::TRP1 rad52::HIS3 mph1::HIS3 
KHSY2420 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 rev3::TRP1 rad52::HIS3 
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TABLE A1.1 (continued) 
KHSY2492 MATa ura3-52 trp1Δ63 his3Δ200 leu2Δ1 lys2ΔBgl hom3-10 ade2Δ1 ade8 
hxt13::URA3 mph1::HIS3 rad51::HIS3 
KHSY3042 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph mec3::TRP1 mph1::HIS3 
KHSY3056 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph rev3::TRP1 mph1::HIS3 
KHSY3065 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph mec3::TRP1 
KHSY3067 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 
KHSY3101 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 mph1::HIS3 
KHSY3123 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 mph1::HIS3 
rev3::TRP1 
KHSY3126 MATa ura3-52 leu2Δ1 trp1Δ63 his3Δ200 lys2ΔBgl hom3-10 ade2Δ1 ade8 
can1::hisG yel072w::CAN1/URA3 iYEL072::hph srs2::HIS3 mph1::HIS3 
mec3::TRP1 
a Obtained from Richard Kolodner (University of California—San Diego). 
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TABLE A.2. Effect of defects in DNA lesion bypass, homologous recombination, 
DNA helicases, and the DNA damage checkpoint on accumulation of gross 
chromosomal rearrangements in the standard GCR strain background RDKY3615 
 
Relevant 
genotype 
Strain GCR rate (Canr 5-
FOAr) (× 10−10)a 
95% CIb (Canr 5-
FOAr) (× 10−10) 
Fold increase over 
wild-type level 
Wild type RDKY3615 3.5c  1 
mph1 KHSY1557 20 5–34 6 
rev3 KHSY1954 10 5–21 3 
rev3 
mph1 
KHSY1976 56 44–71 16 
rev3 
mph1 
srs2 
KHSY2226 <14 <11–18 <4 
srs2 RDKY5557 2d <2–11 0.6 
mph1 
srs2 
KHSY1702 1.2 <2–6 0.3 
mph1 
mec3 
KHSY1878 55 24–73 16 
mph1 
mec3 
srs2 
KHSY2038 56 30–68 16 
mec1 
sml1 
KHSY895 471 209–859 135 
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Table A.2 (continued) 	
mec1 
sml1 
mph1 
KHSY1894 290 154–467 83 
apn1 KHSY1957 19 14–41 5 
apn1 
mph1 
KHSY1970 15 <15–51 4 
rad52 KHSY1258 435 317–520 124 
rad52 
mph1 
KHSY1598 275 131–467 79 
sgs1 KHSY1630 220 144–276 64 
sgs1 
mph1 
KHSY1600 239 162–528 68 
chl1 KHSY1561 14 <14–94 4 
chl1 
mph1 
KHSY1725 40 <10–202 11 
rrm3 KHSY1399 14d 5–28 4 
rrm3 
mph1 
KHSY1713 21 <17–48 6 
  a 5-FOA, 5-fluoroorotic acid.  
  b Ninety-five percent confidence intervals (CIs) were calculated according to the 
method of Nair (Nair 1940), with nonoverlapping confidence intervals indicating 
statistically significant differences (α < 0.05) between median GCR rates.  
  c GCR rate from reference (Chen, Umezu et al. 1998).  
 d GCR rate from reference (Schmidt and Kolodner 2006). 
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ABSTRACT 
 Rmi1 is a member of the Sgs1/Top3/Rmi1 (STR) complex of Saccharomyces 
cerevisiae and has been implicated in binding and catalytic enhancement of Top3 in the 
dissolution of double Holliday junctions. Deletion of RMI1 results in a severe growth 
defect resembling that of top3Δ. Despite the importance of Rmi1 for cell viability, little is 
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known about its functional domains, particularly in Rmi1 of S. cerevisiae, which does not 
have a resolved crystal structure and the primary sequence is poorly conserved. Here, 
we rationally designed point mutations based on bioinformatics analysis of 
order/disorder and helical propensity to define three functionally important motifs in 
yeast Rmi1 outside of the proposed OB-fold core. Replacing residues F63, Y218 and 
E220 with proline, designed to break predicted N-terminal and C-terminal α-helices, or 
with lysine, designed to eliminate hydrophobic residues at positions 63 and 218, while 
maintaining α-helical structure, caused hypersensitivity to hydroxyurea. Further, Y218P 
and E220P mutations, but not F63P and F63K mutations, led to reduced Rmi1 levels 
compared to wild type Rmi1, suggesting a role of the C-terminal α-helix in Rmi1 
stabilization, most likely by protecting the integrity of the OB-fold core. Our 
bioinformatics analysis also suggests the presence of a disordered linker between the 
N-terminal α-helix and the OB fold core; a P88A mutation, designed to increase helicity 
in this linker, also impaired Rmi1 function in vivo. In conclusion, we propose a model 
that maps all functionally important structural features for yeast Rmi1 based on 
biological findings in yeast and structure-prediction-based alignment with the recently 
established crystal structure of the N-terminus of human Rmi1. 
 
INTRODUCTION 
The RecQ-like DNA helicase family is evolutionarily conserved and necessary for 
genomic stability from bacteria to humans. In yeast the RecQ-like Sgs1 helicase forms a 
complex with the topoisomerase Top3 and the recQ-mediated genome instability 1 
protein Rmi1 (STR) and facilitates both early and late steps of DNA double-strand break 
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(DSB) repair (Chang, Bellaoui et al. 2005, Mullen, Nallaseth et al. 2005, Chu and 
Hickson 2009). Early in the repair of a two-ended DSB, STR contributes to DSB end 
resection to facilitate the formation of a single-strand 3’ overhang on which the 
homologous recombination (HR) factor Rad51 filament assembles (Bennett, Keck et al. 
1999, Mimitou and Symington 2008, Zhu, Chung et al. 2008, Daley, Chiba et al. 2014). 
This Rad51 filament is then able to initiate a genome-wide search for sequence 
homology, eventually leading to the formation of double Holliday Junctions (dHJs) that 
need to be resolved prior to cell division. Resolution can be achieved by the HJ-specific 
endonuclease Yen1, randomly leading to crossover and noncrossover products, or 
dHJs can be dissolved by STR in a process involving dHJ migration and decatenation of 
the single strands, yielding exclusively noncrossover products (Mitchel, Lehner et al. 
2013). STR has also been implicated in the unwinding of strand invasion after extension 
of the invading 3’end by DNA synthesis to promote DSB repair by synthesis-dependent 
strand annealing, as well as reversal of strand invasion prior to 3’end extension 
(Fasching, Cejka et al. 2015). Through these functions, STR promotes noncrossover 
outcomes of HR and regulates HR levels. Hence, yeast cells that lack the helicase 
activity of the STR complex (sgs1Δ) are prone to hyper-recombination, accumulate 
gross chromosomal rearrangements, and are hypersensitive to DNA-damaging agents, 
with cells lacking Top3 or Rmi1 additionally exhibiting a severe growth defect not seen 
in cells lacking Sgs1 (Gangloff, McDonald et al. 1994, Myung, Datta et al. 2001, Chang, 
Bellaoui et al. 2005, Mullen, Nallaseth et al. 2005). Similarly, in mice inactivation of 
RMI1 or Topo IIIα leads to embryonic lethality earlier (no blastocysts) than inactivation 
of BLM (day 13.5), the human RecQ-like helicase most closely related Sgs1 (Chen, You 
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et al. 2011). 
Despite the growth defect of the rmi1Δ mutant, the contribution of Rmi1 to the 
function of the STR complex and the regions of Rmi1 that are critical for these functional 
contributions are still poorly understood. Rmi1, was first discovered in S. cerevisiae in a 
screen for components of the Sgs1/Top3 pathway (Mullen, Nallaseth et al. 2005). Yeast 
cells lacking Rmi1 are hypersensitive to hydroxyurea (HU) and several other genotoxic 
agents, have an increased rate of spontaneous DNA damage as indicated by an 
increase in Rad52 foci, an increase in chromosomal rearrangements, and deficiency in 
activation of the DNA-damage checkpoint kinase Rad53 (Chang, Bellaoui et al. 2005, 
Mullen, Nallaseth et al. 2005). Diploids lacking Rmi1 are defective in meiosis, and 
deletion of genes with roles in the checkpoint response to replication stress, such as 
Mrc1, Tof1, Csm3, cause synthetic lethality, implying a diverse role for Rmi1 in several 
chromatin processes (Chang, Bellaoui et al. 2005, Mullen, Nallaseth et al. 2005). 
Despite the severity of rmi1Δ phenotypes, Rmi1 has no known catalytic function. It has 
been shown to stimulate the final decatenation step of dHJ dissolution by Sgs1/Top3, 
while inhibiting the relaxation activity of the topoisomerase on negatively supercoiled 
DNA, possibly by affecting the conformation of the topoisomerase gate (Chen and Brill 
2007, Cejka, Plank et al. 2010, Yang, O'Donnell et al. 2012). This function is conserved 
in the BLM/Topo IIIα/Rmi1/Rmi2 (BTR) complex, the human variant of STR, and studies 
in human cell lines also imply a role for Rmi1 in Topo IIIα stability (Wu, Bachrati et al. 
2006, Yang, O'Donnell et al. 2012, Guiraldelli, Eyster et al. 2013). 
The N-terminal 219 residues of the 625-residue long human Rmi1 have been 
crystallized, providing some clues to its role in catalytic enhancement and stability of the 
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BTR complex (Wang, Yang et al. 2010, Bocquet, Bizard et al. 2014). The N-terminus of 
human Rmi1 is most closely related to S. cerevisiae Rmi1, is capable of binding BLM 
and Topo IIIα, and contains an oligonucleotide-binding (OB) fold that is similar in 
structure to that of the replication protein A subunit RPA70, though it is suggested that it 
is incapable of binding DNA like RPA (Raynard, Bussen et al. 2006, Wang, Yang et al. 
2010). Human Rmi1 contains a disordered loop needed for dHJ dissolution 
enhancement of Topo IIIα (Bocquet, Bizard et al. 2014). Co-crystallization of the Rmi1 
N-terminal lobe peptide with Topo IIIα reveals that the OB-fold of Rmi1 lies opposite of 
the ssDNA-binding domain of Topo IIIα, and a mostly disordered loop that protrudes 
from the OB fold of Rmi1 physically interacts with the topoisomerase by inserting itself 
into the central topoisomerase gate (Ira, Malkova et al. 2003). It has been hypothesized 
that this loop may be what facilitates the catalytic enhancement of Topo IIIα by 
regulating opening and closing of the gate (Wang, Yang et al. 2010, Bocquet, Bizard et 
al. 2014). 
Because of the severe growth retardation, low viability and rapid accumulation of 
suppressor mutations, the identification and functional analysis of deleterious rmi1 
mutations through genetic screens has proved difficult; one rmi1 mutant, the 
temperature-sensitive E69K, was identified through this conventional approach (Ashton, 
Mankouri et al. 2011). In an effort to better understand the molecular basis of Rmi1 
function, we have combined structure prediction tools with an in vivo mutational analysis 
of RMI1 function in yeast. This approach has identified structural motifs that are 
essential for Rmi1 function and stability and we propose hypotheses for how these 
motifs contribute to Rmi1’s role in maintaining the functional integrity of the STR 
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complex. As an alternative to primary sequence alignments, which have been only 
minimally informative because of the poor sequence conservation among Rmi1 
homologues, we present a structure-based alignment between yeast and human Rmi1 
that maps the location of conserved motifs and suggests differences in the size and 
structure of the DUF1767 domain. 
 
MATERIALS AND METHODS 
Bioinformatics analysis 
The 241 residues of S. cerevisiae Rmi1 and the N-terminal 240 residues of the 
625-residue human Rmi1 were analyzed with algorithms for helical propensity (Munoz 
and Serrano 1995, Munoz and Serrano 1997), structural disorder using a combination 
of three predictors in VL-XT (Li, Romero et al. 1999, Romero, Obradovic et al. 2001), 
and amino acid sequence alignments based on phylogenetic analysis in PhylomeDB v4 
(Huerta-Cepas, Capella-Gutierrez et al. 2014). 
 
Plasmids 
The open reading frame of RMI1 plus 500 bp up- and downstream was amplified 
by PCR from the endogenous RMI1 locus of KHSY1338 (ura3-52, leu2Δ1, trp1Δ63, 
his3Δ200, lys2-Bgl, hom3-10, ade2Δ1, ade8, sgs1::HIS3, YEL069C::URA3,). The 
fragment was inserted into XbaI-digested pRS415 by gap-repair cloning using the non-
homologous-endjoining deficient yeast strain KHSY2331 (ura3-52, leu2Δ1, trp1Δ63, 
his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3, lig4::loxP-G418-loxP) 
and standard lithium-acetate transformation (Gietz and Woods 2006). The integrity of 
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RMI1 and the promoter region in the resulting plasmid pKHS621 was verified by 
sequencing. Point mutations were introduced into the RMI1 ORF in pKHS621 by 
QuikChange site-directed mutagenesis (Agilent Technologies). To construct pKHS621 
derivatives that express myc-epitope-tagged Rmi1 and rmi1 mutant proteins, pKHS621 
was linearized with BoxI and the HIS3-linked myc-epitope-coding sequence from 
pFA6a-13MYC-HIS3MX6 (Longtine, McKenzie et al. 1998) was inserted by gap-repair 
cloning. Point mutations were introduced into the resulting plasmid (pKHS630, S1 Table 
Plasmids used in this study) using the QuikChange protocol (Agilent Technologies). 
 
Hydroxyurea hypersensitivity assay 
Derivatives of pKHS621 were transformed into KHSY4695 (MATα, ura3Δ0, 
leu2Δ0, his3Δ1, lys2Δ0, rmi1::HIS3, TOP3.V5.VSV.KANMX6), grown to OD600 = 0.5 in 
synthetic complete media lacking leucine (SC-Leu), and spotted in 10-fold dilutions on 
yeast extract/peptone/dextrose (YPD) and on YPD supplemented with 150 mM 
hydroxyurea. Growth was documented after 3 to 5 days of incubation at 30°C. 
 
Viability assay 
Yeast strain KHSY4695 (rmi1Δ) was transformed with plasmids pKHS621, 
pKHS624, and pKHS626. Independent cultures were set up from 9 to 12 transformants 
for each plasmid and grown to approximately 2 x 107 cells/ml. Actual cell counts were 
determined using a hemocytometer and cultures were diluted to plate ~ 400 cells. 
Plates were incubated for 3 days at 30°C and colonies counted. Viability was calculated 
by dividing the number of colony forming units by the number of cells plated based on 
259
the hemocytometer count. 
 
Protein extraction and western blotting 
A BY4741 derivative (MATa, ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0, RAD51-V5-
6xHIS.KANMX6) from the Yeast Cross and Capture Collection (GE Dharmacon) was 
transformed with pKHS630 or its derivatives (S1 Table Plasmids used in this study) 
expressing myc-tagged Rmi1 or rmi1 mutants and grown in synthetic complete media 
lacking histidine overnight. Cultures were then diluted to OD600 = 0.2 and grown to 
OD600 = 0.4. Cultures were synchronized in G1 phase with 2 µg/ml of α-factor for one 
hour, followed by addition of 1 µg/ml of α-factor for a second hour. Cells were released 
for 30 min and cells equivalent to 2 ODs were harvested and washed twice in distilled 
water. Whole cell extract was prepared with 20% trichloroacetic acid as previously 
described (Kennedy, Daughdrill et al. 2013), separated by SDS-PAGE, and myc-tagged 
Rmi1 and rmi1 mutants detected by Western blotting on PVDF and hybridization with c-
myc (9E10) monoclonal antibody (Covance). 
 
RESULTS 
Computational analysis of yeast Rmi1 structure 
Determining functionally important residues in S. cerevisiae Rmi1 has been 
challenging as it lacks catalytic activity and a crystal structure has not been resolved. 
The primary sequence is only minimally conserved (~35% identical residues between 
yeast genera, 18% between S. cerevisiae and human Rmi1) and lengths range from 
241 residues in S. cerevisiae to 625 residues in humans. The crystal structure of the N-
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terminal 219 residues of human Rmi1 was recently resolved (Wang, Yang et al. 2010). 
It revealed an N-terminal three-helix bundle of unknown function (DUF1767) followed by 
an OB-fold with a largely unstructured loop inserted between strands β1 and β2 by 
which Rmi1 binds to Topo IIIα. In the absence of catalytic activity/domains and very 
limited sequence identity, we reasoned that structure prediction tools (Munoz and 
Serrano 1997, Lacroix, Viguera et al. 1998, Peng, Vucetic et al. 2005) could reveal 
functionally important motifs in yeast Rmi1. Analyzing the distribution of ordered and 
disordered residues, we noticed disordered N- and C-termini as well as two internal 
regions of increased disorder (Fig 1A). Further, we identified two regions of increased 
helical propensity, spanning residues 58–74 and residues 212–228 near the N- and C-
terminal disordered regions, as well as two regions of lesser helical propensity between 
residues 125–132 and 137–145 (Fig 1B). Alignment of these two predictors would be 
consistent with the putative OB-fold core mapping to the central, ordered region, and 
the topoisomerase-binding loop to the disordered insertion with two segments of weak 
helical propensity. The DUF1767 domain, predicted to be present in Rmi1 of all species, 
is typically located N-terminally of the OB-fold core, and appears to be connected to it in 
yeast Rmi1 by a disordered linker (Fig 1A). 
 
Mutational analysis of predicted structural elements of yeast Rmi1 
We had previously determined that disruption of an α-helix was most effective 
when a residue with high helical propensity near the peak or in the N-terminal half of the 
helix was replaced with the helix breaker proline (Kennedy, Daughdrill et al. 2013). 
Therefore, to determine the importance of the four regions of increased helicity for Rmi1 
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function, we constructed F63P, A128P, A139P and E220P mutations. The proline 
substitutions led to marked decreases in predicted helical propensity in these regions 
(Fig 1C–1F). We also noticed that the proline at position 88 seemed to disrupt what 
might otherwise be a region with high helical propensity, and hypothesized that this 
native break was helping to maintain a degree of flexibility in what would otherwise be a 
persistent, structured region. We considered that replacing P88 with a residue with high 
helical propensity that was otherwise benign, such as alanine, would restore helicity to 
this region. Indeed, the P88A mutation is predicted to lead to an extraordinary increase 
in helical propensity not seen in any region of the wildtype forms of yeast or human 
Rmi1 (Fig 1G). We exploited the HU hypersensitivity of yeast cells lacking Rmi1 
(Chang, Bellaoui et al. 2005) to assess the functional impact of these proline 
substitutions in vivo. We found that rmi1Δ cells expressing rmi1-A128P and rmi1-A139P 
exhibited the same HU sensitivity as the rmi1Δ mutant complemented with wildtype 
RMI1, whereas the rmi1-P88A allele was only able to partially suppress the HU 
hypersensitivity of rmi1Δ (Fig 1H). This mild, 5- to 10-fold, increase in HU sensitivity of 
the rmi1-P88A mutant compared to wildtype or the rmi1-A128P mutant was not due to 
decreased viability of the rmi1-P88A mutant as the viability of all three strains was 
similar (33–36%). 
The rmi1-F63P allele caused the same degree of HU hypersensitivity as a 
deletion of RMI1, indicating that it was a null allele (Fig 1H). We also considered the 
possibility that the phenotype of the F63P mutation could be due to the loss of a strong 
hydrophobic interaction via the aromatic residue. Thus, we chose to replace F63 with a 
hydrophilic residue with high helical propensity, such as lysine, that would be predicted 
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to maintain the structural integrity of the motif, but change its chemical properties. We 
found that the F63K mutation caused the same hypersensitivity to HU as the F63P 
mutation (Fig 1H), implicating that this residue maps to an α-helical structure that must 
conserve both its shape and hydrophobic character in order to maintain wildtype 
function of Rmi1. Similar to F63, proline substitution of E220 in the predicted C-terminal 
helix abolished Rmi1 function in vivo (Fig 1F and 1H). 
The function of the putative helices defined by F63 and E220 may arise from 
stabilizing the putative OB-fold core of Rmi1 as seen in other proteins containing this 
fold type (Theobald, Mitton-Fry et al. 2003) or by otherwise contributing to Rmi1 
stability. To test this possibility, we inserted a myc-epitope-coding sequence at the 3’ 
end of RMI1 in pRS415 and introduced the deleterious F63P, F63K and E220P 
mutations, as well as the benign A128P mutation as a control. Equal numbers of cells 
were harvested from synchronized cultures for protein extraction and Western blotting, 
which revealed that mutations in the C-terminal helix, but neither in the N-terminal helix 
nor the helical elements in the insertion loop led to reduced Rmi1 levels (Fig 2). 
 
Structure predictions and in vivo mutagenesis suggest differences in the 
N-termini of yeast and human Rmi1 
Structural prediction analysis indicated a single α-helical region in the N-terminus 
of yeast Rmi1, centered on F63 (Fig 3A). When we extended this analysis to the N-
terminus of human Rmi1, we identified three segments of increased helical propensity 
(Fig 3B), which form a three-helix bundle in the crystal structure (Wang, Yang et al. 
2010, Bocquet, Bizard et al. 2014). The lack of helical propensity in the first 57 residues 
263
of yeast Rmi1 suggests that this region may not adopt helical structures in the apo form 
as human Rmi1 does. To identify conserved residues and regions of conserved 
chemical character that could be indicative of a functional role, we analyzed primary 
sequence alignments of Rmi1. We found that S.c. Rmi1 is ~85% identical to Rmi1 of 
other Saccharomyces species, but identity markedly decreased to ~30% when 
compared to yeast species outside of the genus (e.g., K. lactis, C. glabrata), and to 
~18% when compared to the N-terminal 241 residues of human Rmi1. Because of the 
low level of sequence identity between human and yeast Rmi1 we decided to analyze 
the alignment of the N-termini of twelve closely related Rmi1 sequences from fully 
sequenced Saccharomyces and non-Saccharomyces yeast species in PhylomeDB v4 
(Huerta-Cepas, Capella-Gutierrez et al. 2014). We noticed two discrete regions (Fig 3C, 
residues S2-I15 and R27-L41 of S.c. Rmi1) that contain hydrophobic residues in the 
i,i+4 pattern typical of an α-helix and are separated from each other by residues with the 
lowest helical propensity, proline and glycine. To test the possibility that these two 
regions could become helical upon binding to another protein, possibly Sgs1, or could 
be analogous to α1 and α2 in human Rmi1, we replaced L7 and Y35 with proline (Fig 
3C). Expression of either mutant, however, was sufficient to fully restore wildtype growth 
to the rmi1Δ mutant on HU (Fig 3D), suggesting either that, unlike in human Rmi1, this 
region in yeast Rmi1 does not adopt α-helical structures or that any helical structure or 
binding-induced folding in this region is not required for Rmi1’s role in tolerating HU-
induced DNA-damage. Based on comparisons of helical propensity and primary 
sequences of yeast Rmi1 and the N-terminus of human Rmi1 (Fig 3A–3C), we propose 
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structural equivalence between the sole predicted α-helix in yeast and α3 in human 
Rmi1, with a potential equivalent of F63 at residue F53 in human Rmi1. 
 
A conserved alpha helix in the C-terminus contributes to yeast Rmi1 
stability 
When we extended the analysis of sequence alignments to the C-terminus of 
Rmi1 it revealed that the chemical characteristics of the predicted α-helical region 
centered on residue E220 were conserved, with a short stretch of hydrophobic residues 
surrounded by charged residues (Fig 4C). Whereas neither E220 nor the acidic or 
hydrophilic character of the residue was conserved outside of the Saccharomyces 
genus, the hydrophobic residues were, including a tyrosine at position 218. We 
hypothesized that this residue was not only part of the functional α-helical structure we 
had inferred from the E220P mutant, but was also a key residue for binding in an 
otherwise fairly charged α-helix. Indeed, we found that either breaking the helix (rmi1-
Y218P) or increasing its hydrophilicity (rmi1-Y218K) abolished Rmi1 function (Fig 4D). 
Although yeast and human Rmi1 are only 18% identical, we found that they share 
regions of similar helical propensity, including the region that surrounds Y218 in yeast 
and Y201 in an amphipathic α-helix in human Rmi1 (Fig 4A–4C). Similar to the 
disruption of the C-terminal helix by the E220P mutation, the Y218P mutation led to 
reduced Rmi1 levels (Fig 2). 
Taken together, the bioinformatics analysis and corresponding mutagenesis of 
Rmi1 in vivo indicates the presence of two functionally critical N-terminal and C-terminal 
α-helices, with the latter contributing to Rmi1 stability. It further indicates a disordered 
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linker, defined by the P88A mutation, that appears to connect the N-terminal α-helix to 
the putative OB-fold core. The function of a disordered loop in the OB fold whose 
equivalent in human Rmi1 binds Topo IIIα, was not disrupted by mutagenesis of two 
predicted, albeit very weak, helical motifs. 
 
DISCUSSION 
In this study, we have combined three bioinformatics tools—order/disorder 
prediction, helical propensity and phylomes (Munoz and Serrano 1994, Munoz and 
Serrano 1997, Lacroix, Viguera et al. 1998, Li, Romero et al. 1999, Peng, Vucetic et al. 
2005, Huerta-Cepas, Capella-Gutierrez et al. 2014)–with in vivo mutagenesis to 
elucidate structure/function relationships in yeast Rmi1. We focused on the regions that 
surround a putative OB-fold core previously identified in human Rmi1 that is involved in 
binding BLM and Topo IIIα (Munoz and Serrano 1997, Ira, Malkova et al. 2003). The 
regions surrounding the central OB-fold core are predicted to contain two short regions 
of increased helical propensity (residues 58–74, 212–228) and a highly disordered 
linker (residues 82–97) connecting the N-terminal helix to the OB-fold core. We 
determined that the structural and chemical integrity of the N-terminal α-helix defined by 
F63P/K, and the C-terminal α-helix defined by E220P and Y218P/K, are critical for Rmi1 
function in vivo, and that the disorder of the linker, defined by P88A, contributes to 
normal Rmi1 function. 
Performing the same structural prediction analysis for human Rmi1 suggests that 
the two N- and C-terminal α-helices and the spacing between them, where the core of 
an OB-fold has been confirmed in human Rmi1, are conserved (Fig 5). In human Rmi1, 
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a loop that maps to residues 98–134 emerges from the OB-fold between strands β1 and 
β2 and inserts itself into the Topo IIIα gate; its deletion eliminates complex formation of 
Rmi1 with BLM and Topo IIIα (Wang, Yang et al. 2010). Based on a sequence 
alignment Bocquet and colleagues (Bocquet, Bizard et al. 2014) suggested that the 
equivalent loop for Top3 binding in yeast Rmi1 maps to residues 87–146 and showed 
that replacement of this region with a scrambled version of equal chemistry still 
mediated binding to Sgs1 and Top3, but failed to stimulate Top3 catalytic activity and 
dHJ dissolution. The structural alignment in our study, however, which we explored 
because of the poor sequence conservation of only 18% between yeast and human 
Rmi1, suggests that residues 87–116 of yeast Rmi1 contain the β1 strand of the OB-fold 
and the disordered linker that connects β1 to the N-terminal helical region (Fig 5). The 
insertion loop in yeast Rmi1, therefore, may be significantly shorter, mapping to 
residues 116–145. As in human Rmi1, this insertion loop contains two segments of 
increased helical propensity (Figs 1B and 6E), but proline mutagenesis of these 
segments (A128P, A139P) suggests that the adoption of helical structure is not required 
for Rmi1’s function. Since both regions adopt short helices, if any, and the prolines 
replaced alanines that are likely to be in the first turn, it is also possible that proline 
substitution is not structurally disruptive in this disordered loop. 
The N-terminal region flanking the OB-fold in the crystal structure of human Rmi1 
forms a three-helix bundle that has been designated a DUF1767 domain (Ira, Malkova 
et al. 2003). The three α-helices are also indicated in our structural analysis, whereas 
the corresponding region in yeast Rmi1 contains only one predicted α-helix (residues 
58–74). Our structural alignment (Fig 5) suggests that it corresponds to α3 of human 
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Rmi1 (Fig 6C); this is also supported by our manual alignment of the N-terminus of 
human Rmi1 with the N-terminal sequences of the yeast Rmi1 phylome (Fig 3C). How 
this α-helix contributes to yeast Rmi1 function is unclear. Genetic analysis of Rmi1 from 
Arabidopsis thaliana showed that the OB-fold core and the N-terminal helical region 
DUF1767 can function independently of each other (Bonnet, Knoll et al. 2013). In 
human Rmi1, the three-helix bundle in the corresponding DUF1767 region makes 
contacts with the top region of the OB-fold core and was shown to be indispensable for 
its folding and solubility (Ira, Malkova et al. 2003). The F63P mutation, which we 
designed to disrupt the N-terminal α-helix in yeast Rmi1, caused a null phenotype; 
however, it had no noticeable effect on Rmi1 levels in the cell. This is in contrast to the 
C-terminal α-helix whose amphipathic properties and importance for Rmi1 stability 
strongly suggest that it protects the OB-fold core. Instead, the N-terminal α-helix—and 
the region N-terminal of the OB-fold in general—could also mediate association with 
another protein, possibly Sgs1, whose binding site on Top3/Rmi1 is unknown. This type 
of small binding motif paired with disorder has been seen in other proteins, including 
yeast Adr1, which contains two small zinc finger motifs in a disordered domain (Hyre 
and Klevit 1998); interestingly, the disordered components of this domain undergo 
extensive folding when contact is made between the zinc fingers and DNA. The 
structural alignment between yeast and human Rmi1 put forth in this study also 
suggests that the N-terminus of yeast Rmi1 is extended by approximately 18 residues. 
Since residues 1–16 are arranged in the typical i,i+4 pattern of an α-helix (residues F3, 
L7, I11, I15) and the yeast phylome indicates two regions of similarity in the N-terminal 
57 residues, we tested if binding-induced helix formation could also be a function of the 
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extended unstructured N-terminus of yeast Rmi1, but found that introducing proline 
residues where prospective helices might form (L7, Y35), did not impair Rmi1 function. 
This limited analysis, however, cannot exclude the possibility that shorter helices fully 
capable of supporting Rmi1 function in vivo can still be induced with the L7P and Y35P 
mutations present. 
In contrast to the N-terminal α-helix, our findings suggest that the C-terminal α-
helix defined by the Y218P/K and E220P mutations plays a major role in stabilizing 
Rmi1 as seen in other proteins containing an OB-fold (Theobald, Mitton-Fry et al. 2003). 
Our structural prediction suggests that the C-terminal α-helix extends from residues 212 
to 228 and is equivalent to the α-helix between residues 194–211 in human Rmi1, with 
Y201 corresponding to Y218 in yeast Rmi1 (Figs 4A–4C and 5). In contrast to mutations 
that disrupt the N-terminal helix, the Y218P and E220P mutations cause substantially 
reduced Rmi1 levels, which is the most likely cause of their null phenotype. Indeed, in 
the crystal structure of human Rmi1 the hydrophobic face of the corresponding 
amphipathic α-helix packs against the bottom of the OB-fold core, which is likely to 
stabilize it by shielding it from the solvent (Fig 6D) (Bocquet, Bizard et al. 2014). Binding 
of human Rmi1 to Rmi2 involves extensive interactions between the α-helices C-
terminal of the second OB-fold of Rmi1 and the OB-fold of Rmi2 (Ira, Malkova et al. 
2003, Hoadley, Xu et al. 2010); however, a similar function in mediating interaction with 
another protein has not been identified for the α-helix C-terminal of the N-terminal OB-
folds of human or yeast Rmi1. 
Finally, our bioinformatics analysis suggests a disordered loop in yeast Rmi1 
linking the OB-fold core to an N-terminal α-helix. The structural disorder in this linker 
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appears to depend largely on a single proline, whereas multiple prolines are present in 
human Rmi1, suggesting a more flexible linkage of the three-helix bundle to the OB-fold 
core (Fig 6F). A mutation predicted to increase helicity of this flexible linker partially 
impaired Rmi1 function. This mutant grows normally, but exhibits increased DNA-
damage sensitivity, most likely by reducing the overall conformational elasticity of Rmi1. 
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FIGURES 
 
Figure B.1. Structure-prediction-guided mutagenesis of S.c. Rmi1. 
A, prediction of order/disorder in Rmi1 by the VLXT algorithm (Li, Romero et al. 1999, 
Romero, Obradovic et al. 2001). A score of 1 denotes an ideal prediction of disorder 
and a score of 0 an ideal prediction of order with the order/disorder threshold at a score 
of 0.5. A domain of unknown function (DUF1767), and an OB-fold with an insertion loop 
are conserved in all Rmi1 species (Xu, Guo et al. 2008). The position of DUF1767, the 
OB-fold, the insertion loop and a predicted flexible linker between DUF1767 and the 
OB-fold shown above the disorder plot are based on the VLXT order/disorder prediction. 
α-helices (cylinders) and β-strands (arrows) in this region of human Rmi1 are indicated 
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below the domain map. B, prediction of four regions of increased helical in Rmi1 with 
residues F63, A128,A139, E220 having some of the highest helical propensity in the 
DUF1767 domain, the insertion loop, and the C-terminus, respectively. We predict that 
P88 is responsible for the sudden loss in helical propensity in the linker that connects N-
terminal domain and the OB-fold. C–G, substitution of F63, A128, A139 and E220 with 
proline, which has the lowest helical propensity of all amino acids, is predicted to disrupt 
the increased helical propensity in these regions, whereas substitution of P88 with 
alanine, which has excellent helical propensity, is predicted to lead to a strong increase 
in continuous helical propensity of the linker. H, plasmid pRS415 expressing RMI1 and 
rmi1 mutants under control of the endogenous RMI1 promoter were transformed into 
Δrmi1 mutant KHSY4695 and tested for the ability to suppress the hypersensitivity of 
the rmi1Δ strain to hydroxyurea. 
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 Figure B.2. Effect on expression levels of mutations designed to disrupt 
structural motifs of yeast Rmi1. 
Mutants of Rmi1 with point mutations that disrupt the function of the putative N-terminal 
α-helix (F63P, F63K) are expressed at similar levels as wildtype Rmi1 and the benign 
rmi1-A128P mutant, whereas mutations that disrupt the function of the putative C-
terminal α-helix (Y218P, E220P) are expressed at reduced levels. Whole cells extracts 
from equal numbers of cells from synchronized cultures expressing myc-epitope-tagged 
Rmi1 or rmi1 mutants were analyzed by Western blotting. Expression levels of two 
independently constructed plasmids expressing rmi1-Y218P are shown. 
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 Figure B.3. Structural prediction and in vivo functional analysis suggest 
differences between the N-termini of yeast and human Rmi1. 
A and B, one segment of increased helical propensity (residues 58–74) is predicted for 
the N-terminus of yeast Rmi1, whereas three such segments (residues 5–18, 23–32, 
44–55) are predicted for human Rmi1, corresponding to the three-helix bundle 
confirmed in the Rmi1 crystal structure [4CGY (Bocquet, Bizard et al. 2014)]. The 
estimated equivalent to yeast F63, F53 in α3 of human Rmi1, is indicated. C, alignment 
of Rmi1 N-termini from twelve yeast species in PhylomeDB (Huerta-Cepas, Capella-
Gutierrez et al. 2014) suggests two segments of conserved residue chemistry between 
residues 2–15 and residues 27–41 (indicated below the alignment by light red 
rectangles), in addition to the highly conserved segment predicted to have high helical 
propensity (indicated by a red rectangle). The N-terminus of human Rmi1 was aligned 
to S.c. Rmi1 by ClustalW and manually adjusted. The three segments of increased 
helical propensity predicted in the DUF1767 region of human Rmi1 are shown as light 
blue rectangles (residues 5–18, 23–32, 44–55) and dark blue rectangles (residues 3–
19, 23–38, 44–58) indicate the confirmed location of α-helices that make up the three-
helix bundle in the DUF1767 domain in the crystal structure of the N-terminus of Rmi1 
with Topo IIIα (4CGY) (Bocquet, Bizard et al. 2014). D, substitution of L7 and Y35 with 
proline, aimed at preventing the two segments from adopting α-helical structure induced 
by intra- or intermolecular binding events, does not impair Rmi1 function in vivo. 
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Figure B.4. Mutational analysis of the C-terminal region of increased helical 
propensity. 
A and B, Yeast Rmi1 and human Rmi1-N, the N-terminal 240-residue region of human 
Rmi1 that is most similar to yeast Rmi1, have comparable predicted structure in the far 
C-terminus. Y218 is in the same predicted helix as E220 and has a potential equivalent 
in Y201 in human Rmi1. C, PhylomeDB alignment of Rmi1 C-termini from different 
yeast species reveals a highly conserved tyrosine at position 218. The corresponding 
region of human Rmi1 (residues 178–231) was manually aligned to the yeast Rmi1 
phylome. The position of the predicted α-helix in yeast Rmi1 is indicated by a red 
rectangle below the alignment. The corresponding α-helix defined by Y201 in the crystal 
structure of human Rmi1 (PDB: 4CGY) is indicated by a blue rectangle. D, like rmi1-
E220P, rmi1-Y218P and rmi1-Y218K mutants fail to complement the hydroxyurea 
hypersensitivity of an Δrmi1 mutant. 
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Figure B.5. Proposed structure-prediction-based alignment of yeast and human 
Rmi1. 
Residues to which confirmed domains in the human Rmi1 crystal structure (4CGY) map 
are indicated above the alignment in black. Proposed location of conserved domains 
and motifs in yeast Rmi1 are indicated in red. Conserved residues whose mutation to 
proline abolished Rmi1 function in vivo are indicated in the alignment with the proposed 
corresponding residue in human Rmi1 (F63/F53; Y281/Y201). Compared to human 
Rmi1, the N-terminus (DUF1767) of yeast Rmi1 appears to be extended by 
approximately 18 residues. The predicted size and location of the topoisomerase-
binding loop (residues 116–145) differs from that previously proposed (residues 87–
145) for yeast Rmi1 (Bocquet, Bizard et al. 2014). 
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Figure B.6. Conserved domains, and putative differences between yeast Rmi1 and 
the N-terminus of human Rmi1. 
A, functional importance of seven structural motifs predicted in yeast Rmi1 was tested 
by analyzing point mutations in vivo. Mutation of putative motifs highlighted in light 
yellow did not impair Rmi1 function in vivo, including L7P and Y35P mutations in the 
putative DUF1767 domain, and A128P and A139P in the topoisomerase-binding loop. 
Mutations in motifs highlighted in dark yellow impaired Rmi1 function in vivo; F63P and 
F63K mutations in an N-terminal α-helix (H), Y218P, Y218K, and E220P mutations in a 
C-terminal α-helix (H) caused null phenotypes, and the P88A mutation in the flexible 
linker (fL) between the DUF1767 domain and the OB-fold caused intermediate 
functional impairment. B, he crystal structure of the N-terminus of human Rmi1 bound to 
Topo IIIα (4CGY (Bocquet, Bizard et al. 2014)) was rendered in PyMol. The DUF1767 
domain, the OB-fold core and the insertion loop extending between strands β1 and β2 
are shown in grey, blue, and red, respectively. A part of the disordered insertion loop 
missing from the crystal structure is indicated by a red dashed line. Topo IIIα is shown in 
green. C, the domain structure of Rmi1 is shown as in (B) with α3, corresponding to the 
functionally important, putative α-helix in yeast Rmi1, highlighted in yellow. Residue F53 
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of human Rmi1 and the corresponding F63P null mutation in yeast Rmi1 (in brackets) 
are indicated. D, the C-terminal α-helix interacting with the bottom of the OB-fold core is 
shown in yellow. Y201 and the corresponding Y218P null mutation in yeast Rmi1 (in 
parentheses) are indicated. Disruption of this α-helix leads to lower Rmi1 expression 
levels and total loss of Rmi1 function (Fig 3E). E, human Rmi1 contains two helical 
segments in the insertion loop, shown in yellow. A128P and A139P mutations were 
designed to disrupt helical propensity in the corresponding insertion loop in yeast Rmi1, 
but did not interrupt Rmi1 function. F, a flexible linker connects the DUF1767 domain to 
the OB-fold in human Rmi1, indicated in yellow. A single proline at position 88 is 
predicted to disrupt the strong helical propensity of this linker in yeast Rmi1 whereas 
this linker is more proline-rich in human Rmi1. The location of P70 in human Rmi1, 
corresponding to P88 in yeast Rmi1, is indicated. 
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SUPPORTING INFORMATION 
Table B.S1. Plasmids used in this study 
 
Plasmid Description 
pKHS621 pRS415-RMI1  
pKHS622 pRS415-rmi1-F63P  
pKHS635 pRS415-rmi1-F63K  
pKHS623 pRS415-rmi1-E220P  
pKHS624 pRS415-rmi1-A128P  
pKHS625 pRS415-rmi1-A139P  
pKHS626 pRS415-rmi1-P88A  
pKHS627 pRS415-rmi1-Y218P  
pKHS634 pRS415-rmi1-Y218K  
pKHS628 pRS415-rmi1-L7P  
pKHS629 pRS415-rmi1-Y35P  
pKHS630 pRS415-RMI1-myc.HIS3MX6  
pKHS631 pRS415-rmi1-F63P-myc.HIS3MX6  
pKHS632 pRS415-rmi1-A128P-myc.HIS3MX6  
pKHS633 pRS415-rmi1-Y218P-myc.HIS3MX6  
pKHS642 pRS415-rmi1-F63K-myc.HIS3MX6  
pKHS643 pRS415-rmi1-E220P-myc.HIS3MX6  
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APPENDIX C:  
YEAST STRAINS 
 
 
Strains 
(KHSY) 
Genotype 
304 his3Δ200, trp1Δ63,ura3-52, rrm3::TRP1 
421 ura3-52, trp1Δ63, his3Δ200, leu2Δ1 
802 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3 
1062 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3,  rrm3::TRP1 
1063 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3,  rrm3::TRP1 
1064 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3,  rrm3::TRP1 
1338 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::HIS3 
1866 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1-hd.TRP1 
1867 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1-hd.TRP1 
1868 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1-hd.TRP1 
1869 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1.ΔC795.TRP1 
1870 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1ΔC795.TRP1 
1871 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1ΔC795.TRP1 
1875 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1ΔC200.TRP1 
1876 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1ΔC200.TRP1 
1877 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1ΔC200.TRP1 
1999 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
2000 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
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2001 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::sgs1-hd.myc.HIS 
2017 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::HIS3 
2018 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::HIS3 
2019 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1::HIS3 
2341 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3 
2342 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3 
2343 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3 
2344 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C200.myc.HIS3 
2345 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C200.myc.HIS3 
2346 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C200.myc.HIS3 
2347 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3 
2348 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3 
2349 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3 
2350 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, mec3::G418, sgs1C300.myc.HIS3 
2351 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C300.myc.HIS3 
2352 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C300.myc.HIS3 
2353 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C400.myc.HIS3, 
MEC3/mec3::G418 
2354 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C400.myc.HIS3, 
MEC3/mec3::G418 
2355 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C400.myc.HIS3, 
MEC3/mec3::G418 
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2356 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C500.myc.HIS3, 
MEC3/mec3::G418 
2357 
 
 
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200,  
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C500.myc.HIS3, 
MEC3/mec3::G418 
2358 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C500.myc.HIS3, 
MEC3/mec3::G418 
2383 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), SGS1.V5.6xHIS 
2385 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), RAD51.V5.VSV 
2473 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), SGS1/SGS1.V5.6xHIS, RAD51/RAD51.V5.3xVSV 
2474 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), SGS1/SGS1.V5.6xHIS, RAD51/RAD51.V5.3xVSV 
2475 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), SGS1/SGS1.V5.6xHIS, RAD51/RAD51.V5.3xVSV 
2494 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), RAD51.V5.6xHIS 
2495 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), TOP3.V5.6xHIS 
2496 (ura3Δ0, leu2Δ0, his3Δ1, met15Δ0), MLH1.V5.6xHIS 
2497 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), TOP3.V5.3xVSV.G418 
2498 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), SGS1.V5.3xVSV 
2499 (ura3Δ0, leu2Δ0, his3Δ1, lys2Δ0), MLH1.V5.3xVSV 
2529 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Rad51/Rad51.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2530 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Rad51/Rad51.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2531 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Rad51/Rad51.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2532 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Top3/Top3.V5.3xVSV 
2533 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Top3/Top3.V5.3xVSV 
2534 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Top3/Top3.V5.3xVSV 
2535 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Mlh1/Mlh1.V5.3xVSV 
2536 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Mlh1/Mlh1.V5.3xVSV 
2537 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Sgs1/Sgs1.V5.6xHIS, Mlh1/Mlh1.V5.3xVSV 
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2538 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Top3/Top3.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2539 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Top3/Top3.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2540 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Top3/Top3.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2541 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Mlh1/Mlh1.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2542 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Mlh1/Mlh1.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2543 (ura3Δ0/ura3Δ0, leu2Δ0/leu2Δ0, his3Δ1/his3Δ1, met15Δ0/met15, 
lys2Δ0/lys2), Mlh1/Mlh1.V5.6xHIS, Sgs1/Sgs1.V5.3xVSV 
2651 can1Δ::STE2pr-Sp_his5 lyp1Δ; his3Δ1 leu2Δ0 ura3Δ0 met15Δ0 
2681 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, SGS1.myc.HIS3 
2682 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, top3.v5.6xHIS/top3 
2683 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, top3.v5.6xHIS/top3 
2684 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1 
2685 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1 
2686 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad51.v5.6xHIS/rad51 
2687 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad51.v5.6xHIS/rad51 
2946 ura3Δ0, leu2Δ0, his3Δ1, met15Δ0, RAD16.V5.6xHIS 
2947 ura3Δ0, leu2Δ0, his3Δ1, met15Δ0, SRS2.V5.6xHIS 
2948 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1 
2949 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1 
2950 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, top3.v5.6xHIS/top3 
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2952 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, top3.v5.6xHIS/top3 
2953 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad51.v5.6xHIS/rad51 
2954 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad51.v5.6xHIS/rad51 
2955 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C200.myc.HIS3 
2956 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C200.myc.HIS3 
2957 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C300.myc.HIS3 
2958 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1C300.myc.HIS3 
2959 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3, 
MEC3/mec3::G418 
2960 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3, 
MEC3/mec3::G418 
2970 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1.myc.His3 
2971 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1.myc.His3 
2972 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C200.myc.HIS3 
2973 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C300.myc.HIS3 
2974 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C400.myc.HIS3 
2975 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C500.myc.HIS3 
2976 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C600.myc.HIS3 
288
Yeast Strains (continued) 	
2977 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C700.myc.HIS3 
2978 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C800.myc.HIS3 
2979 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1428.myc.HIS3 
2980 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, SGS1.myc.HIS3 
2981 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, SGS1.myc.HIS3 
2982 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, SGS1.myc.HIS3 
2983 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3 
2984 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3 
2985 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3 
2986 ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, 
lys2ΔBgl/lys2ΔBgl, hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, SGS1/sgs1.myc.HIS3 
2987 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad51.v5.6xHIS/rad51 
2988 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad51.v5.6xHIS/rad51 
2989 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1 
2990 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, mlh1.v5.6xHIS/mlh1 
2991 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, top3.v5.6xHIS/top3 
2992 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, top3.v5.6xHIS/top3 
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2993 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, srs2.v5.6xHIS/srs2 
2994 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, srs2.v5.6xHIS/srs2 
2995 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad16.v5.6xHIS/rad16 
2996 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1.myc.his3/sgs1, rad16.v5.6xHIS/rad16 
2997 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, srs2.v5.6xHIS/srs2 
2998 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, srs2.v5.6xHIS/srs2 
2999 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad16.v5.6xHIS/rad16 
3000 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C200.myc.his3/sgs1, rad16.v5.6xHIS/rad16 
3001 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, srs2.v5.6xHIS/srs2 
3002 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, srs2.v5.6xHIS/srs2 
3003 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad16.v5.6xHIS/rad16 
3004 ura3-52/ura3Δ0, leu2Δ1/leu2Δ0, trp1Δ63/trp1, his3Δ200/his3Δ1, 
lys2ΔBgl/lys2Δ0, hom3-10/hom3, ade2Δ1/ade2, ade8/ade8. 
YEL069C::URA3/YEL069C, sgs1C300.myc.his3/sgs1, rad16.v5.6xHIS/rad16 
3130 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ 
3467 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C200.myc.HIS3 
3468 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C200.myc.HIS3 
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3469 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C200.myc.HIS3 
3470 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C220.myc.HIS3 
3471 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C220.myc.HIS3 
3472 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C220.myc.HIS3 
3473 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C240.myc.HIS3 
3474 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C240.myc.HIS3 
3475 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C240.myc.HIS3 
3476 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C260.myc.HIS3 
3477 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C260.myc.HIS3 
3478 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C260.myc.HIS3 
3479 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C280.myc.HIS3 
3480 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C280.myc.HIS3 
3481 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C280.myc.HIS3 
3482 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C300.myc.HIS3 
3483 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C300.myc.HIS3 
3484 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C300.myc.HIS3 
3485 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C400.myc.HIS3 
3486 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C400.myc.HIS3 
3487 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C400.myc.HIS3 
3488 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C500.myc.HIS3 
3489 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C500.myc.HIS3 
3490 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C500.myc.HIS3 
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3491 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C600.myc.HIS3 
3492 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C600.myc.HIS3 
3493 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C600.myc.HIS3 
3494 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C700.myc.HIS3 
3495 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C700.myc.HIS3 
3496 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C700.myc.HIS3 
3497 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C800.myc.HIS3 
3498 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C800.myc.HIS3 
3499 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C800.myc.HIS3 
3500 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C900.myc.HIS3 
3501 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C900.myc.HIS3 
3502 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1000.myc.HIS3 
3503 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1000.myc.HIS3 
3504 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1100.myc.HIS3 
3505 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1100.myc.HIS3 
3506 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1100.myc.HIS3 
3507 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1428.myc.HIS3 
3508 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1428.myc.HIS3 
3509 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1428.myc.HIS3 
3510 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, Pgal.TRP1.SGS1.myc.HIS3 
3511 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, Pgal.TRP1.SGS1.myc.HIS3 
3512 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, Pgal.TRP1.SGS1.myc.HIS3 
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3513 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1047F.TRP1 
3514 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1047F.TRP1 
3515 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1047F.TRP1 
3516 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1F1056A.TRP1 
3517 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1047F.myc.HIS3 
3518 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1047F.myc.HIS3 
3519 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1C1047F.myc.HIS3 
3520 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1F1056A.myc.HIS3 
3521 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1F1056A.myc.HIS3 
3522 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1F1056A.myc.HIS3 
3543 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1ΔC800-blmΔN647.MYC.TRP1 
3544 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, sgs1ΔC800-blmΔN647.MYC.TRP1 
3545 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, Pgal.G418.BLM.MYC.TRP1 
3546 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, Pgal.G418.BLM.MYC.TRP1 
3547 ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. 
YEL069C::URA3, Pgal.G418.BLM.MYC.TRP1 
3558 MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
3559 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ 
3560 MATalpha trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-
HIS3 GAL2-ADE2 met2::GAL7-lacZ, pBDC 
3777 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::RECQL5.HIS3 
3778 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::RECQL5.HIS3 
3779 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::RECQL5.HIS3 
3827 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3 
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3828 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3 
3829 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.HIS3 
3925 Y258 pep4-3, his4-580, ura3-53, leu2-3, 112 
3926 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 
3927 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 Mgs1 
3928 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 Exo1 
3929 Y258 is MATa pep4-3, his4-580, ura3-53, leu2-3, 112 Sgs1 
3930 Empty pOAD vector in 3558 
3983 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ pOAD  (empty) vector is in this strain 
3984 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ Mec3 in pOAD 
3985 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ 
3986  trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
pOBD vector in this strain 
3987  trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 
GAL2-ADE2 met2::GAL7-lacZ 
Rad17 in pOBD 
3988 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ 
4062 his3, trp1, ura3-52, lex(leu2)3a 
4107 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 647-1447 in pBDC 
4108 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 647-1447 in pBDC 
4109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-347 in pBDC 
4110 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-347 in pBDC 
4111 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC 
4112 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC 
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4113 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC 
4114 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC 
4115 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC 
4116 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC 
4117 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC 
4118 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC 
4119 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4120 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4121 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4122 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4123 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4124 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4125 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4126 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4156 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 647-1447 in pBDC 
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4157 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 647-1447 in pBDC 
4158 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC 
4159 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC 
4160 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC 
4161 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-265 in pBDC 
4162 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC 
4163 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC 
4164 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC 
4165 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC 
4166 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4167 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4168 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4169 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4170 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4171 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4172 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4173 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4174 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC 
4175 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-187 in pBDC 
4176 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4177 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
4178 trp1-901 leu2-3,112 ura3-52 his3-200 gal4∆ gal80∆ LYS2::GAL1-HIS3 GAL2-
ADE2 met2::GAL7-lacZ SGS1 1-100 in pBDC 
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4179 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 647-1447 in pBDC 
4180 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-347 in pBDC 
4181 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC 
4182 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC 
4183 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC 
4184 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4185 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4186 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4187 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC 
4188 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 647-1447 in pBDC and empty pOAD 
4189 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 647-1447 in pBDC and empty pOAD 
4190 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-347 in pBDC and empty pOAD 
4191 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-347 in pBDC and empty pOAD 
4192 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD 
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4193 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD 
4194 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD 
4195 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-265 in pBDC and empty pOAD 
4196 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD 
4197 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD 
4198 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD 
4199 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-187 in pBDC and empty pOAD 
4200 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4201 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4202 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4203 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4204 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4205 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4206 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
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4207 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ SGS1 1-100 in pBDC and empty pOAD 
4208 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ empty pBDC and empty pOAD vectors 
4209 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ empty pBDC and empty pOAD vectors 
4210 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ empty pBDC and empty pOAD vectors 
4211 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ empty pBDC and empty pOAD vectors 
4743 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, rrm3::TRP1/RRM3 
4744 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, rrm3::TRP1/RRM3 
4745 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1 
4746 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1 
4747 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1 
4748 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, sgs1::HIS3/SGS1 
4749 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2 
4750 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2 
4751 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2 
4752 his3Δ200/his3Δ200, trp1Δ63/trp1Δ63,ura3-52/ura3-52, srs2::HIS3/SRS2 
4753 ura3-52, trp1Δ63, hisΔ200 
4754 ura3-52, trp1Δ63, hisΔ200 
4755 ura3-52, trp1Δ63, hisΔ200 
4756 ura3-52, trp1Δ63, hisΔ200 
4757 ura3-52, trp1Δ63, hisΔ200 
4758 ura3-52, trp1Δ63, hisΔ200, rrm3::TRP1 
4759 ura3-52, trp1Δ63, hisΔ200, rrm3::TRP1 
4760 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418 
4761 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418 
4762 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418 
4763 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆lys2::HIS3, ∆arg4::G418 
4764 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4765 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4766 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
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4767 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4768 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4769 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4770 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4771 his3∆200/his3∆200, trp1∆63/trp1∆63, ∆ura3-52/∆ura3-52, 
RRM3/∆rrm3::TRP1, LYS2/∆lys2::HIS3, ARG4/∆arg4::G418 
4772 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3 
4773 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3 
4774 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3 
4775 his3∆200, trp1∆63, ∆ura3-52, ∆tof1::His3 
4776 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆tof1::His3 
4777 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆tof1::His3 
4778 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆tof1::His3 
4779 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3 
4780 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3 
4781 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3 
4782 his3∆200, trp1∆63, ∆ura3-52, ∆ume1::His3 
4783 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3 
4784 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3 
4785 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3 
4786 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆ume1::His3 
4787 his3∆200, trp1∆63, ∆ura3-52, ∆dpb4::His3 
4788 his3∆200, trp1∆63, ∆ura3-52, ∆dpb4::His3 
4789 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3 
4790 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3 
4791 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3 
4792 his3∆200, trp1∆63, ∆ura3-52, ∆rrm3::TRP1, ∆dpb4::His3 
5036 ura3-52, trp1Δ63, hisΔ200 
5143 MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3 
5144 MATα ura3-52, trp1Δ63, his3Δ200, arg4::G418, lys2::HIS3, rrm3::TRP1 
5145 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rad5::HIS3 
5146 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, rad5::HIS3 
5147 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rdh54::HIS3 
5148 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3 
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5149 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rad5::HIS3 rdh54::G418 
5150 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, rdh54::HIS3, rad5::TRP1 
5151 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, set3::HIS3 
5152 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, set3::HIS3 
5153 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, tof1::HIS3 
5154 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, tof1::HIS3 
5155 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, ies4::HIS3 
5156 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, ies4::HIS3 
5157 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, had1::HIS3 
5158 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, had1::HIS3 
5159 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, mgm101::HIS3 
5160 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, rrm3::TRP1, mgm101::HIS3 
5161 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sml1::G418 
5162 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1 
5163 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8, YEL069C::URA3, sml1::G418, rrm3::TRP1, rad53::HIS3 
5164 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3,  rdh54::HIS3/rdh54::HIS3 
5165 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, rrm3::TRP1/rrm3::TRP1,  
rdh54::HIS3/rdh54::HIS3 
5166 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, rrm3::TRP1/rrm3::TRP1 
5167 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, RRM3/rrm3::TRP1,  RDH54/rdh54::HIS3 
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5168 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, RRM3/rrm3::TRP1 
5169 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, RDH54/rdh54::HIS3 
5170 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, RRM3/rrm3::TRP1,  
rdh54::HIS3/rdh54::HIS3 
5171 ura3-52/ura3-52, leu2∆1/leu2∆1, trp1∆63/trp1∆63, his3∆200/his3∆200, 
lys2∆Bgl/lys2∆Bgl, hom3-10/hom3-10, ade2∆1/ade2∆1, ade8/ade8. 
YEL069C::URA3/YEL069C::URA3, rrm3::TRP1/rrm3::TRP1,  
RDH54/rdh54::HIS3 
5172 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::RECQL5.13MYC.TRP1 
5173 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::RECQL5.13MYC.TRP1 
5174 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::RECQL5.13MYC.TRP1 
5175 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.13MYC.kanMX6 
5176 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.13MYC.kanMX6 
5177 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1::TRP1.PGAL1.RECQL5.13MYC.kanMX6 
5178 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.HIS3 
5179 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.HIS3 
5180 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.HIS3 
5181 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.13MYC.TRP1 
5182 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.13MYC.TRP1 
5183 MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, 
ade8. YEL069C::URA3, sgs1∆C800-RECQL5.13MYC.TRP1 
5184 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ RECQL5 in pBDC 
5185 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ RECQL5 in pBDC 
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5186 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ RECQL5 in pBDC  
5187 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ RECQL5 in pBDC and empty pOAD 
5188 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ RECQL5 in pBDC and empty pOAD 
5189 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, 
lys2::Gal1uas-Gal1tata-HIS3, GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-
MEL1tata-lacZ RECQL5 in pBDC and empty pOAD 	
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Strain 
(pKHS) 
Description Source 
pRS303 HIS3 (Sikorski and Hieter 1989) 
pRS304 TRP1 (Sikorski and Hieter 1989) 
pRS306 URA3 (Sikorski and Hieter 1989) 
pRS415 CEN/ARS, LEU2 (Sikorski and Hieter 1989) 
124 pKHS619-RRM3 (Schmidt, Derry et al. 2002) 
125 pKHS619-POL30 (Schmidt, Derry et al. 2002) 
126 pKHS620-RRM3 (Schmidt, Derry et al. 2002) 
127 pKHS620-POL30 (Schmidt, Derry et al. 2002) 
133 pKHS620-rrm3∆N54 This study 
135 pKHS620-rrm3∆N230 This study 
136 pRS315-rrm3∆N54 This study 
137 pRS315-rrm3∆N230 This study 
220 pFA6a-kanMX6 (Longtine, McKenzie et al. 1998) 
221 pFA6a-TRP1 (Longtine, McKenzie et al. 1998) 
222 pFA6a-His3MX6 (Longtine, McKenzie et al. 1998) 
226 pFA6a-3HA-kanMX6 (Longtine, McKenzie et al. 1998) 
227 pFA6a-3HA-TRP1 (Longtine, McKenzie et al. 1998) 
228 pFA6a-3HA-His3MX6 (Longtine, McKenzie et al. 1998) 
229 pFA6a-13Myc-kanMX6 (Longtine, McKenzie et al. 1998) 
230 pFA6a-13Myc-TRP1 (Longtine, McKenzie et al. 1998) 
231 pFA6a-13Myc-His3MX6 (Longtine, McKenzie et al. 1998) 
232 pFA6a-GST-kanMX6 (Longtine, McKenzie et al. 1998) 
233 pFA6a-GST-TRP1 (Longtine, McKenzie et al. 1998) 
234 pFA6a-GST-His3MX6 (Longtine, McKenzie et al. 1998) 
235 pFA6a-kanMX6-PGAL1 (Longtine, McKenzie et al. 1998) 
236 pFA6a-TRP1-PGAL1 (Longtine, McKenzie et al. 1998) 
237 pFA6a-His3MX6-PGAL1 (Longtine, McKenzie et al. 1998) 
257 pFA-kanMX (Goldstein and McCusker 1999) 
265 pCMV-SPORT6-RECQL5 Open Biosystems 
273 sgs1∆C795 (Mullen, Kaliraman et al. 2000) 
274 sgs1-hd (Mullen, Kaliraman et al. 2000) 
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275 sgs1∆C200 (Mullen, Kaliraman et al. 2000) 
276 SGS1 (Mullen, Kaliraman et al. 2000) 
277 sgs1∆N158 (Mullen, Kaliraman et al. 2000) 
278 sgs1∆N644 (Mullen, Kaliraman et al. 2000) 
301 sgs1-hd.TRP1 This study 
334 sgs1∆C200.TRP1 This study 
335 sgs1∆C200.TRP1 This study 
336 sgs1∆N158.TRP1 This study 
360 pKHS276-SGS1.TRP1 This study 
392 pBDC (Uetz, Giot et al. 2000) 
481 pRS415-SGS1 (Mullen, Kaliraman et al. 2000) 
487 pOAD (Uetz, Giot et al. 2000) 
503 pKHS360-sgs1-F30P This study 
504 pKHS360-sgs1-I33P This study 
505 pKHS360-sgs1-V29P This study 
506 pKHS392-sgs1-1-347 This study 
507 pKHS392-sgs1-1-265 This study 
508 pKHS392-sgs1-1-265 This study 
509 pKHS392-sgs1-1-187 This study 
510 pKHS392-sgs1-1-187 This study 
511 pKHS392-sgs1-1-100 This study 
512 pKHS392-sgs1-1-100 This study 
513 pKHS392-sgs1-1-100 This study 
514 pKHS392-sgs1-1-100 This study 
515 pKHS392-sgs1-647-1447 This study 
516 pKHS392-sgs1-647-1447 This study 
517 pKHS392-sgs1-647-1447 This study 
520 pJG-4-5*-MLH1 This study 
521 pBC6, pJH1074 This study 
522 pJM100-SGS1 (Mullen, Kaliraman et al. 2000) 
523 pJM100-SGS1 (Mullen, Kaliraman et al. 2000) 
524 pJM100-SGS1 (Mullen, Kaliraman et al. 2000) 
525 pKHS392-RECQL5 This study 
526 pKHS392-RECQL5 This study 
527 pKHS392-RECQL5 This study 
615 rad5 (C914,C917àAA) Ub ligase 
mutant 
(Blastyak, Pinter et al. 2007) 
616 Wt Rad5 (Blastyak, Pinter et al. 2007) 
617 rad5 (D681, E682 àAA) ATPase 
mutant 
(Blastyak, Pinter et al. 2007) 
619 2-Hyb. Prey pJG4-5* vector (Schmidt, Derry et al. 2002) 
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620 2-Hyb. Bait. pEG202 Vector (Schmidt, Derry et al. 2002) 
644 pR5-30-rad5-
D681A/E682A/C914A/C917A 
This study 
645 pRS315-rrm3-N∆142 This study 
646 pRS315-rrm3-∆N186 This study 
647 pRS315-rrm3-∆212 This study 
648 pRS315-rrm3-K260A This study 
649 pRS315-rrm3-K260D This study 
650 pRS315-rrm3-D102P This study 
651 pRS315-rrm3-S605A This study 
652 pRS315-rrm3-S605D This study 
653 pKHS620-rrm3-∆N186 This study 
654 pKHS620-rrm3-∆N212 This study 
655 pKHS620-rrm3-∆N230 This study 
656 pKHS619-ORC5 This study 
671 pKHS265-RECQL5.HIS3MX6 This study 
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